Identification	O
of	O
a	O
novel	O
cyclosporin-sensitive	B-DNA
element	I-DNA
in	O
the	O
human	B-DNA
tumor	I-DNA
necrosis	I-DNA
factor	I-DNA
alpha	I-DNA
gene	I-DNA
promoter	I-DNA
.	O

Tumor	B-protein
necrosis	I-protein
factor	I-protein
alpha	I-protein
(	O
TNF-alpha	B-protein
)	O
,	O
a	O
cytokine	B-protein
with	O
pleiotropic	O
biological	O
effects	O
,	O
is	O
produced	O
by	O
a	O
variety	O
of	O
cell	O
types	O
in	O
response	O
to	O
induction	O
by	O
diverse	O
stimuli	O
.	O

In	O
this	O
paper	O
,	O
TNF-alpha	B-RNA
mRNA	I-RNA
is	O
shown	O
to	O
be	O
highly	O
induced	O
in	O
a	O
murine	B-cell_line
T	I-cell_line
cell	I-cell_line
clone	I-cell_line
by	O
stimulation	O
with	O
T	B-protein
cell	I-protein
receptor	I-protein
(	O
TCR	B-protein
)	O
ligands	O
or	O
by	O
calcium	O
ionophores	O
alone	O
.	O

Induction	O
is	O
rapid	O
,	O
does	O
not	O
require	O
de	O
novo	O
protein	O
synthesis	O
,	O
and	O
is	O
completely	O
blocked	O
by	O
the	O
immunosuppressant	O
cyclosporin	O
A	O
(	O
CsA	O
)	O
.	O

We	O
have	O
identified	O
a	O
human	B-DNA
TNF-alpha	I-DNA
promoter	I-DNA
element	I-DNA
,	O
kappa	B-DNA
3	I-DNA
,	O
which	O
plays	O
a	O
key	O
role	O
in	O
the	O
calcium-mediated	O
inducibility	O
and	O
CsA	O
sensitivity	O
of	O
the	O
gene	O
.	O

In	O
electrophoretic	O
mobility	O
shift	O
assays	O
,	O
an	O
oligonucleotide	O
containing	O
kappa	B-DNA
3	I-DNA
forms	O
two	O
DNA	O
protein	O
complexes	O
with	O
proteins	O
that	O
are	O
present	O
in	O
extracts	O
from	O
unstimulated	B-cell_type
T	I-cell_type
cells	I-cell_type
.	O

These	O
complexes	O
appear	O
in	O
nuclear	O
extracts	O
only	O
after	O
T	O
cell	O
stimulation	O
.	O

Induction	O
of	O
the	O
inducible	O
nuclear	B-protein
complexes	I-protein
is	O
rapid	O
,	O
independent	O
of	O
protein	O
synthesis	O
,	O
and	O
blocked	O
by	O
CsA	O
,	O
and	O
thus	O
,	O
exactly	O
parallels	O
the	O
induction	O
of	O
TNF-alpha	B-RNA
mRNA	I-RNA
by	O
TCR	O
ligands	O
or	O
by	O
calcium	O
ionophore	O
.	O

Our	O
studies	O
indicate	O
that	O
the	O
kappa	B-protein
3	I-protein
binding	I-protein
factor	I-protein
resembles	O
the	O
preexisting	O
component	O
of	O
nuclear	B-protein
factor	I-protein
of	O
activated	B-cell_type
T	I-cell_type
cells	I-cell_type
.	O

Thus	O
,	O
the	O
TNF-alpha	B-DNA
gene	I-DNA
is	O
an	O
immediate	O
early	O
gene	O
in	O
activated	O
T	B-cell_type
cells	I-cell_type
and	O
provides	O
a	O
new	O
model	O
system	O
in	O
which	O
to	O
study	O
CsA-sensitive	B-DNA
gene	I-DNA
induction	O
in	O
activated	B-cell_type
T	I-cell_type
cells	I-cell_type
.	O

Identification	NULL
of	NULL
a	NULL
Novel	NULL
Cyclosporin-sensitive	NULL
Element	NULL
in	NULL
the	NULL
Human	NULL
Tumor	NULL
Necrosis	NULL
Factor	NULL
a	NULL
Gene	NULL
Promoter	NULL
By	NULL
Anne	NULL
E.	NULL
Goldfeld	NULL
,	NULL
*	NULL
Patricia	NULL
G.	NULL
McCaffrey	NULL
,	NULL
f	NULL
Jack	NULL
L.	NULL
Strominger	NULL
,	NULL
t	NULL
and	NULL
Anjana	NULL
Raof	NULL
From	NULL
the	NULL
Division	NULL
of	NULL
Tumor	NULL
Virology	NULL
and	NULL
Departments	NULL
of	NULL
*Medicine	NULL
and	NULL
*Pathology	NULL
,	NULL
Dana-Farber	NULL
Cancer	NULL
Institute	NULL
,	NULL
Harvard	NULL
Medical	NULL
School	NULL
,	NULL
Boston	NULL
,	NULL
Massachusetts	NULL
02114	NULL
Summary	NULL
Tumor	NULL
necrosis	NULL
factor	NULL
«	NULL
(	NULL
TNF-a	NULL
)	NULL
,	NULL
a	NULL
cytokine	NULL
with	NULL
pleiotropic	NULL
biological	NULL
effects	NULL
,	NULL
is	NULL
produced	NULL
by	NULL
a	NULL
variety	NULL
of	NULL
cell	NULL
types	NULL
in	NULL
response	NULL
to	NULL
induction	NULL
by	NULL
diverse	NULL
stimuli	NULL
.	NULL

In	NULL
this	NULL
paper	NULL
,	NULL
TNF-a	NULL
mRNA	NULL
is	NULL
shown	NULL
to	NULL
be	NULL
highly	NULL
induced	NULL
in	NULL
a	NULL
murine	NULL
T	NULL
cell	NULL
clone	NULL
by	NULL
stimulation	NULL
with	NULL
T	NULL
cell	NULL
receptor	NULL
{	NULL
(	NULL
TCR	NULL
)	NULL
ligands	NULL
or	NULL
by	NULL
calcium	NULL
ionophores	NULL
alone	NULL
.	NULL

Induction	NULL
is	NULL
rapid	NULL
,	NULL
does	NULL
not	NULL
require	NULL
de	NULL
novo	NULL
protein	NULL
synthesis	NULL
,	NULL
and	NULL
is	NULL
completely	NULL
blocked	NULL
by	NULL
the	NULL
immunosuppressant	NULL
cyclosporin	NULL
A	NULL
(	NULL
CsA	NULL
)	NULL
.	NULL

We	NULL
have	NULL
identified	NULL
a	NULL
human	NULL
TNF-	NULL
promoter	NULL
element	NULL
,	NULL
«	NULL
3	NULL
,	NULL
which	NULL
plays	NULL
a	NULL
key	NULL
role	NULL
in	NULL
the	NULL
calcium-mediated	NULL
inducibility	NULL
and	NULL
CsA	NULL
sensitivity	NULL
of	NULL
the	NULL
gene	NULL
.	NULL

In	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assays	NULL
,	NULL
an	NULL
oligonucleotide	NULL
containing	NULL
«	NULL
3	NULL
forms	NULL
two	NULL
DNA	NULL
protein	NULL
complexes	NULL
with	NULL
proteins	NULL
that	NULL
are	NULL
present	NULL
in	NULL
extracts	NULL
from	NULL
unstimulated	NULL
T	NULL
cells	NULL
.	NULL

These	NULL
complexes	NULL
appear	NULL
in	NULL
nuclear	NULL
extracts	NULL
only	NULL
after	NULL
T	NULL
cell	NULL
stimulation	NULL
.	NULL

Induction	NULL
of	NULL
the	NULL
inducible	NULL
nuclear	NULL
complexes	NULL
is	NULL
rapid	NULL
,	NULL
independent	NULL
of	NULL
protein	NULL
synthesis	NULL
,	NULL
and	NULL
blocked	NULL
by	NULL
CsA	NULL
,	NULL
and	NULL
thus	NULL
,	NULL
exactly	NULL
parallels	NULL
the	NULL
induction	NULL
of	NULL
TNF-a	NULL
mRNA	NULL
by	NULL
TCR	NULL
ligands	NULL
or	NULL
by	NULL
calcium	NULL
ionophore	NULL
.	NULL

Our	NULL
studies	NULL
indicate	NULL
that	NULL
the	NULL
x3	NULL
binding	NULL
factor	NULL
resembles	NULL
the	NULL
preexisting	NULL
component	NULL
of	NULL
nuclear	NULL
factor	NULL
of	NULL
activated	NULL
T	NULL
cells	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
TNF-	NULL
gene	NULL
is	NULL
an	NULL
immediate	NULL
early	NULL
gene	NULL
in	NULL
activated	NULL
T	NULL
cells	NULL
and	NULL
provides	NULL
a	NULL
new	NULL
model	NULL
system	NULL
in	NULL
which	NULL
to	NULL
study	NULL
CsA-sensitive	NULL
gene	NULL
induction	NULL
in	NULL
activated	NULL
T	NULL
cells	NULL
.	NULL

he	NULL
human	NULL
TNF-a	NULL
gene	NULL
encodes	NULL
a	NULL
cytotoxic	NULL
protein	NULL
with	NULL
diverse	NULL
biological	NULL
activities	NULL
including	NULL
the	NULL
ability	NULL
to	NULL
promote	NULL
T	NULL
and	NULL
B	NULL
cell	NULL
growth	NULL
(	NULL
1-8	NULL
and	NULL
for	NULL
reviews	NULL
see	NULL
references	NULL
9-11	NULL
)	NULL
.	NULL

TNF-a	NULL
is	NULL
produced	NULL
by	NULL
multiple	NULL
cell	NULL
types	NULL
including	NULL
lymphocytes	NULL
after	NULL
viral	NULL
infection	NULL
or	NULL
stimulation	NULL
through	NULL
cell-surface	NULL
receptors	NULL
(	NULL
12-19	NULL
)	NULL
.	NULL

In	NULL
primary	NULL
T	NULL
cells	NULL
for	NULL
example	NULL
,	NULL
TNF-a	NULL
mRNA	NULL
is	NULL
induced	NULL
upon	NULL
stimulation	NULL
with	NULL
the	NULL
phorbol	NULL
ester	NULL
(	NULL
PMA	NULL
)	NULL
plus	NULL
activating	NULL
antibodies	NULL
to	NULL
CD3	NULL
polypeptides	NULL
(	NULL
12	NULL
)	NULL
,	NULL
which	NULL
are	NULL
closely	NULL
associated	NULL
with	NULL
the	NULL
TCR	NULL
.	NULL

TNF-	NULL
@	NULL
«	NULL
mRNA	NULL
is	NULL
also	NULL
induced	NULL
in	NULL
T	NULL
cells	NULL
by	NULL
stimulation	NULL
with	NULL
PMA	NULL
alone	NULL
(	NULL
12	NULL
,	NULL
18	NULL
)	NULL
,	NULL
and	NULL
by	NULL
PMA	NULL
plus	NULL
calcium	NULL
ionophore	NULL
(	NULL
12	NULL
,	NULL
15	NULL
)	NULL
,	NULL
which	NULL
mimics	NULL
stimulation	NULL
through	NULL
the	NULL
TCR-CD3	NULL
complex	NULL
(	NULL
for	NULL
reviews	NULL
see	NULL
references	NULL
20	NULL
and	NULL
21	NULL
)	NULL
.	NULL

The	NULL
promoter	NULL
sequences	NULL
required	NULL
for	NULL
virus	NULL
,	NULL
LPS	NULL
(	NULL
16	NULL
)	NULL
,	NULL
PMA	NULL
(	NULL
18	NULL
,	NULL
22-25	NULL
)	NULL
,	NULL
and	NULL
TNF-a	NULL
induction	NULL
(	NULL
26	NULL
)	NULL
of	NULL
the	NULL
human	NULL
TNF-gene	NULL
have	NULL
been	NULL
identified	NULL
.	NULL

These	NULL
studies	NULL
have	NULL
yielded	NULL
a	NULL
complex	NULL
picture	NULL
of	NULL
TNF-a	NULL
gene	NULL
regulation	NULL
in	NULL
that	NULL
the	NULL
promoter	NULL
sequences	NULL
required	NULL
for	NULL
inducibility	NULL
have	NULL
varied	NULL
with	NULL
the	NULL
cell	NULL
type	NULL
and	NULL
stimulus	NULL
studied	NULL
.	NULL

Although	NULL
the	NULL
5	NULL
'	NULL
flanking	NULL
region	NULL
of	NULL
the	NULL
human	NULL
TNF-a	NULL
gene	NULL
contains	NULL
three	NULL
sequences	NULL
,	NULL
K1	NULL
,	NULL
K2	NULL
,	NULL
and	NULL
«	NULL
3	NULL
,	NULL
that	NULL
match	NULL
the	NULL
consensus	NULL
sequence	NULL
for	NULL
a	NULL
binding	NULL
site	NULL
for	NULL
the	NULL
transcription	NULL
factor	NULL
NF-KB	NULL
,	NULL
the	NULL
induction	NULL
of	NULL
the	NULL
human	NULL
TNF-a	NULL
gene	NULL
by	NULL
virus	NULL
,	NULL
LPS	NULL
,	NULL
or	NULL
PMA	NULL
in	NULL
the	NULL
cell	NULL
lines	NULL
studied	NULL
does	NULL
not	NULL
appear	NULL
to	NULL
be	NULL
primarily	NULL
mediated	NULL
by	NULL
NF-	NULL
«	NULL
b	NULL
(	NULL
16	NULL
,	NULL
18	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
in	NULL
contrast	NULL
to	NULL
the	NULL
NF-	NULL
«	NULL
B-mediated	NULL
inducible	NULL
transcription	NULL
of	NULL
other	NULL
promoters	NULL
containing	NULL
NF-KB	NULL
binding	NULL
sites	NULL
(	NULL
for	NULL
a	NULL
review	NULL
see	NULL
reference	NULL
27	NULL
)	NULL
,	NULL
and	NULL
in	NULL
contrast	NULL
to	NULL
studies	NULL
with	NULL
the	NULL
murine	NULL
TNF-a	NULL
gene	NULL
in	NULL
which	NULL
NF-KB	NULL
binding	NULL
sites	NULL
have	NULL
been	NULL
implicated	NULL
in	NULL
LPS	NULL
induction	NULL
in	NULL
macrophages	NULL
(	NULL
28	NULL
,	NULL
29	NULL
)	NULL
,	NULL
studies	NULL
of	NULL
the	NULL
human	NULL
TNF-a	NULL
gene	NULL
promoter	NULL
argue	NULL
against	NULL
a	NULL
major	NULL
role	NULL
for	NULL
NF-KB	NULL
in	NULL
the	NULL
virus	NULL
,	NULL
LPS	NULL
,	NULL
or	NULL
PMA	NULL
induction	NULL
of	NULL
the	NULL
gene	NULL
(	NULL
16	NULL
,	NULL
18	NULL
)	NULL
.	NULL

The	NULL
immunosuppressive	NULL
agents	NULL
cyclosporin	NULL
A	NULL
(	NULL
CsA	NULL
)	NULL
!	NULL

and	NULL
FK	NULL
506	NULL
,	NULL
inhibit	NULL
the	NULL
transcription	NULL
of	NULL
many	NULL
cytokine	NULL
genes	NULL
in	NULL
activated	NULL
T	NULL
cells	NULL
(	NULL
15	NULL
,	NULL
30-32	NULL
)	NULL
.	NULL

CsA	NULL
and	NULL
FK506	NULL
,	NULL
when	NULL
com-plexed	NULL
to	NULL
their	NULL
intracellular	NULL
receptors	NULL
(	NULL
cyclophilin	NULL
and	NULL
FKBP	NULL
,	NULL
respectively	NULL
)	NULL
,	NULL
bind	NULL
to	NULL
and	NULL
inhibit	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
calcium-and	NULL
calmodulin-dependent	NULL
phosphatase	NULL
calcineurin	NULL
(	NULL
33	NULL
;	NULL
for	NULL
reviews	NULL
see	NULL
references	NULL
34	NULL
and	NULL
35	NULL
)	NULL
.	NULL

Recent	NULL
studies	NULL
(	NULL
36-39	NULL
)	NULL
have	NULL
suggested	NULL
that	NULL
calcineurin	NULL
regulates	NULL
the	NULL
activity	NULL
of	NULL
at	NULL
least	NULL
two	NULL
elements	NULL
in	NULL
the	NULL
II-2	NULL
gene	NULL
promoter	NULL
,	NULL
nuclear	NULL
factor	NULL
of	NULL
activated	NULL
T	NULL
cells	NULL
(	NULL
NFAT	NULL
)	NULL
and	NULL
NFILZA	NULL
.	NULL

The	NULL
nuclear	NULL
factors	NULL
binding	NULL
to	NULL
these	NULL
two	NULL
elements	NULL
appear	NULL
to	NULL
be	NULL
distinct	NULL
:	NULL
the	NULL
NFAT	NULL
\	NULL
Abbreviations	NULL
used	NULL
in	NULL
this	NULL
paper	NULL
:	NULL
CAT	NULL
,	NULL
chloramphenicol	NULL
acetyl	NULL
transferase	NULL
;	NULL
CsA	NULL
,	NULL
cyclosporin	NULL
A	NULL
;	NULL
n	NULL
,	NULL
nucleotide	NULL
;	NULL
NFAT	NULL
,	NULL
nuclear	NULL
factor	NULL
of	NULL
activated	NULL
T	NULL
cells	NULL
;	NULL
OAP-40	NULL
,	NULL
octamer-associated	NULL
protein	NULL
.	NULL

1365	NULL
_	NULL
J.	NULL
Exp	NULL
,	NULL
Med	NULL
.	NULL

©	NULL
The	NULL
Rockefeller	NULL
University	NULL
Press	NULL
+	NULL
0022-1007/93/10/1365/15	NULL
$	NULL
2.00	NULL
Volume	NULL
178	NULL
October	NULL
1993	NULL
1365-1379	NULL
site	NULL
binds	NULL
to	NULL
a	NULL
Iymphoid-specific	NULL
factor	NULL
,	NULL
NFAT	NULL
(	NULL
40	NULL
)	NULL
,	NULL
which	NULL
consists	NULL
of	NULL
a	NULL
preexisting	NULL
DNA-binding	NULL
subunit	NULL
(	NULL
NFATp	NULL
)	NULL
in	NULL
association	NULL
with	NULL
fos	NULL
and	NULL
jun	NULL
proteins	NULL
(	NULL
41-43	NULL
)	NULL
,	NULL
whereas	NULL
the	NULL
NFILZA	NULL
site	NULL
binds	NULL
oct-1	NULL
and	NULL
oct-2	NULL
proteins	NULL
in	NULL
association	NULL
with	NULL
an	NULL
inducible	NULL
octamer-associated	NULL
protein	NULL
,	NULL
OAP-40	NULL
(	NULL
44	NULL
)	NULL
.	NULL

Calcineurin	NULL
may	NULL
directly	NULL
dephosphorylate	NULL
NFATp	NULL
(	NULL
45	NULL
)	NULL
,	NULL
however	NULL
its	NULL
effect	NULL
on	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
Oct-OAP	NULL
complex	NULL
may	NULL
be	NULL
more	NULL
involved	NULL
.	NULL

Using	NULL
an	NULL
untransformed	NULL
murine	NULL
T	NULL
cell	NULL
clone	NULL
that	NULL
responds	NULL
to	NULL
stimulation	NULL
with	NULL
antigen	NULL
and	NULL
TCR	NULL
ligands	NULL
(	NULL
46	NULL
,	NULL
47	NULL
)	NULL
,	NULL
the	NULL
TNF-	NULL
@	NULL
gene	NULL
is	NULL
shown	NULL
to	NULL
be	NULL
one	NULL
of	NULL
the	NULL
earliest	NULL
genes	NULL
transcribed	NULL
after	NULL
T	NULL
cell	NULL
activation	NULL
.	NULL

Induction	NULL
of	NULL
TNF-a	NULL
mRNA	NULL
does	NULL
not	NULL
require	NULL
de	NULL
novo	NULL
protein	NULL
synthesis	NULL
but	NULL
is	NULL
sensitive	NULL
to	NULL
CsA	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
TNF-a	NULL
gene	NULL
represents	NULL
a	NULL
new	NULL
model	NULL
system	NULL
in	NULL
which	NULL
to	NULL
study	NULL
CsA-sensitive	NULL
gene	NULL
induction	NULL
.	NULL

We	NULL
have	NULL
identified	NULL
a	NULL
TNF-a	NULL
promoter	NULL
element	NULL
,	NULL
K3	NULL
,	NULL
as	NULL
a	NULL
CsA-sensitive	NULL
regulatory	NULL
element	NULL
required	NULL
for	NULL
TNF-	NULL
gene	NULL
transcription	NULL
in	NULL
activated	NULL
T	NULL
cells	NULL
.	NULL

The	NULL
requirements	NULL
for	NULL
induction	NULL
of	NULL
the	NULL
K3	NULL
binding	NULL
factor	NULL
parallel	NULL
closely	NULL
the	NULL
requirements	NULL
for	NULL
induction	NULL
of	NULL
endogenous	NULL
murine	NULL
TNF-a	NULL
mRNA	NULL
levels	NULL
:	NULL
both	NULL
TNF-a	NULL
mRNA	NULL
and	NULL
the	NULL
«	NULL
3	NULL
binding	NULL
factor	NULL
are	NULL
rapidly	NULL
induced	NULL
by	NULL
TCR	NULL
ligands	NULL
or	NULL
by	NULL
calcium	NULL
ionophore	NULL
alone	NULL
.	NULL

Their	NULL
induction	NULL
does	NULL
not	NULL
require	NULL
de	NULL
novo	NULL
protein	NULL
synthesis	NULL
and	NULL
is	NULL
blocked	NULL
by	NULL
CsA	NULL
.	NULL

Our	NULL
studies	NULL
indicate	NULL
that	NULL
the	NULL
nuclear	NULL
x3	NULL
binding	NULL
factor	NULL
is	NULL
present	NULL
in	NULL
unstimulated	NULL
T	NULL
cells	NULL
and	NULL
that	NULL
it	NULL
resembles	NULL
the	NULL
preexisting	NULL
component	NULL
of	NULL
NFAT	NULL
.	NULL

Activation	NULL
of	NULL
the	NULL
«	NULL
3	NULL
binding	NULL
factor	NULL
appears	NULL
to	NULL
require	NULL
posttranslational	NULL
modification	NULL
and/or	NULL
translocation	NULL
to	NULL
the	NULL
nucleus	NULL
via	NULL
a	NULL
calcium-dependent	NULL
,	NULL
CsA-sensitive	NULL
pathway	NULL
.	NULL

Materials	NULL
and	NULL
Methods	NULL
Cell	NULL
Culture	NULL
,	NULL
Activation	NULL
,	NULL
and	NULL
Transfections	NULL
.	NULL

|	NULL
The	NULL
murine	NULL
IL-2-de-pendent	NULL
T	NULL
cell	NULL
clone	NULL
Ar-5	NULL
(	NULL
48	NULL
)	NULL
was	NULL
grown	NULL
and	NULL
activated	NULL
with	NULL
mAbs	NULL
to	NULL
murine	NULL
CD3¢	NULL
(	NULL
145-2C11	NULL
;	NULL
eCD3	NULL
)	NULL
or	NULL
to	NULL
a	NULL
framework	NULL
determinant	NULL
of	NULL
the	NULL
murine	NULL
TCR-	NULL
«	NULL
/8	NULL
(	NULL
H57-597	NULL
;	NULL
TCR-	NULL
)	NULL
for	NULL
the	NULL
times	NULL
indicated	NULL
in	NULL
the	NULL
figure	NULL
legends	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
49	NULL
)	NULL
.	NULL

Ionomycin	NULL
(	NULL
Calbiochem-Novabiochem	NULL
Corp.	NULL
,	NULL
La	NULL
Jolla	NULL
,	NULL
CA	NULL
)	NULL
inductions	NULL
were	NULL
carried	NULL
out	NULL
at	NULL
100	NULL
nM	NULL
or	NULL
1	NULL
4M	NULL
as	NULL
indicated	NULL
in	NULL
the	NULL
figures	NULL
for	NULL
30	NULL
min	NULL
.	NULL

Where	NULL
indicated	NULL
,	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
10	NULL
uM	NULL
cycloheximide	NULL
and	NULL
40	NULL
uM	NULL
anisomycin	NULL
(	NULL
both	NULL
from	NULL
Sigma	NULL
Chemical	NULL
Co.	NULL
,	NULL
St.	NULL
Louis	NULL
,	NULL
MO	NULL
)	NULL
for	NULL
30	NULL
min	NULL
or	NULL
with	NULL
1	NULL
uM	NULL
CsA	NULL
(	NULL
Sandoz	NULL
,	NULL
Vienna	NULL
,	NULL
Aus-tria	NULL
)	NULL
before	NULL
the	NULL
addition	NULL
of	NULL
antibodies	NULL
or	NULL
ionomycin	NULL
.	NULL

The	NULL
ability	NULL
of	NULL
cycloheximide	NULL
and	NULL
anisomycin	NULL
to	NULL
block	NULL
protein	NULL
synthesis	NULL
under	NULL
these	NULL
conditions	NULL
was	NULL
verified	NULL
by	NULL
testing	NULL
the	NULL
effect	NULL
of	NULL
these	NULL
reagents	NULL
on	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
EBV	NULL
lytic	NULL
switch	NULL
gene	NULL
,	NULL
BZLF1	NULL
,	NULL
whose	NULL
transcription	NULL
is	NULL
dependent	NULL
on	NULL
de	NULL
novo	NULL
protein	NULL
synthesis	NULL
(	NULL
50	NULL
)	NULL
.	NULL

Trans-fections	NULL
were	NULL
performed	NULL
as	NULL
described	NULL
(	NULL
47	NULL
)	NULL
and	NULL
cells	NULL
were	NULL
activated	NULL
the	NULL
next	NULL
day	NULL
with	NULL
@	NULL
CD3	NULL
or	NULL
ionomycin	NULL
and	NULL
harvested	NULL
~148	NULL
h	NULL
later	NULL
.	NULL

Chloramphenicol	NULL
acetyl	NULL
transferase	NULL
(	NULL
CAT	NULL
)	NULL
assays	NULL
were	NULL
performed	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
18	NULL
)	NULL
.	NULL

RNA	NULL
Analysis	NULL
RNA	NULL
was	NULL
prepared	NULL
from	NULL
Ar-5	NULL
cells	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
51	NULL
)	NULL
.	NULL

P-labeled	NULL
RNA	NULL
probes	NULL
were	NULL
prepared	NULL
from	NULL
SP6	NULL
y-actin	NULL
(	NULL
52	NULL
)	NULL
and	NULL
a	NULL
murine	NULL
TNF-a	NULL
probe	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
16	NULL
,	NULL
51	NULL
)	NULL
.	NULL

RNA	NULL
fragments	NULL
protected	NULL
from	NULL
RNase	NULL
cleavage	NULL
were	NULL
separated	NULL
by	NULL
electrophoresis	NULL
on	NULL
a	NULL
6	NULL
%	NULL
denaturing	NULL
polyacrylamide	NULL
gel	NULL
.	NULL

Preparation	NULL
of	NULL
Cellular	NULL
Extracts	NULL
and	NULL
EMSAs	NULL
.	NULL

-	NULL
Nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
49	NULL
)	NULL
.	NULL

To	NULL
prepare	NULL
cytosolic	NULL
extracts	NULL
,	NULL
unstimulated	NULL
Ar-5	NULL
cells	NULL
were	NULL
harvested	NULL
by	NULL
centrifugation	NULL
,	NULL
washed	NULL
with	NULL
PBS	NULL
and	NULL
resuspended	NULL
and	NULL
lysed	NULL
at	NULL
a	NULL
concentration	NULL
of	NULL
2.5	NULL
x	NULL
1366	NULL
10	NULL
``	NULL
cells/ml	NULL
in	NULL
a	NULL
buffer	NULL
containing	NULL
50	NULL
mM	NULL
NaCI	NULL
,	NULL
20	NULL
mM	NULL
Tris	NULL
,	NULL
pH	NULL
7.5	NULL
,	NULL
10	NULL
mM	NULL
iodoacetamide	NULL
,	NULL
2	NULL
mM	NULL
PMSF	NULL
,	NULL
0.1	NULL
mM	NULL
EDTA	NULL
,	NULL
25	NULL
uM	NULL
leupeptin	NULL
,	NULL
100	NULL
ug	NULL
aprotinin	NULL
,	NULL
and	NULL
0.05	NULL
%	NULL
NP-40	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
first	NULL
centrifuged	NULL
at	NULL
200	NULL
g	NULL
to	NULL
remove	NULL
nuclei	NULL
,	NULL
and	NULL
then	NULL
centrifuged	NULL
further	NULL
at	NULL
100,000	NULL
g	NULL
for	NULL
60	NULL
min	NULL
,	NULL
The	NULL
100,000	NULL
g	NULL
supernatant	NULL
was	NULL
then	NULL
adjusted	NULL
to	NULL
a	NULL
concentration	NULL
of	NULL
1.5	NULL
M	NULL
ammonium	NULL
sulfate	NULL
,	NULL
and	NULL
the	NULL
precipitated	NULL
proteins	NULL
were	NULL
collected	NULL
by	NULL
centrifugation	NULL
at	NULL
10,000	NULL
g.	NULL
The	NULL
protein	NULL
pellets	NULL
were	NULL
resuspended	NULL
in	NULL
a	NULL
buffer	NULL
containing	NULL
100	NULL
mM	NULL
NaCl	NULL
,	NULL
20	NULL
mM	NULL
Hepes	NULL
,	NULL
pH	NULL
7.4	NULL
,	NULL
10	NULL
mM	NULL
iodoacetamide	NULL
,	NULL
2	NULL
mM	NULL
EDTA	NULL
,	NULL
2	NULL
mM	NULL
PMSF	NULL
,	NULL
25	NULL
gM	NULL
leupeptin	NULL
,	NULL
100	NULL
ug/ml	NULL
aprotinin	NULL
,	NULL
and	NULL
10	NULL
%	NULL
glycerol	NULL
,	NULL
and	NULL
were	NULL
extensively	NULL
dialyzed	NULL
against	NULL
the	NULL
same	NULL
buffer	NULL
without	NULL
iodoacetamide	NULL
and	NULL
with	NULL
0.5	NULL
mM	NULL
DTT	NULL
.	NULL

EMSAs	NULL
using	NULL
nuclear	NULL
proteins	NULL
were	NULL
performed	NULL
using	NULL
V5	NULL
ug	NULL
nuclear	NULL
protein	NULL
in	NULL
a	NULL
total	NULL
volume	NULL
of	NULL
15	NULL
pl	NULL
containing	NULL
4	NULL
mM	NULL
Hepes	NULL
,	NULL
pH	NULL
7.4	NULL
,	NULL
90	NULL
mM	NULL
NaCl	NULL
,	NULL
20	NULL
mM	NULL
KCl	NULL
,	NULL
0.08	NULL
mM	NULL
EDTA	NULL
,	NULL
9	NULL
%	NULL
glycerol	NULL
,	NULL
133	NULL
ug/ml	NULL
poly	NULL
(	NULL
dl	NULL
:	NULL
dC	NULL
)	NULL
,	NULL
and	NULL
0.125	NULL
ng	NULL
P-labeled	NULL
oligonucleotide	NULL
.	NULL

For	NULL
competition	NULL
assays	NULL
,	NULL
a	NULL
200-fold	NULL
excess	NULL
of	NULL
unlabeled	NULL
oligonucleotide	NULL
was	NULL
added	NULL
to	NULL
the	NULL
reaction	NULL
.	NULL

Binding	NULL
reactions	NULL
were	NULL
incubated	NULL
on	NULL
ice	NULL
for	NULL
15	NULL
min	NULL
.	NULL

Unbound	NULL
oligonucleotide	NULL
and	NULL
protein-oligonu-cleotide	NULL
complexes	NULL
were	NULL
separated	NULL
by	NULL
electrophoresis	NULL
at	NULL
4°C	NULL
on	NULL
Tris/borate/EDTA/4	NULL
%	NULL
acrylamide	NULL
gels	NULL
as	NULL
described	NULL
earlier	NULL
(	NULL
49	NULL
)	NULL
.	NULL

Cytosolic	NULL
extracts	NULL
(	NULL
0.5~1	NULL
pug	NULL
protein	NULL
)	NULL
were	NULL
assayed	NULL
for	NULL
DNA	NULL
binding	NULL
in	NULL
a	NULL
reaction	NULL
mix	NULL
containing	NULL
4	NULL
mM	NULL
Hepes	NULL
,	NULL
pH	NULL
7.4	NULL
,	NULL
100	NULL
mM	NULL
NaCl	NULL
,	NULL
9	NULL
%	NULL
glycerol	NULL
,	NULL
0.7	NULL
mg/ml	NULL
BSA	NULL
,	NULL
17	NULL
ug/ml	NULL
poly	NULL
(	NULL
dl	NULL
:	NULL
dC	NULL
)	NULL
,	NULL
and	NULL
0.125	NULL
ng	NULL
P-endlabeled	NULL
oligonucleotide	NULL
,	NULL
followed	NULL
by	NULL
electrophoresis	NULL
under	NULL
the	NULL
same	NULL
conditions	NULL
described	NULL
for	NULL
nuclear	NULL
extracts	NULL
.	NULL

Methylation	NULL
interference	NULL
assays	NULL
were	NULL
performed	NULL
as	NULL
described	NULL
(	NULL
49	NULL
)	NULL
.	NULL

The	NULL
sequences	NULL
of	NULL
the	NULL
synthetic	NULL
oligonucleotides	NULL
used	NULL
in	NULL
the	NULL
gel	NULL
shift	NULL
and	NULL
methylation	NULL
interference	NULL
assays	NULL
were	NULL
as	NULL
follows	NULL
:	NULL
x3	NULL
,	NULL
(	NULL
5'-GATCCGAGCTCATGGGTTTCTCCACA-3	NULL
'	NULL
)	NULL
;	NULL
«	NULL
1	NULL
,	NULL
(	NULL
5-GATCCT	NULL
GGGACAGCCCA-3	NULL
'	NULL
)	NULL
;	NULL
£2	NULL
,	NULL
(	NULL
5-GATCCGGGGTATCCA-3	NULL
'	NULL
)	NULL
;	NULL
NF-	NULL
«	NULL
B	NULL
(	NULL
WT	NULL
)	NULL
,	NULL
(	NULL
5-CAGAGGGCGACTTTCCGAGA3	NULL
'	NULL
)	NULL
;	NULL
NF-KB	NULL
(	NULL
M5	NULL
)	NULL
,	NULL
(	NULL
5-CAGAATTCACTTTCCGAGA-3	NULL
'	NULL
)	NULL
;	NULL
NF-	NULL
«	NULL
B	NULL
(	NULL
M3	NULL
'	NULL
)	NULL
,	NULL
(	NULL
5'-CAG-AGGGGACTTGAAGAGA-3	NULL
'	NULL
)	NULL
;	NULL
NFAT	NULL
,	NULL
(	NULL
5-CTGTATCAAACA-AATTTTCCTCTTTGGGC-3	NULL
'	NULL
)	NULL
;	NULL
-62	NULL
to	NULL
-27	NULL
nucleotides	NULL
(	NULL
n	NULL
)	NULL
:	NULL
(	NULL
5-GATCCGATTCTTTITCCCCGCCCTCCTCTCGCCCCAGA-GAC-3	NULL
'	NULL
)	NULL
;	NULL
Sp1	NULL
M	NULL
,	NULL
(	NULL
5-AATGATTCTTTCCGAAGCCTCCTCTCG-CCC-3	NULL
'	NULL
)	NULL
;	NULL
and	NULL
AP1	NULL
,	NULL
(	NULL
5-TCGAAAGCATGAGTCAGACA-3	NULL
'	NULL
)	NULL
.	NULL

Plasmids	NULL
.	NULL

-	NULL
The	NULL
TNF-o	NULL
promoter/CAT	NULL
gene	NULL
constructs	NULL
and	NULL
the	NULL
-61	NULL
TNF-a	NULL
CAT	NULL
and	NULL
(	NULL
«	NULL
3	NULL
)	NULL
5-61	NULL
TNF-	NULL
CAT	NULL
constructs	NULL
have	NULL
been	NULL
previously	NULL
described	NULL
(	NULL
16	NULL
)	NULL
.	NULL

The	NULL
«	NULL
3	NULL
mutant	NULL
constructs	NULL
were	NULL
constructed	NULL
by	NULL
subcloning	NULL
a	NULL
TNF-	NULL
«	NULL
promoter	NULL
fragment	NULL
into	NULL
M13mp18	NULL
and	NULL
performing	NULL
in	NULL
vitro	NULL
mutagenesis	NULL
with	NULL
a	NULL
Mutagene	NULL
M13	NULL
in	NULL
vitro	NULL
Mutagenesis	NULL
Kit	NULL
(	NULL
Biorad	NULL
Laboratories	NULL
,	NULL
Richmond	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Mutants	NULL
were	NULL
confirmed	NULL
by	NULL
dideoxy	NULL
sequencing	NULL
.	NULL

Promoter	NULL
sequences	NULL
from	NULL
-199	NULL
to	NULL
+87	NULL
nucleotides	NULL
relative	NULL
to	NULL
the	NULL
TNF-a	NULL
transcription	NULL
start	NULL
site	NULL
were	NULL
amplified	NULL
by	NULL
PCR	NULL
and	NULL
were	NULL
subcloned	NULL
into	NULL
the	NULL
POCAT	NULL
vector	NULL
(	NULL
53	NULL
)	NULL
and	NULL
reconfirmed	NULL
by	NULL
sequencing	NULL
.	NULL

The	NULL
wild-type	NULL
~199	NULL
to	NULL
+87	NULL
TNF-a	NULL
sequences	NULL
were	NULL
also	NULL
subcloned	NULL
in	NULL
this	NULL
manner	NULL
,	NULL
insuring	NULL
that	NULL
all	NULL
of	NULL
the	NULL
constructs	NULL
were	NULL
isogenic	NULL
.	NULL

Results	NULL
Regulation	NULL
of	NULL
the	NULL
Endogenous	NULL
Murine	NULL
TNF	NULL
Gene	NULL
in	NULL
the	NULL
Murine	NULL
T	NULL
Cell	NULL
Clone	NULL
,	NULL
Ar-5	NULL
TCR	NULL
Stimuli	NULL
.	NULL

|	NULL
'To	NULL
characterize	NULL
the	NULL
transcriptional	NULL
induction	NULL
of	NULL
the	NULL
TNF-	NULL
gene	NULL
in	NULL
activated	NULL
T	NULL
cells	NULL
,	NULL
the	NULL
untransformed	NULL
murine	NULL
T	NULL
cell	NULL
clone	NULL
,	NULL
Ar-5	NULL
,	NULL
was	NULL
stimulated	NULL
with	NULL
antibodies	NULL
directed	NULL
towards	NULL
the	NULL
CD3	NULL
complex	NULL
(	NULL
CD3	NULL
)	NULL
or	NULL
the	NULL
TCR-a	NULL
«	NULL
/B	NULL
(	NULL
TCR-	NULL
)	NULL
.	NULL

TNF-	NULL
mRNA	NULL
levels	NULL
were	NULL
increased	NULL
strikingly	NULL
within	NULL
30	NULL
min	NULL
of	NULL
stimulation	NULL
by	NULL
either	NULL
eCD3	NULL
or	NULL
Novel	NULL
CsA-sensitive	NULL
Element	NULL
in	NULL
Human	NULL
TNF-	NULL
Gene	NULL
Promoter	NULL
rm	NULL
--	NULL
--	NULL
0.5	NULL
hr	NULL
aCD03	NULL
aTCR	NULL
|	NULL
|	NULL
CHX/ANI	NULL
CHX/ANI	NULL
CHX/ANI	NULL
<	NULL
T	NULL
<	NULL
L	NULL
u	NULL
u	NULL
©	NULL
C	NULL
|	NULL
CsA	NULL
|	NULL
CsA	NULL
f	NULL
CHX/ANT	NULL
TNF	NULL
-a	NULL
«	NULL
a	NULL
»	NULL
{	NULL
1	NULL
y-octhn	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
by	NULL
TCR-ax	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
,	NULL
lanes	NULL
4	NULL
and	NULL
7	NULL
)	NULL
.	NULL

This	NULL
burst-in	NULL
mRNA	NULL
expression	NULL
after	NULL
eCD3	NULL
or	NULL
TCR-a	NULL
induction	NULL
was	NULL
associated	NULL
with	NULL
TNF-a	NULL
protein	NULL
production	NULL
as	NULL
determined	NULL
by	NULL
TNF-a	NULL
bioac-tivity	NULL
in	NULL
an	NULL
L	NULL
cell	NULL
killing	NULL
assay	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
indicating	NULL
that	NULL
Ar-5	NULL
cells	NULL
are	NULL
a	NULL
physiological	NULL
system	NULL
in	NULL
which	NULL
to	NULL
study	NULL
TNF-a	NULL
gene	NULL
induction	NULL
by	NULL
immunological	NULL
stimuli	NULL
.	NULL

Induction	NULL
of	NULL
TNF-a	NULL
mRNA	NULL
levels	NULL
was	NULL
blocked	NULL
by	NULL
pretreatment	NULL
of	NULL
the	NULL
cells	NULL
with	NULL
CsA	NULL
for	NULL
10	NULL
min	NULL
before	NULL
the	NULL
addition	NULL
of	NULL
stimulus	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
,	NULL
lanes	NULL
5	NULL
and	NULL
8	NULL
)	NULL
,	NULL
but	NULL
not	NULL
by	NULL
pretreatment	NULL
of	NULL
the	NULL
cells	NULL
with	NULL
the	NULL
protein	NULL
synthesis	NULL
inhibitors	NULL
cycloheximide	NULL
and	NULL
anisomycin	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
,	NULL
lanes	NULL
6	NULL
and	NULL
9	NULL
)	NULL
.	NULL

Expression	NULL
of	NULL
TNF-mRNA	NULL
at	NULL
4	NULL
h	NULL
after	NULL
activation	NULL
was	NULL
also	NULL
unaffected	NULL
by	NULL
protein	NULL
synthesis	NULL
inhibitors	NULL
but	NULL
sensitive	NULL
to	NULL
CsA	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
,	NULL
lanes	NULL
10-18	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
induction	NULL
of	NULL
TNF-a	NULL
gene	NULL
expression	NULL
by	NULL
TCR	NULL
stimuli	NULL
was	NULL
not	NULL
dependent	NULL
upon	NULL
de	NULL
novo	NULL
protein	NULL
synthesis	NULL
and	NULL
hence	NULL
can	NULL
be	NULL
differentiated	NULL
from	NULL
the	NULL
induction	NULL
of	NULL
mRNAs	NULL
encoding	NULL
other	NULL
CsA-sensitive	NULL
genes	NULL
such	NULL
as	NULL
IL-2	NULL
in	NULL
activated	NULL
T	NULL
cells	NULL
(	NULL
40	NULL
)	NULL
.	NULL

In	NULL
a	NULL
related	NULL
study	NULL
,	NULL
TNF-a	NULL
gene	NULL
expression	NULL
in	NULL
activated	NULL
B	NULL
cells	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
occur	NULL
within	NULL
30	NULL
min	NULL
of	NULL
activation	NULL
,	NULL
does	NULL
not	NULL
require	NULL
protein	NULL
synthesis	NULL
,	NULL
and	NULL
is	NULL
sensitive	NULL
to	NULL
CsA	NULL
(	NULL
19	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
TNF-	NULL
gene	NULL
behaves	NULL
as	NULL
a	NULL
CsA-sensitive	NULL
early	NULL
response	NULL
gene	NULL
during	NULL
activation	NULL
of	NULL
both	NULL
T	NULL
and	NULL
B	NULL
lymphocytes	NULL
.	NULL

Ca	NULL
``	NULL
*	NULL
Ionophore	NULL
.	NULL

-	NULL
Stimulation	NULL
of	NULL
T	NULL
cells	NULL
through	NULL
the	NULL
TCR	NULL
results	NULL
in	NULL
an	NULL
increase	NULL
in	NULL
intracellular	NULL
free	NULL
calcium	NULL
levels	NULL
and	NULL
activation	NULL
of	NULL
protein	NULL
kinase	NULL
C	NULL
,	NULL
and	NULL
can	NULL
be	NULL
mimicked	NULL
with	NULL
a	NULL
combination	NULL
of	NULL
calcium	NULL
ionophore	NULL
and	NULL
phorbol	NULL
esters	NULL
(	NULL
for	NULL
a	NULL
review	NULL
see	NULL
reference	NULL
21	NULL
)	NULL
.	NULL

CsA	NULL
is	NULL
known	NULL
to	NULL
inhibit	NULL
the	NULL
calcium-dependent	NULL
pathway	NULL
of	NULL
T	NULL
cell	NULL
activation	NULL
by	NULL
inhibiting	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
calcium-	NULL
and	NULL
calmodulin-dependent	NULL
phosphatase	NULL
calcineurin	NULL
(	NULL
33	NULL
)	NULL
.	NULL

Since	NULL
the	NULL
induction	NULL
of	NULL
TNF-	NULL
mRNA	NULL
in	NULL
activated	NULL
T	NULL
cells	NULL
was	NULL
completely	NULL
sensitive	NULL
to	NULL
CsA	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
,	NULL
it	NULL
seem	NULL
probable	NULL
that	NULL
a	NULL
calcium-dependent	NULL
pathway	NULL
was	NULL
involved	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
calcium	NULL
flux	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
protein	NULL
kinase	NULL
C	NULL
activation	NULL
was	NULL
sufficient	NULL
to	NULL
induce	NULL
TNF-mRNA	NULL
levels	NULL
,	NULL
Ar-5	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
the	NULL
calcium	NULL
ionophore	NULL
ionomycin	NULL
.	NULL

TNF-	NULL
mRNA	NULL
levels	NULL
were	NULL
highly	NULL
induced	NULL
within	NULL
30	NULL
min	NULL
after	NULL
stimulation	NULL
with	NULL
1	NULL
LM	NULL
ionomycin	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
A	NULL
,	NULL
lane	NULL
5	NULL
and	NULL
Fig	NULL
.	NULL

2	NULL
B	NULL
,	NULL
lane	NULL
2	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
this	NULL
induction	NULL
was	NULL
blocked	NULL
by	NULL
CsA	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
A	NULL
,	NULL
lane	NULL
7	NULL
and	NULL
Fig	NULL
.	NULL

1367	NULL
Goldfeld	NULL
et	NULL
al	NULL
.	NULL

4	NULL
&	NULL
hr	NULL
aCD3	NULL
|	NULL
|	NULL
CHX/ANI	NULL
<	NULL
w	NULL
&	NULL
10	NULL
11	NULL
12	NULL
13	NULL
14	NULL
15	NULL
16	NULL
17	NULL
18	NULL
aTCR	NULL
Figure	NULL
1	NULL
.	NULL

-	NULL
Anti-CD3	NULL
and	NULL
anti'TCR-	NULL
@	NULL
/	NULL
$	NULL
induction	NULL
of	NULL
TNF-a	NULL
gene	NULL
expression	NULL
in	NULL
murine	NULL
Ar5	NULL
T	NULL
cells	NULL
.	NULL

Cells	NULL
were	NULL
induced	NULL
with	NULL
anti-CD3	NULL
or	NULL
anti	NULL
TCR-	NULL
@	NULL
/8	NULL
(	NULL
@	NULL
TCR	NULL
)	NULL
for	NULL
30	NULL
min	NULL
or	NULL
4	NULL
h	NULL
as	NULL
indicated	NULL
,	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
cyclosporin	NULL
A	NULL
(	NULL
CsA	NULL
)	NULL
or	NULL
cycloheximide	NULL
(	NULL
CHX	NULL
)	NULL
and	NULL
anisomycin	NULL
(	NULL
ANT	NULL
)	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

RNase	NULL
mapping	NULL
of	NULL
TNF-	NULL
and	NULL
y-actin	NULL
mRNA	NULL
was	NULL
carried	NULL
out	NULL
with	NULL
5	NULL
ug	NULL
of	NULL
total	NULL
cellular	NULL
RNA	NULL
.	NULL

A	NULL
P-labeled	NULL
mouse	NULL
TNF-a	NULL
probe	NULL
was	NULL
used	NULL
to	NULL
map	NULL
murine	NULL
TNF-a	NULL
mRNA	NULL
levels	NULL
and	NULL
an	NULL
RNA	NULL
probe	NULL
complementary	NULL
to	NULL
the	NULL
y-actin	NULL
gene	NULL
was	NULL
used	NULL
as	NULL
an	NULL
internal	NULL
control	NULL
for	NULL
mRNA	NULL
levels	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
15	NULL
)	NULL
.	NULL

The	NULL
y-actin	NULL
probe	NULL
was	NULL
made	NULL
to	NULL
have	NULL
a	NULL
sp	NULL
act	NULL
one	NULL
fifth	NULL
of	NULL
the	NULL
mouse	NULL
TNF-a	NULL
probe	NULL
.	NULL

(	NULL
Leff	NULL
)	NULL
Positions	NULL
of	NULL
the	NULL
TNF-a	NULL
and	NULL
y-actin	NULL
protected	NULL
fragments	NULL
.	NULL

CHX/ANI	NULL
<	NULL
L	NULL
3	NULL
&	NULL
2	NULL
B	NULL
,	NULL
lane	NULL
3	NULL
)	NULL
,	NULL
and	NULL
was	NULL
unaffected	NULL
by	NULL
protein	NULL
synthesis	NULL
inhibitors	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
B	NULL
,	NULL
lane	NULL
4	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
like	NULL
CsA	NULL
,	NULL
FK506	NULL
was	NULL
able	NULL
to	NULL
block	NULL
the	NULL
transcriptional	NULL
induction	NULL
of	NULL
TNF-	NULL
mRNA	NULL
in	NULL
Ar-5	NULL
cells	NULL
stimulated	NULL
with	NULL
«	NULL
CD3	NULL
or	NULL
ionomycin	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Identification	NULL
of	NULL
Promoter	NULL
Elements	NULL
Necessary	NULL
for	NULL
Transcriptional	NULL
Induction	NULL
and	NULL
CsA	NULL
Sensitivity	NULL
TCR	NULL
Stimuli	NULL
.	NULL

-	NULL
To	NULL
identify	NULL
the	NULL
promoter	NULL
elements	NULL
required	NULL
for	NULL
the	NULL
induction	NULL
and	NULL
CsA	NULL
sensitivity	NULL
of	NULL
TNF-	NULL
gene	NULL
ex-pression	NULL
,	NULL
a	NULL
human	NULL
TNF-a	NULL
5	NULL
promoter	NULL
deletion	NULL
series	NULL
fused	NULL
to	NULL
the	NULL
CAT	NULL
reporter	NULL
gene	NULL
(	NULL
described	NULL
in	NULL
reference	NULL
16	NULL
)	NULL
was	NULL
trans-	NULL
A.	NULL
D.	NULL
Tono	NULL
Iono	NULL
Tono	NULL
[	NULL
—1OOnM—|	NULL
,	NULL
—1	NULL
,	NULL
u.M—1	NULL
[	NULL
_1	NULL
,	NULL
U~M_|	NULL
4	NULL
y	NULL
:	NULL
g	NULL
,	NULL
.	NULL

.	NULL

,	NULL
S	NULL
C	NULL
<	NULL
%	NULL
min	NULL
.	NULL

post	NULL
induction	NULL
-	NULL
30	NULL
60	NULL
30	NULL
30	NULL
60	NULL
3	NULL
-	NULL
3	NULL
5	NULL
TNF-a	NULL
<	NULL
¥ABD	NULL
y-actin	NULL
«	NULL
=	NULL
102	NULL
3	NULL
4	NULL
50°06	NULL
7	NULL
1°	NULL
2	NULL
3	NULL
4	NULL
Figure	NULL
2	NULL
.	NULL

-	NULL
lonomycin	NULL
induction	NULL
of	NULL
TNF-	NULL
«	NULL
gene	NULL
expression	NULL
in	NULL
murine	NULL
Ar-5	NULL
T	NULL
cells	NULL
.	NULL

(	NULL
4	NULL
)	NULL
Cells	NULL
were	NULL
mock	NULL
(	NULL
-	NULL
)	NULL
induced	NULL
,	NULL
induced	NULL
with	NULL
100	NULL
nm	NULL
or	NULL
1	NULL
uM	NULL
ionomycin	NULL
for	NULL
30	NULL
or	NULL
60	NULL
min	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
1	NULL
uM	NULL
CsA	NULL
as	NULL
indicated	NULL
.	NULL

CsA	NULL
was	NULL
added	NULL
10	NULL
min	NULL
before	NULL
induction	NULL
with	NULL
ionomycin	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Cells	NULL
were	NULL
mock	NULL
(	NULL
-	NULL
)	NULL
induced	NULL
or	NULL
induced	NULL
for	NULL
30	NULL
min	NULL
with	NULL
1	NULL
uM	NULL
ionomycin	NULL
alone	NULL
or	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
CsA	NULL
or	NULL
CHX	NULL
and	NULL
ANIS	NULL
as	NULL
indicated	NULL
.	NULL

CsA	NULL
and	NULL
CHX/ANIS	NULL
were	NULL
added	NULL
10	NULL
and	NULL
30	NULL
min	NULL
,	NULL
respectively	NULL
,	NULL
before	NULL
induction	NULL
with	NULL
ionomycin	NULL
.	NULL

RNase	NULL
mapping	NULL
of	NULL
TNF-a	NULL
and	NULL
y-actin	NULL
mRNA	NULL
was	NULL
carried	NULL
out	NULL
as	NULL
described	NULL
in	NULL
the	NULL
legend	NULL
to	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

(	NULL
Left	NULL
)	NULL
Positions	NULL
of	NULL
the	NULL
TNF-a	NULL
and	NULL
y-actin	NULL
protected	NULL
fragments	NULL
.	NULL

CsA	NULL
or	NULL
CHX	NULL
plus	NULL
ANIS	NULL
have	NULL
no	NULL
effect	NULL
on	NULL
constitutive	NULL
TNF-	NULL
mRNA	NULL
expression	NULL
(	NULL
see	NULL
Fig	NULL
.	NULL

1	NULL
,	NULL
lanes	NULL
1	NULL
and	NULL
2	NULL
and	NULL
10	NULL
and	NULL
11	NULL
)	NULL
.	NULL

A	NULL
Ar-	NULL
5	NULL
m-	NULL
~600	NULL
-im	NULL
-§76	NULL
--	NULL
r	NULL
-	NULL
242	NULL
--	NULL
-	NULL
-~199	NULL
--	NULL
~T	NULL
ar	NULL
O	NULL
COC	NULL
°	NULL
C	NULL
°	NULL
Ct	NULL
»	NULL
G8	NULL
#	NULL
0	NULL
*	NULL
eo	NULL
@	NULL
#	NULL
«	NULL
e	NULL
lut	NULL
a	NULL
1	NULL
200	NULL
30	NULL
4	NULL
5	NULL
60	NULL
7	NULL
8	NULL
9	NULL
10	NULL
11	NULL
12	NULL
600	NULL
-576	NULL
«	NULL
2120	NULL
499	NULL
00	NULL
118	NULL
~80	NULL
52004	NULL
+89	NULL
-z	NULL
-z	NULL
!	NULL

._	NULL
L	NULL
...	NULL
!	NULL

EL	NULL
xi	NULL
x2	NULL
x3	NULL
cat	NULL
f	NULL
*	NULL
5	NULL
'	NULL
wo	NULL
!	NULL

!	NULL

wage	NULL
:	NULL
a	NULL
tecsacase	NULL
?	NULL

ecsotatee	NULL
teetTicrec	NULL
m-	NULL
118	NULL
-	NULL
m-	NULL
80	NULL
--	NULL
-	NULL
52	NULL
--	NULL
it	NULL
-	NULL
Pocat	NULL
--	NULL
+-	NULL
+-	NULL
+-	NULL
-+	NULL
--	NULL
[	NULL
_Csﬂ\	NULL
-	NULL
r	NULL
“	NULL
Csﬂ	NULL
-	NULL
[	NULL
_Cs	NULL
!	NULL

1	NULL
l	NULL
CsA	NULL
#	NULL
¥	NULL
a	NULL
%	NULL
®	NULL
%	NULL
LJ	NULL
13	NULL
14	NULL
15	NULL
16	NULL
17	NULL
18	NULL
sas	NULL
M499	NULL
m	NULL
_____	NULL
se	NULL
|	NULL
Bl	NULL
|	NULL
.	NULL

600	NULL
576	NULL
~118	NULL
base	NULL
pairs	NULL
of	NULL
promoter	NULL
19	NULL
20	NULL
21	NULL
22	NULL
23	NULL
24	NULL
8	NULL
8	NULL
percent	NULL
conversion	NULL
a	NULL
>	NULL
1g	NULL
PR	NULL
o	NULL
L	NULL
H	NULL
C	NULL
[	NULL
Z	NULL
]	NULL
Unstimulated	NULL
[	NULL
ifl	NULL
Stimulated	NULL
[	NULL
C	NULL
]	NULL
Stimulated	NULL
+	NULL
CsA	NULL
1368	NULL
Figure	NULL
3	NULL
.	NULL

(	NULL
4	NULL
)	NULL
«	NULL
CD3	NULL
induction	NULL
of	NULL
human	NULL
TNF-	NULL
«	NULL
/CAT	NULL
gene	NULL
fusions	NULL
in	NULL
Ar-5	NULL
T	NULL
cells	NULL
.	NULL

Autoradiogram	NULL
shows	NULL
results	NULL
of	NULL
CAT	NULL
assays	NULL
of	NULL
extracts	NULL
prepared	NULL
from	NULL
Ar-5	NULL
cells	NULL
transfected	NULL
with	NULL
5	NULL
deletion	NULL
constructs	NULL
of	NULL
the	NULL
human	NULL
TNF-ox/CAT	NULL
reporter	NULL
gene	NULL
fusions	NULL
diagrammed	NULL
in	NULL
the	NULL
figure	NULL
.	NULL

Cells	NULL
were	NULL
transfected	NULL
and	NULL
mock	NULL
induced	NULL
(	NULL
-	NULL
)	NULL
or	NULL
induced	NULL
with	NULL
eCD3	NULL
{	NULL
+	NULL
)	NULL
for	NULL
18	NULL
h	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
CsA	NULL
as	NULL
indicated	NULL
.	NULL

CsA	NULL
was	NULL
added	NULL
10	NULL
min	NULL
before	NULL
«	NULL
CD3	NULL
.	NULL

A	NULL
promoterless	NULL
CAT	NULL
construct	NULL
(	NULL
Porat	NULL
)	NULL
showed	NULL
no	NULL
activity	NULL
.	NULL

(	NULL
Diagram	NULL
)	NULL
Positions	NULL
of	NULL
three	NULL
NF-xB	NULL
binding	NULL
sites	NULL
(	NULL
«	NULL
1	NULL
,	NULL
x2	NULL
,	NULL
and	NULL
«	NULL
3	NULL
)	NULL
relative	NULL
to	NULL
the	NULL
deletion	NULL
endpoints	NULL
and	NULL
the	NULL
transcription	NULL
start	NULL
site	NULL
.	NULL

(	NULL
B	NULL
)	NULL
A	NULL
histogram	NULL
depicting	NULL
the	NULL
percent	NULL
conversion	NULL
of	NULL
[	NULL
!	NULL

*CJchloramphenicol	NULL
to	NULL
its	NULL
acetylated	NULL
forms	NULL
quantified	NULL
by	NULL
a	NULL
betascope	NULL
(	NULL
Betagen	NULL
,	NULL
Waltham	NULL
,	NULL
MA	NULL
)	NULL
of	NULL
the	NULL
experiment	NULL
displayed	NULL
in	NULL
(	NULL
A4	NULL
)	NULL
.	NULL

The	NULL
experiment	NULL
displayed	NULL
is	NULL
representative	NULL
of	NULL
four	NULL
independent	NULL
transfection	NULL
experiments	NULL
.	NULL

Novel	NULL
CsA-sensitive	NULL
Element	NULL
in	NULL
Human	NULL
TNF-	NULL
Gene	NULL
Promoter	NULL
fected	NULL
into	NULL
Ar-5	NULL
cells	NULL
and	NULL
the	NULL
cells	NULL
were	NULL
then	NULL
stimulated	NULL
with	NULL
«	NULL
CD3	NULL
in	NULL
the	NULL
presence	NULL
and	NULL
absence	NULL
of	NULL
CsA	NULL
.	NULL

This	NULL
series	NULL
of	NULL
plasmids	NULL
contains	NULL
progressive	NULL
deletions	NULL
of	NULL
each	NULL
of	NULL
the	NULL
«	NULL
B-like	NULL
binding	NULL
sites	NULL
(	NULL
1	NULL
,	NULL
«	NULL
2	NULL
,	NULL
and	NULL
K3	NULL
)	NULL
in	NULL
the	NULL
TNF-a	NULL
promoter	NULL
(	NULL
dia-gram	NULL
,	NULL
Fig	NULL
.	NULL

3	NULL
A	NULL
)	NULL
,	NULL
and	NULL
thus	NULL
can	NULL
be	NULL
used	NULL
to	NULL
evaluate	NULL
the	NULL
functional	NULL
contribution	NULL
of	NULL
these	NULL
sites	NULL
to	NULL
TCR-mediated	NULL
activation	NULL
and	NULL
CsA	NULL
sensitivity	NULL
of	NULL
the	NULL
gene	NULL
.	NULL

The	NULL
TNF-	NULL
CAT	NULL
fusion	NULL
construct	NULL
containing	NULL
-600	NULL
n	NULL
relative	NULL
to	NULL
the	NULL
TNF-a	NULL
mRNA	NULL
cap	NULL
site	NULL
was	NULL
highly	NULL
inducible	NULL
by	NULL
eCD3	NULL
and	NULL
this	NULL
induction	NULL
was	NULL
effectively	NULL
blocked	NULL
when	NULL
the	NULL
cells	NULL
were	NULL
pretreated	NULL
with	NULL
CsA	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
A	NULL
,	NULL
lanes	NULL
1-3	NULL
)	NULL
.	NULL

Deletion	NULL
of	NULL
«	NULL
1	NULL
which	NULL
lies	NULL
between	NULL
the	NULL
sequences	NULL
spanning	NULL
-600	NULL
and	NULL
-576	NULL
,	NULL
or	NULL
deletion	NULL
of	NULL
«	NULL
2	NULL
,	NULL
which	NULL
lies	NULL
between	NULL
the	NULL
sequences	NULL
-242	NULL
and	NULL
-199	NULL
n	NULL
,	NULL
had	NULL
little	NULL
effect	NULL
on	NULL
the	NULL
promoter	NULL
's	NULL
inducibility	NULL
by	NULL
eCD3	NULL
or	NULL
its	NULL
sensitivity	NULL
to	NULL
CsA	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
A	NULL
,	NULL
lanes	NULL
4-12	NULL
)	NULL
.	NULL

Deletion	NULL
of	NULL
the	NULL
sequences	NULL
between	NULL
-199	NULL
and	NULL
-118	NULL
n	NULL
reduced	NULL
the	NULL
absolute	NULL
values	NULL
of	NULL
both	NULL
basal	NULL
and	NULL
induced	NULL
CAT	NULL
activity	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
A	NULL
,	NULL
lanes	NULL
13-15	NULL
)	NULL
.	NULL

However	NULL
,	NULL
the	NULL
promoter	NULL
's	NULL
inducibility	NULL
is	NULL
not	NULL
affected	NULL
by	NULL
the	NULL
deletion	NULL
of	NULL
these	NULL
sequences	NULL
,	NULL
and	NULL
the	NULL
-118	NULL
deletion	NULL
construct	NULL
was	NULL
still	NULL
sensitive	NULL
to	NULL
CsA	NULL
(	NULL
see	NULL
Fig	NULL
.	NULL

3	NULL
B	NULL
)	NULL
.	NULL

We	NULL
conclude	NULL
that	NULL
the	NULL
sequences	NULL
between	NULL
-199	NULL
and	NULL
-118	NULL
n	NULL
contain	NULL
a	NULL
positive	NULL
regulatory	NULL
region	NULL
that	NULL
is	NULL
required	NULL
for	NULL
maximal	NULL
levels	NULL
of	NULL
induction	NULL
of	NULL
a	NULL
linked	NULL
CAT	NULL
reporter	NULL
gene	NULL
by	NULL
«	NULL
CD3	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
deletion	NULL
of	NULL
the	NULL
sequences	NULL
between	NULL
-118	NULL
and	NULL
-80	NULL
n	NULL
,	NULL
which	NULL
removes	NULL
the	NULL
«	NULL
3	NULL
element	NULL
,	NULL
almost	NULL
eliminated	NULL
aeCD3	NULL
inducibility	NULL
and	NULL
CsA	NULL
sensitivity	NULL
of	NULL
the	NULL
TNF-	NULL
gene	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
A	NULL
,	NULL
lanes	NULL
13-18	NULL
,	NULL
and	NULL
see	NULL
Fig	NULL
.	NULL

3	NULL
B	NULL
)	NULL
.	NULL

Further	NULL
deletion	NULL
of	NULL
the	NULL
TNF-a	NULL
promoter	NULL
to	NULL
-52	NULL
n	NULL
relative	NULL
to	NULL
the	NULL
mRNA	NULL
cap	NULL
site	NULL
had	NULL
no	NULL
additional	NULL
effect	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
,	NULL
lanes	NULL
19-21	NULL
)	NULL
,	NULL
indicating	NULL
that	NULL
the	NULL
sequences	NULL
lying	NULL
between	NULL
-52	NULL
and	NULL
+89	NULL
n	NULL
relative	NULL
to	NULL
the	NULL
TNF-	NULL
mRNA	NULL
cap	NULL
site	NULL
are	NULL
sufficient	NULL
for	NULL
basal	NULL
activity	NULL
and	NULL
minimal	NULL
inducibility	NULL
.	NULL

In	NULL
conclusion	NULL
,	NULL
the	NULL
sequences	NULL
between	NULL
-118	NULL
and	NULL
-80	NULL
n	NULL
contain	NULL
a	NULL
CsA-sensitive	NULL
promoter	NULL
element	NULL
that	NULL
is	NULL
involved	NULL
in	NULL
«	NULL
CD3	NULL
inducibility	NULL
of	NULL
the	NULL
gene	NULL
.	NULL

Ca	NULL
``	NULL
*	NULL
Ionophore	NULL
.	NULL

-	NULL
The	NULL
same	NULL
TNF-a	NULL
5	NULL
'	NULL
promoter	NULL
deletion	NULL
series	NULL
was	NULL
tested	NULL
in	NULL
cells	NULL
induced	NULL
with	NULL
calcium	NULL
ionophore	NULL
alone	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

4	NULL
,	NULL
the	NULL
-199	NULL
TNF-	NULL
CAT	NULL
fusion	NULL
construct	NULL
was	NULL
highly	NULL
inducible	NULL
by	NULL
ionomycin	NULL
and	NULL
this	NULL
induction	NULL
was	NULL
blocked	NULL
by	NULL
CsA	NULL
(	NULL
lanes	NULL
1-3	NULL
)	NULL
.	NULL

The	NULL
level	NULL
of	NULL
induction	NULL
with	NULL
ionomycin	NULL
was	NULL
roughly	NULL
equivalent	NULL
to	NULL
the	NULL
level	NULL
of	NULL
induction	NULL
obtained	NULL
with	NULL
«	NULL
CD3	NULL
(	NULL
compare	NULL
Fig	NULL
.	NULL

4	NULL
,	NULL
lanes	NULL
13-15	NULL
to	NULL
lanes	NULL
1-3	NULL
)	NULL
.	NULL

As	NULL
previously	NULL
noted	NULL
with	NULL
«	NULL
CD3	NULL
,	NULL
deletion	NULL
of	NULL
the	NULL
sequences	NULL
between	NULL
-199	NULL
and	NULL
-118	NULL
resulted	NULL
in	NULL
a	NULL
marked	NULL
decrease	NULL
in	NULL
the	NULL
absolute	NULL
levels	NULL
of	NULL
CAT	NULL
activity	NULL
,	NULL
however	NULL
,	NULL
the	NULL
decrease	NULL
in	NULL
activity	NULL
was	NULL
much	NULL
more	NULL
pronounced	NULL
in	NULL
the	NULL
case	NULL
of	NULL
ionomycin	NULL
induction	NULL
(	NULL
compare	NULL
Fig	NULL
.	NULL

4	NULL
,	NULL
lanes	NULL
1-6	NULL
with	NULL
Fig	NULL
.	NULL

3	NULL
A	NULL
,	NULL
lanes	NULL
10-15	NULL
)	NULL
.	NULL

Nevertheless	NULL
,	NULL
the	NULL
-118	NULL
construct	NULL
was	NULL
clearly	NULL
induced	NULL
by	NULL
ionomycin	NULL
treatment	NULL
and	NULL
this	NULL
induction	NULL
was	NULL
blocked	NULL
by	NULL
CsA	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
,	NULL
lanes	NULL
4-6	NULL
)	NULL
.	NULL

When	NULL
the	NULL
sequences	NULL
between	NULL
-118	NULL
and	NULL
-80	NULL
,	NULL
which	NULL
contain	NULL
the	NULL
K3	NULL
site	NULL
,	NULL
were	NULL
deleted	NULL
,	NULL
induction	NULL
by	NULL
ionomycin	NULL
was	NULL
no	NULL
longer	NULL
detectable	NULL
(	NULL
lanes	NULL
7-9	NULL
)	NULL
.	NULL

Deletion	NULL
of	NULL
the	NULL
sequences	NULL
between	NULL
-600	NULL
and	NULL
-199	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
the	NULL
ionomycin	NULL
inducibility	NULL
of	NULL
the	NULL
TNF-a	NULL
promoter	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

In	NULL
conclusion	NULL
,	NULL
these	NULL
results	NULL
indicate	NULL
that	NULL
the	NULL
sequences	NULL
between	NULL
-199	NULL
and	NULL
+89	NULL
n	NULL
relative	NULL
to	NULL
the	NULL
TNF-start	NULL
site	NULL
mediate	NULL
induction	NULL
of	NULL
the	NULL
gene	NULL
by	NULL
both	NULL
TCR	NULL
ligands	NULL
and	NULL
calcium	NULL
ionophore	NULL
,	NULL
and	NULL
that	NULL
the	NULL
sequences	NULL
between	NULL
-118	NULL
1369	NULL
Goldfeld	NULL
et	NULL
al	NULL
.	NULL

-	NULL
OSA	NULL
-	NULL
CsA	NULL
-	NULL
CsA	NULL
000000000000	NULL
oce	NULL
8	NULL
9	NULL
10	NULL
-	NULL
#	NULL
Figure	NULL
4	NULL
.	NULL

-	NULL
Tonomycin	NULL
induction	NULL
of	NULL
human	NULL
TNF-	NULL
«	NULL
/CAT	NULL
gene	NULL
fusions	NULL
in	NULL
Ar-5	NULL
T	NULL
cells	NULL
.	NULL

Autoradiogram	NULL
shows	NULL
results	NULL
of	NULL
CAT	NULL
assays	NULL
of	NULL
extracts	NULL
prepared	NULL
from	NULL
Ar-5	NULL
cells	NULL
transfected	NULL
with	NULL
the	NULL
5	NULL
'	NULL
deletion	NULL
constructs	NULL
of	NULL
the	NULL
human	NULL
TNF	NULL
@	NULL
/CAT	NULL
constructs	NULL
diagrammed	NULL
in	NULL
Fig	NULL
.	NULL

3	NULL
.	NULL

Cells	NULL
were	NULL
transfected	NULL
and	NULL
mock	NULL
induced	NULL
(	NULL
-	NULL
)	NULL
or	NULL
induced	NULL
with	NULL
1	NULL
uM	NULL
ionomycin	NULL
(	NULL
Jono	NULL
)	NULL
or	NULL
eCD3	NULL
for	NULL
18	NULL
h	NULL
in	NULL
the	NULL
presence	NULL
(	NULL
+	NULL
)	NULL
or	NULL
absence	NULL
(	NULL
-	NULL
)	NULL
of	NULL
CsA	NULL
as	NULL
indicated	NULL
.	NULL

CsA	NULL
was	NULL
added	NULL
10	NULL
min	NULL
before	NULL
ionomycin	NULL
induction	NULL
.	NULL

Deletion	NULL
of	NULL
the	NULL
sequences	NULL
between	NULL
-600	NULL
and	NULL
-199	NULL
relative	NULL
to	NULL
the	NULL
TNF-a	NULL
cap	NULL
site	NULL
did	NULL
not	NULL
affect	NULL
constitutive	NULL
or	NULL
ionomycin-induced	NULL
levels	NULL
of	NULL
CAT	NULL
activity	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
results	NULL
are	NULL
representative	NULL
of	NULL
three	NULL
independent	NULL
experiments	NULL
.	NULL

and	NULL
-80	NULL
are	NULL
also	NULL
required	NULL
for	NULL
inducibility	NULL
and	NULL
CsA	NULL
sensitivity	NULL
in	NULL
the	NULL
case	NULL
of	NULL
both	NULL
inducers	NULL
.	NULL

The	NULL
«	NULL
3	NULL
Site	NULL
Functions	NULL
as	NULL
an	NULL
Inducible	NULL
,	NULL
CsA-sensitive	NULL
Transcriptional	NULL
Element	NULL
In	NULL
Vivo	NULL
within	NULL
the	NULL
Context	NULL
of	NULL
the	NULL
TNF-xPromoter	NULL
The	NULL
significant	NULL
drop	NULL
in	NULL
inducibility	NULL
and	NULL
CsA	NULL
sensitivity	NULL
of	NULL
the	NULL
TNF-a	NULL
promoter	NULL
seen	NULL
upon	NULL
deletion	NULL
of	NULL
the	NULL
sequences	NULL
between	NULL
-118	NULL
and	NULL
-80	NULL
suggested	NULL
that	NULL
these	NULL
sequences	NULL
contained	NULL
an	NULL
«	NULL
CD3	NULL
and	NULL
calcium-inducible	NULL
,	NULL
CsA-sensitive	NULL
promoter	NULL
element	NULL
.	NULL

The	NULL
region	NULL
defined	NULL
by	NULL
this	NULL
deletion	NULL
contained	NULL
the	NULL
previously	NULL
characterized	NULL
«	NULL
B-like	NULL
binding	NULL
site	NULL
,	NULL
x3	NULL
,	NULL
and	NULL
its	NULL
surrounding	NULL
sequences	NULL
(	NULL
spanning	NULL
-106	NULL
to	NULL
-87	NULL
nt	NULL
relative	NULL
to	NULL
the	NULL
TNF-a	NULL
transcription	NULL
start	NULL
site	NULL
)	NULL
(	NULL
18	NULL
)	NULL
.	NULL

To	NULL
determine	NULL
the	NULL
importance	NULL
of	NULL
these	NULL
sequences	NULL
,	NULL
(	NULL
referred	NULL
to	NULL
as	NULL
x3	NULL
or	NULL
the	NULL
«	NULL
3	NULL
element	NULL
throughout	NULL
this	NULL
paper	NULL
)	NULL
,	NULL
and	NULL
to	NULL
evaluate	NULL
its	NULL
in	NULL
vivo	NULL
function	NULL
within	NULL
the	NULL
context	NULL
of	NULL
the	NULL
TNF-	NULL
promoter	NULL
during	NULL
T	NULL
cell	NULL
activation	NULL
,	NULL
TNF-a	NULL
promoter	NULL
CAT	NULL
fusion	NULL
genes	NULL
with	NULL
base	NULL
substitution	NULL
mutations	NULL
in	NULL
the	NULL
«	NULL
3	NULL
site	NULL
were	NULL
constructed	NULL
.	NULL

These	NULL
mutations	NULL
named	NULL
55	NULL
,	NULL
middle	NULL
,	NULL
3	NULL
,	NULL
and	NULL
3	NULL
'	NULL
flank	NULL
are	NULL
depicted	NULL
in	NULL
Fig	NULL
.	NULL

5	NULL
C.	NULL
They	NULL
were	NULL
created	NULL
in	NULL
the	NULL
context	NULL
of	NULL
the	NULL
-199	NULL
TNF-	NULL
promoter	NULL
(	NULL
WT	NULL
)	NULL
and	NULL
are	NULL
all	NULL
isogenic	NULL
except	NULL
for	NULL
the	NULL
base	NULL
changes	NULL
noted	NULL
.	NULL

TCR	NULL
Stimuli	NULL
.	NULL

-	NULL
Mutation	NULL
of	NULL
any	NULL
of	NULL
the	NULL
nucleotides	NULL
within	NULL
the	NULL
NF-kB	NULL
consensus	NULL
motif	NULL
of	NULL
the	NULL
x3	NULL
site	NULL
caused	NULL
a	NULL
reduction	NULL
in	NULL
the	NULL
relative	NULL
induction	NULL
of	NULL
CAT	NULL
activity	NULL
in	NULL
response	NULL
to	NULL
«	NULL
CD3	NULL
stimulation	NULL
of	NULL
transiently	NULL
transfected	NULL
Ar-5	NULL
cells	NULL
.	NULL

Mutations	NULL
in	NULL
the	NULL
5¢	NULL
or	NULL
3	NULL
'	NULL
ends	NULL
of	NULL
the	NULL
site	NULL
reduced	NULL
the	NULL
induction	NULL
:	NULL
of	NULL
CAT	NULL
activity	NULL
to	NULL
~28	NULL
%	NULL
(	NULL
5	NULL
M	NULL
)	NULL
and	NULL
44	NULL
%	NULL
(	NULL
3	NULL
'	NULL
M	NULL
)	NULL
,	NULL
respectively	NULL
,	NULL
of	NULL
the	NULL
level	NULL
of	NULL
induction	NULL
seen	NULL
with	NULL
the	NULL
WT	NULL
plasmid	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
A	NULL
)	NULL
.	NULL

The	NULL
effect	NULL
of	NULL
mutating	NULL
the	NULL
middle	NULL
nucleotides	NULL
(	NULL
MM	NULL
)	NULL
,	NULL
was	NULL
more	NULL
modest	NULL
,	NULL
decreasing	NULL
induction	NULL
to	NULL
~70	NULL
%	NULL
of	NULL
WT	NULL
levels	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
mutation	NULL
of	NULL
the	NULL
nucleotides	NULL
flanking	NULL
the	NULL
3	NULL
'	NULL
end	NULL
of	NULL
the	NULL
x3	NULL
site	NULL
(	NULL
3	NULL
'	NULL
flank	NULL
M	NULL
)	NULL
,	NULL
did	NULL
not	NULL
decrease	NULL
induction	NULL
of	NULL
CAT	NULL
activity	NULL
,	NULL
but	NULL
rather	NULL
caused	NULL
a	NULL
slight	NULL
increase	NULL
in	NULL
the	NULL
average	NULL
level	NULL
of	NULL
induction	NULL
(	NULL
~116	NULL
%	NULL
of	NULL
WT	NULL
induced	NULL
levels	NULL
)	NULL
.	NULL

These	NULL
results	NULL
A.	NULL
aCD3	NULL
induction	NULL
150	NULL
|-100	NULL
|-50	NULL
|-6	NULL
o	NULL
hes	NULL
©	NULL
wT	NULL
5M	NULL
MM	NULL
am	NULL
M	NULL
-	NULL
Spi	NULL
M	NULL
f	NULL
Bg	NULL
*	NULL
g	NULL
B.	NULL
lonomycin	NULL
induction	NULL
l	NULL
WT	NULL
5M	NULL
MM	NULL
3M	NULL
site	NULL
of	NULL
mutation	NULL
``	NULL
flank	NULL
M	NULL
Sp1	NULL
M	NULL
Unstimulated	NULL
ffl	NULL
)	NULL
Stimulated	NULL
Stimulated	NULL
+	NULL
CsA	NULL
C.	NULL
-106	NULL
-87	NULL
GAGCTCA	NULL
ACC	NULL
5°	NULL
Mutant	NULL
ATTA	NULL
Middle	NULL
Mutant	NULL
ACG	NULL
3	NULL
``	NULL
Mutant	NULL
aaca	NULL
3	NULL
'	NULL
Flank	NULL
Mutant	NULL
GAT	NULL
-61	NULL
27	NULL
GATTCTTTECCCGCCCICCTCTCGCCCCAGGGACA	NULL
Sp1	NULL
Mutant	NULL
GaaG	NULL
Figure	NULL
5	NULL
.	NULL

The	NULL
relative	NULL
activity	NULL
of	NULL
human	NULL
TNF-	NULL
CAT	NULL
fusion	NULL
constructs	NULL
containing	NULL
mutations	NULL
in	NULL
the	NULL
«	NULL
3	NULL
or	NULL
Sp1	NULL
sites	NULL
(	NULL
diagrammed	NULL
in	NULL
Fig	NULL
.	NULL

6	NULL
C	NULL
)	NULL
in	NULL
Ar-5	NULL
cells	NULL
induced	NULL
with	NULL
«	NULL
CD3	NULL
or	NULL
ionomycin	NULL
.	NULL

The	NULL
x3	NULL
site-directed	NULL
mutations	NULL
(	NULL
5M	NULL
,	NULL
MM	NULL
,	NULL
3	NULL
'M	NULL
,	NULL
and	NULL
3'flank	NULL
M	NULL
)	NULL
and	NULL
the	NULL
Sp1	NULL
mutation	NULL
(	NULL
Sp1	NULL
M	NULL
)	NULL
were	NULL
introduced	NULL
into	NULL
the	NULL
«	NULL
3	NULL
site	NULL
within	NULL
the	NULL
context	NULL
of	NULL
the	NULL
unmutated	NULL
wild-type	NULL
-199	NULL
TNF-a	NULL
promoter	NULL
(	NULL
WT	NULL
)	NULL
CAT	NULL
fusion	NULL
construct	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

(	NULL
4	NULL
)	NULL
The	NULL
«	NULL
3	NULL
site	NULL
participates	NULL
in	NULL
CsA-sensitive	NULL
eCD3	NULL
induction	NULL
of	NULL
the	NULL
human	NULL
TNF-	NULL
promoter	NULL
in	NULL
Ar-5	NULL
cells	NULL
.	NULL

Cells	NULL
were	NULL
transfected	NULL
with	NULL
the	NULL
WT	NULL
and	NULL
mutated	NULL
TNF-	NULL
promoter	NULL
CAT	NULL
plasmids	NULL
and	NULL
24	NULL
h	NULL
later	NULL
were	NULL
mock	NULL
induced	NULL
(	NULL
unstimulated	NULL
)	NULL
or	NULL
induced	NULL
with	NULL
«	NULL
CD3	NULL
(	NULL
stimulated	NULL
)	NULL
for	NULL
18	NULL
h	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
CsA	NULL
as	NULL
indicated	NULL
.	NULL

CsA	NULL
was	NULL
added	NULL
10	NULL
min	NULL
before	NULL
activation	NULL
with	NULL
eCD3	NULL
.	NULL

Cellular	NULL
extracts	NULL
were	NULL
harvested	NULL
,	NULL
CAT	NULL
assays	NULL
were	NULL
performed	NULL
,	NULL
and	NULL
the	NULL
percent	NULL
conversion	NULL
of	NULL
[	NULL
**C	NULL
]	NULL
chloramphenicol	NULL
to	NULL
its	NULL
acetylated	NULL
forms	NULL
was	NULL
quantified	NULL
using	NULL
a	NULL
Be-tagen	NULL
Betascope	NULL
.	NULL

Within	NULL
individual	NULL
experiments	NULL
,	NULL
the	NULL
results	NULL
were	NULL
normalized	NULL
to	NULL
the	NULL
-199	NULL
WT	NULL
induced	NULL
level	NULL
(	NULL
100	NULL
%	NULL
)	NULL
,	NULL
and	NULL
then	NULL
averaged	NULL
and	NULL
plotted	NULL
in	NULL
the	NULL
displayed	NULL
histograms	NULL
.	NULL

The	NULL
SD	NULL
is	NULL
represented	NULL
by	NULL
the	NULL
error	NULL
bars	NULL
.	NULL

The	NULL
figure	NULL
shows	NULL
the	NULL
results	NULL
of	NULL
six	NULL
independent	NULL
transfection	NULL
experiments	NULL
,	NULL
except	NULL
for	NULL
the	NULL
3'flank	NULL
M	NULL
and	NULL
Sp1	NULL
M	NULL
histograms	NULL
,	NULL
which	NULL
summarize	NULL
five	NULL
independent	NULL
experiments	NULL
.	NULL

(	NULL
B	NULL
)	NULL
The	NULL
«	NULL
3	NULL
site	NULL
is	NULL
required	NULL
for	NULL
CsA-sensitive	NULL
induction	NULL
of	NULL
the	NULL
human	NULL
TNF-a	NULL
promoter	NULL
by	NULL
ionomycin	NULL
.	NULL

The	NULL
experiments	NULL
were	NULL
1370	NULL
indicated	NULL
that	NULL
the	NULL
x3	NULL
element	NULL
was	NULL
necessary	NULL
for	NULL
full	NULL
induction	NULL
of	NULL
the	NULL
-199	NULL
TNF-a	NULL
CAT	NULL
fusion	NULL
construct	NULL
in	NULL
response	NULL
to	NULL
«	NULL
CD3	NULL
.	NULL

Inspection	NULL
of	NULL
the	NULL
sequences	NULL
between	NULL
-61	NULL
and	NULL
-27	NULL
n	NULL
relative	NULL
to	NULL
the	NULL
TNF-a	NULL
cap	NULL
site	NULL
revealed	NULL
an	NULL
Sp1	NULL
binding	NULL
motif	NULL
(	NULL
5-CCCCGCCC-3	NULL
'	NULL
)	NULL
between	NULL
-53	NULL
and	NULL
-46	NULL
n	NULL
relative	NULL
to	NULL
the	NULL
TNF-a	NULL
transcription	NULL
start	NULL
site	NULL
(	NULL
16	NULL
)	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
these	NULL
sequences	NULL
were	NULL
involved	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
the	NULL
gene	NULL
by	NULL
«	NULL
CD3	NULL
,	NULL
the	NULL
core	NULL
nucleotides	NULL
of	NULL
this	NULL
site	NULL
within	NULL
the	NULL
context	NULL
of	NULL
the	NULL
-199	NULL
TNF-	NULL
gene	NULL
promoter	NULL
were	NULL
substituted	NULL
with	NULL
the	NULL
bases	NULL
displayed	NULL
in	NULL
Fig	NULL
.	NULL

5	NULL
C.	NULL
Mutation	NULL
of	NULL
the	NULL
Sp1	NULL
motif	NULL
did	NULL
not	NULL
decrease	NULL
basal	NULL
or	NULL
induced	NULL
levels	NULL
of	NULL
CAT	NULL
activity	NULL
,	NULL
but	NULL
rather	NULL
,	NULL
resulted	NULL
in	NULL
an	NULL
increase	NULL
in	NULL
the	NULL
average	NULL
levels	NULL
of	NULL
induction	NULL
(	NULL
~140	NULL
%	NULL
of	NULL
WT	NULL
levels	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
the	NULL
decreased	NULL
inducibility	NULL
and	NULL
relative	NULL
CsA	NULL
sensitivity	NULL
displayed	NULL
by	NULL
the	NULL
5	NULL
'M	NULL
,	NULL
3	NULL
'M	NULL
,	NULL
and	NULL
MM	NULL
constructs	NULL
was	NULL
specific	NULL
to	NULL
these	NULL
base	NULL
substi-tutions	NULL
.	NULL

Ca	NULL
``	NULL
®+	NULL
Ionophore	NULL
Mutation	NULL
of	NULL
the	NULL
x3	NULL
site	NULL
had	NULL
a	NULL
much	NULL
more	NULL
pronounced	NULL
effect	NULL
on	NULL
the	NULL
ionomycin-mediated	NULL
induction	NULL
of	NULL
the	NULL
TNF-a	NULL
promoter	NULL
.	NULL

As	NULL
displayed	NULL
in	NULL
Fig	NULL
.	NULL

5	NULL
B	NULL
,	NULL
mutations	NULL
in	NULL
either	NULL
the	NULL
5	NULL
or	NULL
3	NULL
'	NULL
sequences	NULL
of	NULL
the	NULL
«	NULL
3	NULL
site	NULL
(	NULL
5	NULL
'M	NULL
and	NULL
3	NULL
'M	NULL
)	NULL
essentially	NULL
abrogated	NULL
induction	NULL
by	NULL
ionomycin	NULL
,	NULL
whereas	NULL
mutation	NULL
of	NULL
sequences	NULL
in	NULL
the	NULL
middle	NULL
of	NULL
the	NULL
«	NULL
3	NULL
site	NULL
(	NULL
MM	NULL
)	NULL
significantly	NULL
decreased	NULL
inducibility	NULL
to	NULL
~17	NULL
%	NULL
of	NULL
WT	NULL
levels	NULL
.	NULL

Mutation	NULL
of	NULL
the	NULL
nucleotides	NULL
flanking	NULL
the	NULL
3	NULL
'	NULL
sequences	NULL
of	NULL
the	NULL
«	NULL
3	NULL
site	NULL
(	NULL
3	NULL
'	NULL
flank	NULL
M	NULL
)	NULL
had	NULL
a	NULL
greater	NULL
effect	NULL
on	NULL
ionomycin-mediated	NULL
induction	NULL
than	NULL
on	NULL
eCD3-mediated	NULL
induction	NULL
,	NULL
causing	NULL
a	NULL
decrease	NULL
of	NULL
~30	NULL
%	NULL
in	NULL
the	NULL
absolute	NULL
level	NULL
of	NULL
induction	NULL
of	NULL
CAT	NULL
activity	NULL
.	NULL

Mutation	NULL
of	NULL
the	NULL
SP1	NULL
sequences	NULL
did	NULL
not	NULL
decrease	NULL
the	NULL
inducibility	NULL
or	NULL
CsA	NULL
sensitivity	NULL
of	NULL
the	NULL
promoter	NULL
,	NULL
but	NULL
rather	NULL
increased	NULL
induced	NULL
levels	NULL
of	NULL
CAT	NULL
activity	NULL
as	NULL
previously	NULL
observed	NULL
for	NULL
«	NULL
CD3	NULL
.	NULL

Thus	NULL
,	NULL
although	NULL
promoter	NULL
sequences	NULL
in	NULL
addition	NULL
to	NULL
«	NULL
3	NULL
are	NULL
involved	NULL
in	NULL
the	NULL
induction	NULL
of	NULL
the	NULL
-199	NULL
TNF-a	NULL
promoter/CAT	NULL
fusion	NULL
by	NULL
«	NULL
CD3	NULL
,	NULL
«	NULL
3	NULL
plays	NULL
a	NULL
major	NULL
role	NULL
in	NULL
its	NULL
CsA-sensitive	NULL
induction	NULL
in	NULL
response	NULL
to	NULL
ionomycin	NULL
.	NULL

Multiple	NULL
Copies	NULL
of	NULL
the	NULL
«	NULL
3	NULL
Promoter	NULL
Element	NULL
Confer	NULL
CsA-sensitive	NULL
Inducibility	NULL
on	NULL
a	NULL
Minimal	NULL
TNF-	NULL
Promoter	NULL
To	NULL
further	NULL
characterize	NULL
the	NULL
function	NULL
of	NULL
the	NULL
x3	NULL
element	NULL
and	NULL
to	NULL
determine	NULL
whether	NULL
«	NULL
3	NULL
could	NULL
function	NULL
as	NULL
a	NULL
discrete	NULL
regulatory	NULL
element	NULL
,	NULL
Ar-5	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
a	NULL
construct	NULL
in	NULL
which	NULL
multimers	NULL
of	NULL
«	NULL
3	NULL
were	NULL
placed	NULL
upstream	NULL
of	NULL
a	NULL
minimal	NULL
TNF-a	NULL
promoter	NULL
fused	NULL
to	NULL
CAT	NULL
.	NULL

The	NULL
control	NULL
construct	NULL
containing	NULL
the	NULL
minimal	NULL
TNF-a	NULL
promoter	NULL
(	NULL
-61	NULL
to	NULL
+89	NULL
n	NULL
)	NULL
was	NULL
minimally	NULL
inducible	NULL
by	NULL
«	NULL
CD3	NULL
(	NULL
approximately	NULL
twofold	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
A	NULL
,	NULL
lanes	NULL
1	NULL
and	NULL
2	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
a	NULL
construct	NULL
that	NULL
contained	NULL
six	NULL
copies	NULL
of	NULL
the	NULL
x3	NULL
element	NULL
upstream	NULL
of	NULL
-61	NULL
TNF-CAT	NULL
was	NULL
clearly	NULL
inducible	NULL
by	NULL
eCD3	NULL
(	NULL
approximately	NULL
seven-fold	NULL
)	NULL
and	NULL
this	NULL
augmented	NULL
induction	NULL
was	NULL
blocked	NULL
by	NULL
CsA	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
A	NULL
,	NULL
lanes	NULL
4-6	NULL
)	NULL
.	NULL

The	NULL
x3	NULL
multimers	NULL
also	NULL
conferred	NULL
ionomycin	NULL
inducibility	NULL
on	NULL
the	NULL
minimal	NULL
TNF-a	NULL
promoter	NULL
(	NULL
from	NULL
~3-15-	NULL
performed	NULL
as	NULL
in	NULL
(	NULL
A	NULL
)	NULL
,	NULL
except	NULL
that	NULL
the	NULL
cells	NULL
were	NULL
induced	NULL
with	NULL
1	NULL
uM	NULL
ionomycin	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
CsA	NULL
as	NULL
indicated	NULL
.	NULL

The	NULL
results	NULL
of	NULL
three	NULL
independent	NULL
transfection	NULL
experiments	NULL
are	NULL
shown	NULL
.	NULL

(	NULL
C	NULL
)	NULL
A	NULL
diagram	NULL
of	NULL
the	NULL
base	NULL
substitutions	NULL
introduced	NULL
into	NULL
the	NULL
«	NULL
3	NULL
or	NULL
Sp1	NULL
sites	NULL
.	NULL

(	NULL
Boxes	NULL
)	NULL
The	NULL
«	NULL
3	NULL
and	NULL
Spi	NULL
sites	NULL
.	NULL

Novel	NULL
CsA-sensitive	NULL
Element	NULL
in	NULL
Human	NULL
TNF-	NULL
Gene	NULL
Promoter	NULL
A.	NULL
r-	NULL
-	NULL
r	NULL
(	NULL
«	NULL
3	NULL
)	NULL
°61TNF-a-	NULL
B	NULL
p-+-+	NULL
o	NULL
p-+-	NULL
-Tono	NULL
--	NULL
CsA	NULL
-	NULL
CsA	NULL
-	NULL
CsA	NULL
#	NULL
I	NULL
I	NULL
100r	NULL
3	NULL
#	NULL
®	NULL
U	NULL
#	NULL
#	NULL
&	NULL
A	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
-61	NULL
TNF	NULL
-a	NULL
mea	NULL
LT	NULL
(	NULL
x3	NULL
)	NULL
5-61TNF	NULL
-a	NULL
fold	NULL
)	NULL
that	NULL
was	NULL
blocked	NULL
by	NULL
CsA	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
B	NULL
,	NULL
lanes	NULL
4-6	NULL
)	NULL
.	NULL

In	NULL
conclusion	NULL
,	NULL
this	NULL
analysis	NULL
indicated	NULL
that	NULL
«	NULL
3	NULL
sequences	NULL
are	NULL
sufficient	NULL
to	NULL
mediate	NULL
CsA-sensitive	NULL
transcriptional	NULL
induction	NULL
in	NULL
response	NULL
to	NULL
«	NULL
CD3	NULL
or	NULL
ionomycin	NULL
.	NULL

When	NULL
the	NULL
«	NULL
3	NULL
multimers	NULL
were	NULL
fused	NULL
to	NULL
a	NULL
heterologous	NULL
promoter	NULL
(	NULL
-128	NULL
they	NULL
did	NULL
not	NULL
confer	NULL
either	NULL
inducibility	NULL
or	NULL
CsA	NULL
sensitivity	NULL
on	NULL
the	NULL
CAT	NULL
reporter	NULL
gene	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
the	NULL
x3	NULL
element	NULL
behaved	NULL
in	NULL
T	NULL
cells	NULL
as	NULL
an	NULL
«	NULL
CD3	NULL
,	NULL
calcium-inducible	NULL
,	NULL
and	NULL
CsA-sensitive	NULL
transcriptional	NULL
promoter	NULL
element	NULL
in	NULL
the	NULL
context	NULL
of	NULL
its	NULL
own	NULL
minimal	NULL
TNF-a	NULL
gene	NULL
promoter	NULL
.	NULL

A	NULL
T	NULL
K3	NULL
|	NULL
60	NULL
120	NULL
,	NULL
240	NULL
,	NULL
-o	NULL
-	NULL
4	NULL
-	NULL
4	NULL
--	NULL
+	NULL
“	NULL
Fi'luiuiﬁ	NULL
‘	NULL
r	NULL
1	NULL
2	NULL
3	NULL
min	NULL
post	NULL
induction	NULL
:	NULL
_	NULL
O	NULL
[	NULL
1	NULL
[	NULL
CSA	NULL
:	NULL
-o	NULL
+-	NULL
+	NULL
L	NULL
=-	NULL
Upper	NULL
--	NULL
Lower	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
10	NULL
11	NULL
12	NULL
4	NULL
--	NULL
61TNF-a	NULL
-	NULL
r	NULL
(	NULL
x3	NULL
)	NULL
%	NULL
61TNF-a-	NULL
r	NULL
--	NULL
CsA	NULL
Figure	NULL
6	NULL
.	NULL

-	NULL
Six	NULL
copies	NULL
of	NULL
x3	NULL
act	NULL
as	NULL
an	NULL
@	NULL
CD3	NULL
or	NULL
ionomycin	NULL
.	NULL

inducible	NULL
,	NULL
CsA-sensitive	NULL
promoter	NULL
element	NULL
when	NULL
fused	NULL
to	NULL
a	NULL
minimal	NULL
TNF-	NULL
promoter	NULL
in	NULL
Ar-5	NULL
T	NULL
cells	NULL
.	NULL

(	NULL
4	NULL
)	NULL
Autoradiogram	NULL
shows	NULL
results	NULL
of	NULL
CAT	NULL
assays	NULL
of	NULL
extracts	NULL
prepared	NULL
from	NULL
Ar-5	NULL
cells	NULL
transfected	NULL
with	NULL
the	NULL
plasmids	NULL
diagrammed	NULL
.	NULL

Cells	NULL
were	NULL
transfected	NULL
and	NULL
either	NULL
mock	NULL
induced	NULL
(	NULL
-	NULL
)	NULL
or	NULL
induced	NULL
with	NULL
eCD3	NULL
for	NULL
18	NULL
h	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
CsA	NULL
as	NULL
indicated	NULL
.	NULL

The	NULL
x3	NULL
oligomer	NULL
contains	NULL
-106	NULL
to	NULL
-87	NULL
n	NULL
relative	NULL
to	NULL
the	NULL
TNF-	NULL
cap	NULL
site	NULL
and	NULL
a	NULL
BamHI	NULL
and	NULL
Bglll	NULL
linker	NULL
at	NULL
its	NULL
5°	NULL
and	NULL
3	NULL
'	NULL
ends	NULL
,	NULL
respectively	NULL
.	NULL

The	NULL
(	NULL
«	NULL
3	NULL
)	NULL
5-61TNF-a	NULL
construct	NULL
is	NULL
described	NULL
in	NULL
Goldfeld	NULL
et	NULL
al	NULL
.	NULL

(	NULL
16	NULL
)	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Autoradiogram	NULL
shows	NULL
the	NULL
results	NULL
of	NULL
CAT	NULL
assays	NULL
of	NULL
extracts	NULL
from	NULL
cells	NULL
transfected	NULL
with	NULL
the	NULL
plasmids	NULL
diagrammed	NULL
(	NULL
A	NULL
)	NULL
that	NULL
were	NULL
induced	NULL
with	NULL
1	NULL
uM	NULL
ionomycin	NULL
for	NULL
18	NULL
h	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
CsA	NULL
as	NULL
indicated	NULL
.	NULL

CsA	NULL
was	NULL
added	NULL
10	NULL
min	NULL
before	NULL
stimulation	NULL
with	NULL
«	NULL
CD3	NULL
(	NULL
A	NULL
)	NULL
or	NULL
ionomycin	NULL
(	NULL
B	NULL
)	NULL
.	NULL

The	NULL
results	NULL
are	NULL
representative	NULL
of	NULL
four	NULL
independent	NULL
experiments	NULL
.	NULL

5	NULL
6	NULL
Rapid	NULL
Protein	NULL
Synthesis-independent	NULL
Induction	NULL
of	NULL
a	NULL
CsA-sensitive	NULL
«	NULL
3	NULL
Binding	NULL
Factor	NULL
(	NULL
s	NULL
)	NULL
in	NULL
Stimulated	NULL
T	NULL
Cells	NULL
TCR	NULL
Stimuli	NULL
.	NULL

To	NULL
further	NULL
characterize	NULL
the	NULL
x3	NULL
element	NULL
and	NULL
to	NULL
test	NULL
whether	NULL
«	NULL
3	NULL
could	NULL
bind	NULL
to	NULL
an	NULL
inducible	NULL
,	NULL
CsA-sensitive	NULL
nuclear	NULL
factor	NULL
in	NULL
stimulated	NULL
T	NULL
cells	NULL
,	NULL
nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
from	NULL
Ar-5	NULL
cells	NULL
that	NULL
had	NULL
been	NULL
stimulated	NULL
with	NULL
«	NULL
CD3	NULL
in	NULL
the	NULL
presence	NULL
and	NULL
absence	NULL
of	NULL
CsA	NULL
for	NULL
the	NULL
various	NULL
times	NULL
indicated	NULL
in	NULL
Fig	NULL
.	NULL

7	NULL
A	NULL
.	NULL

Using	NULL
the	NULL
x3	NULL
oligonucleotide	NULL
spanning	NULL
the	NULL
sequences	NULL
from	NULL
-106	NULL
to	NULL
-87	NULL
n	NULL
relative	NULL
to	NULL
the	NULL
TNF	NULL
B	NULL
min	NULL
.	NULL

post	NULL
[	NULL
x3	NULL
'	NULL
induction	NULL
:	NULL
_	NULL
O	NULL
15	NULL
30	NULL
60	NULL
120	NULL
240	NULL
-	NULL
£-	NULL
2	NULL
PLC	NULL
RPC	NULL
PCW	NULL
bud	NULL
bos	NULL
bag	NULL
ly	NULL
}	NULL
W	NULL
#	NULL
®	NULL
un	NULL
=-	NULL
Upper	NULL
=-	NULL
Lower	NULL
Doug	NULL
ag	NULL
ue	NULL
er	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
°	NULL
6	NULL
7	NULL
8	NULL
9	NULL
10	NULL
1112	NULL
Figure	NULL
7	NULL
.	NULL

|	NULL
Induction	NULL
of	NULL
nuclear	NULL
«	NULL
3	NULL
binding	NULL
complexes	NULL
by	NULL
(	NULL
CD3	NULL
.	NULL

Gel	NULL
shift	NULL
experiments	NULL
with	NULL
nuclear	NULL
extracts	NULL
from	NULL
stimulated	NULL
and	NULL
unstimulated	NULL
Ar-5	NULL
T	NULL
cells	NULL
using	NULL
chemically	NULL
synthesized	NULL
x3	NULL
oligonucleotide	NULL
as	NULL
a	NULL
probe	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Kinetics	NULL
and	NULL
CsA	NULL
sensitivity	NULL
of	NULL
induction	NULL
of	NULL
the	NULL
«	NULL
3	NULL
binding	NULL
complexes	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
from	NULL
Ar-5	NULL
T	NULL
cells	NULL
that	NULL
had	NULL
been	NULL
induced	NULL
with	NULL
eCD3	NULL
for	NULL
the	NULL
times	NULL
indicated	NULL
(	NULL
min	NULL
)	NULL
in	NULL
the	NULL
presence	NULL
(	NULL
+	NULL
)	NULL
or	NULL
absence	NULL
(	NULL
-	NULL
)	NULL
of	NULL
CsA	NULL
.	NULL

(	NULL
Arrows	NULL
)	NULL
The	NULL
two	NULL
inducible	NULL
protein-DNA	NULL
complexes	NULL
(	NULL
Upper	NULL
and	NULL
Lower	NULL
)	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Insensitivity	NULL
of	NULL
the	NULL
induction	NULL
of	NULL
the	NULL
x3	NULL
binding	NULL
complexes	NULL
to	NULL
protein	NULL
synthesis	NULL
inhibitors	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
from	NULL
Ar-5	NULL
cells	NULL
that	NULL
had	NULL
been	NULL
induced	NULL
with	NULL
eCD3	NULL
for	NULL
the	NULL
times	NULL
indicated	NULL
in	NULL
the	NULL
presence	NULL
(	NULL
+	NULL
)	NULL
or	NULL
absence	NULL
(	NULL
-	NULL
)	NULL
of	NULL
the	NULL
protein	NULL
synthesis	NULL
inhibitors	NULL
cycloheximide	NULL
(	NULL
CHX	NULL
)	NULL
and	NULL
anisomycin	NULL
(	NULL
ANIS	NULL
)	NULL
.	NULL

CHX/ANIS	NULL
was	NULL
added	NULL
30	NULL
min	NULL
before	NULL
induction	NULL
with	NULL
«	NULL
CD3	NULL
.	NULL

1371	NULL
Goldfeld	NULL
et	NULL
al	NULL
.	NULL

A	NULL
B	NULL
-61n	NULL
Probe	NULL
«	NULL
-	NULL
-27n=-	NULL
Probe	NULL
-	NULL
i	NULL
--	NULL
64n	NULL
to	NULL
-27n	NULL
3	NULL
-	NULL
3	NULL
I=	NULL
C	NULL
s=	NULL
65	NULL
-	NULL
3	NULL
06	NULL
<	NULL
<	NULL
30	NULL
-	NULL
10	NULL
3	NULL
=	NULL
T	NULL
3	NULL
=	NULL
%	NULL
o	NULL
o	NULL
o	NULL
Oo	NULL
4	NULL
o	NULL
O	NULL
zZ	NULL
i	NULL
s	NULL
§	NULL
_	NULL
§	NULL
5	NULL
;	NULL
S	NULL
}	NULL
5	NULL
S	NULL
%	NULL
-	NULL
19	NULL
18	NULL
-	NULL
14	NULL
19	NULL
e	NULL
o	NULL
y	NULL
Q	NULL
o	NULL
o	NULL
o	NULL
<	NULL
C	NULL
C	NULL
c	NULL
<	NULL
GC	NULL
X	NULL
c	NULL
__	NULL
09	NULL
w	NULL
0	NULL
L	NULL
0	NULL
_	NULL
6	NULL
a	NULL
°	NULL
T	NULL
6	NULL
vo	NULL
ue	NULL
on	NULL
an	NULL
mes	NULL
a	NULL
8	NULL
4	NULL
5	NULL
a	NULL
-	NULL
a	NULL
8	NULL
na	NULL
5	NULL
A	NULL
Upper	NULL
-	NULL
H	NULL
-	NULL
»	NULL
W	NULL
WAln	NULL
-	NULL
==	NULL
Uoper-Lower	NULL
|	NULL
Lower	NULL
-	NULL
u	NULL
L_	NULL
bp	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
Figure	NULL
8.	NULL
i	NULL
:	NULL
I	NULL
M.	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
Ionomycin	NULL
induces	NULL
the	NULL
«	NULL
3	NULL
binding	NULL
complexes	NULL
in	NULL
Ar-5	NULL
nuclear	NULL
extracts	NULL
.	NULL

Gel	NULL
shift	NULL
experiments	NULL
were	NULL
performed	NULL
using	NULL
the	NULL
x3	NULL
and	NULL
-61	NULL
to	NULL
¥	NULL
TE	NULL
,	NULL
S	NULL
C	NULL
VC	NULL
CE	NULL
d	NULL
¥	NULL
«	NULL
TIK	NULL
7	NULL
8	NULL
9	NULL
10	NULL
11	NULL
12	NULL
-27	NULL
n	NULL
oligonucleotides	NULL
as	NULL
probes	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Ar-5	NULL
cells	NULL
were	NULL
mock	NULL
(	NULL
-	NULL
)	NULL
induced	NULL
or	NULL
induced	NULL
with	NULL
1	NULL
uM	NULL
ionomycin	NULL
or	NULL
100	NULL
nM	NULL
ionomycin	NULL
as	NULL
indicated	NULL
for	NULL
30	NULL
min	NULL
and	NULL
nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
.	NULL

Treatment	NULL
with	NULL
1	NULL
uM	NULL
ionomycin	NULL
results	NULL
in	NULL
the	NULL
appearance	NULL
of	NULL
the	NULL
upper	NULL
and	NULL
lower	NULL
3	NULL
binding	NULL
complexes	NULL
{	NULL
compare	NULL
lanes	NULL
1	NULL
and	NULL
2	NULL
)	NULL
.	NULL

100	NULL
nM	NULL
of	NULL
ionomycin	NULL
results	NULL
in	NULL
the	NULL
appearance	NULL
of	NULL
the	NULL
lower	NULL
complex	NULL
but	NULL
not	NULL
the	NULL
upper	NULL
complex	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
.	NULL

The	NULL
-61	NULL
to	NULL
-27	NULL
n	NULL
probe	NULL
binds	NULL
to	NULL
a	NULL
constitutive	NULL
factor	NULL
that	NULL
is	NULL
not	NULL
induced	NULL
by	NULL
ionomycin	NULL
(	NULL
lanes	NULL
4-6	NULL
)	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Ionomycin	NULL
induction	NULL
the	NULL
«	NULL
3	NULL
binding	NULL
complex	NULL
is	NULL
blocked	NULL
by	NULL
CsA	NULL
and	NULL
does	NULL
not	NULL
require	NULL
de	NULL
novo	NULL
protein	NULL
synthesis	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
from	NULL
Ar-5	NULL
cells	NULL
that	NULL
were	NULL
mock	NULL
induced	NULL
(	NULL
-	NULL
)	NULL
,	NULL
treated	NULL
with	NULL
CsA	NULL
alone	NULL
,	NULL
or	NULL
CHX/ANIS	NULL
alone	NULL
,	NULL
or	NULL
induced	NULL
with	NULL
1	NULL
uM	NULL
ionomycin	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
CsA	NULL
or	NULL
CHX/ANIS	NULL
as	NULL
indicated	NULL
.	NULL

The	NULL
nuclear	NULL
extracts	NULL
were	NULL
bound	NULL
to	NULL
the	NULL
«	NULL
3	NULL
oligonucleotide	NULL
or	NULL
the	NULL
-61	NULL
n	NULL
to	NULL
-27	NULL
n	NULL
oligonucleotide	NULL
as	NULL
indicated	NULL
.	NULL

mRNA	NULL
cap	NULL
site	NULL
in	NULL
an	NULL
EMSA	NULL
,	NULL
two	NULL
inducible	NULL
complexes	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
,	NULL
upper	NULL
and	NULL
lower	NULL
)	NULL
were	NULL
detected	NULL
.	NULL

These	NULL
complexes	NULL
were	NULL
apparent	NULL
within	NULL
15	NULL
min	NULL
of	NULL
activation	NULL
by	NULL
eCD3	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
,	NULL
lanes	NULL
1	NULL
and	NULL
3	NULL
)	NULL
,	NULL
and	NULL
were	NULL
maximally	NULL
induced	NULL
at	NULL
30	NULL
min	NULL
after	NULL
stimulation	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
,	NULL
lane	NULL
5	NULL
)	NULL
.	NULL

By	NULL
4	NULL
h	NULL
after	NULL
«	NULL
CD3	NULL
induction	NULL
,	NULL
the	NULL
upper	NULL
complex	NULL
was	NULL
barely	NULL
detectable	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
,	NULL
lane	NULL
11	NULL
)	NULL
,	NULL
whereas	NULL
the	NULL
intensity	NULL
of	NULL
the	NULL
lower	NULL
complex	NULL
was	NULL
significantly	NULL
decreased	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
,	NULL
lane	NULL
11	NULL
)	NULL
.	NULL

Induction	NULL
of	NULL
both	NULL
inducible	NULL
complexes	NULL
was	NULL
completely	NULL
blocked	NULL
at	NULL
all	NULL
time	NULL
points	NULL
by	NULL
pretreatment	NULL
of	NULL
the	NULL
cells	NULL
with	NULL
CsA	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
,	NULL
lanes	NULL
4	NULL
,	NULL
6	NULL
,	NULL
8	NULL
,	NULL
and	NULL
10	NULL
)	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
induction	NULL
of	NULL
the	NULL
£3	NULL
binding	NULL
factor	NULL
(	NULL
s	NULL
)	NULL
required	NULL
prior	NULL
protein	NULL
synthesis	NULL
,	NULL
nuclear	NULL
extracts	NULL
from	NULL
Ar-5	NULL
cells	NULL
that	NULL
had	NULL
been	NULL
induced	NULL
with	NULL
«	NULL
CD3	NULL
for	NULL
various	NULL
times	NULL
in	NULL
the	NULL
presence	NULL
and	NULL
absence	NULL
of	NULL
protein	NULL
synthesis	NULL
inhibitors	NULL
were	NULL
tested	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

7	NULL
B	NULL
,	NULL
de	NULL
novo	NULL
protein	NULL
synthesis	NULL
is	NULL
not	NULL
required	NULL
for	NULL
induction	NULL
of	NULL
x3	NULL
binding	NULL
activity	NULL
since	NULL
cycloheximide	NULL
and	NULL
anisomycin	NULL
did	NULL
not	NULL
prevent	NULL
or	NULL
delay	NULL
the	NULL
appearance	NULL
of	NULL
«	NULL
3	NULL
binding	NULL
activity	NULL
after	NULL
«	NULL
CD3	NULL
induction	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
,	NULL
lanes	NULL
3	NULL
and	NULL
4	NULL
)	NULL
.	NULL

We	NULL
conclude	NULL
that	NULL
the	NULL
x3	NULL
element	NULL
specifically	NULL
binds	NULL
to	NULL
an	NULL
eCD3-inducible	NULL
,	NULL
CsA-sensitive	NULL
,	NULL
protein	NULL
synthesis-independent	NULL
factor	NULL
(	NULL
s	NULL
)	NULL
that	NULL
is	NULL
induced	NULL
within	NULL
minutes	NULL
1372	NULL
of	NULL
T	NULL
cell	NULL
activation	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
inducible	NULL
binding	NULL
characteristics	NULL
of	NULL
the	NULL
x3	NULL
binding	NULL
factor	NULL
(	NULL
s	NULL
)	NULL
are	NULL
entirely	NULL
concordant	NULL
with	NULL
the	NULL
requirements	NULL
for	NULL
induction	NULL
of	NULL
TNF-a	NULL
gene	NULL
transcription	NULL
.	NULL

As	NULL
an	NULL
internal	NULL
control	NULL
for	NULL
specificity	NULL
of	NULL
binding	NULL
and	NULL
protein	NULL
loading	NULL
in	NULL
the	NULL
experiments	NULL
displayed	NULL
in	NULL
Fig	NULL
.	NULL

7	NULL
,	NULL
we	NULL
tested	NULL
the	NULL
same	NULL
nuclear	NULL
extracts	NULL
in	NULL
an	NULL
EMSA	NULL
using	NULL
an	NULL
oligonucleotide	NULL
spanning	NULL
the	NULL
sequences	NULL
-61	NULL
to	NULL
-26	NULL
n	NULL
relative	NULL
to	NULL
the	NULL
TNF-	NULL
@	NULL
mRNA	NULL
cap	NULL
site	NULL
(	NULL
-61	NULL
to	NULL
-27	NULL
n	NULL
)	NULL
as	NULL
a	NULL
probe	NULL
.	NULL

As	NULL
expected	NULL
from	NULL
the	NULL
functional	NULL
data	NULL
demonstrating	NULL
that	NULL
these	NULL
sequences	NULL
were	NULL
not	NULL
primarily	NULL
involved	NULL
in	NULL
the	NULL
eCD3	NULL
CsA-sensitive	NULL
induction	NULL
of	NULL
the	NULL
TNF-a	NULL
gene	NULL
,	NULL
the	NULL
expression	NULL
of	NULL
a	NULL
constitutive	NULL
factor	NULL
binding	NULL
these	NULL
sequences	NULL
were	NULL
not	NULL
increased	NULL
by	NULL
«	NULL
CD3	NULL
,	NULL
or	NULL
affected	NULL
by	NULL
treatment	NULL
with	NULL
CsA	NULL
or	NULL
protein	NULL
synthesis	NULL
inhibitors	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
the	NULL
inducible	NULL
CsA-sensitive	NULL
binding	NULL
activity	NULL
in	NULL
these	NULL
nuclear	NULL
extracts	NULL
was	NULL
detected	NULL
specifically	NULL
using	NULL
the	NULL
x3	NULL
oligonucleotide	NULL
as	NULL
a	NULL
probe	NULL
.	NULL

Furthermore	NULL
,	NULL
the	NULL
SP1	NULL
binding	NULL
motif	NULL
that	NULL
occurs	NULL
within	NULL
the	NULL
sequences	NULL
spanning	NULL
-61	NULL
to	NULL
~27	NULL
n	NULL
was	NULL
shown	NULL
to	NULL
be	NULL
involved	NULL
in	NULL
the	NULL
constitutive	NULL
binding	NULL
to	NULL
the	NULL
-61	NULL
to	NULL
-27	NULL
n	NULL
probe	NULL
as	NULL
an	NULL
excess	NULL
of	NULL
nonradiolabeled	NULL
wild-type	NULL
oligonucleotide	NULL
competed	NULL
for	NULL
binding	NULL
,	NULL
whereas	NULL
an	NULL
oligonucleotide	NULL
containing	NULL
a	NULL
Novel	NULL
CsA-sensitive	NULL
Element	NULL
in	NULL
Human	NULL
TNF-	NULL
Gene	NULL
Promoter	NULL
r	NULL
K3	NULL
1	NULL
,	NULL
PRD	NULL
-kB	NULL
--	NULL
Competitor	NULL
-	NULL
k3	NULL
1	NULL
k2	NULL
IL	NULL
WT	NULL
MS	NULL
M3	NULL
NFAT	NULL
\	NULL
.	NULL

A	NULL
=-	NULL
Upper	NULL
bad	NULL
haid	NULL
=-	NULL
Lower	NULL
bue	NULL
bu	NULL
evey	NULL
1002	NULL
?	NULL

3	NULL
4	NULL
5	NULL
06	NULL
7	NULL
8	NULL
9	NULL
Figure	NULL
9	NULL
.	NULL

-	NULL
Specificity	NULL
of	NULL
binding	NULL
of	NULL
the	NULL
x3	NULL
binding	NULL
complexes	NULL
.	NULL

Nuclear	NULL
extracts	NULL
from	NULL
cells	NULL
that	NULL
had	NULL
been	NULL
induced	NULL
for	NULL
30	NULL
min	NULL
with	NULL
eCD3	NULL
were	NULL
bound	NULL
to	NULL
P	NULL
endlabeled	NULL
x3	NULL
oligonucleotide	NULL
alone	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
or	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
a	NULL
500-fold	NULL
excess	NULL
of	NULL
unlabeled	NULL
«	NULL
3	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
,	NULL
«	NULL
1	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
,	NULL
x2	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
,	NULL
PRDII	NULL
(	NULL
lane	NULL
5	NULL
)	NULL
,	NULL
NF-xB	NULL
(	NULL
WT	NULL
)	NULL
(	NULL
lane	NULL
6	NULL
)	NULL
,	NULL
MS5	NULL
'	NULL
(	NULL
lane	NULL
7	NULL
)	NULL
,	NULL
M3	NULL
'	NULL
(	NULL
lane	NULL
8	NULL
)	NULL
,	NULL
or	NULL
NFAT	NULL
(	NULL
lane	NULL
9	NULL
)	NULL
oligonucleotides	NULL
.	NULL

The	NULL
sequences	NULL
of	NULL
the	NULL
oligonucleotides	NULL
are	NULL
detailed	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

mutation	NULL
in	NULL
the	NULL
Sp1	NULL
site	NULL
did	NULL
not	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
sequences	NULL
spanning	NULL
-61	NULL
to	NULL
-27	NULL
n	NULL
specifically	NULL
bind	NULL
to	NULL
a	NULL
constitutive	NULL
factor	NULL
that	NULL
may	NULL
be	NULL
Sp1	NULL
.	NULL

Ca	NULL
``	NULL
+	NULL
Ionophore	NULL
Nuclear	NULL
extracts	NULL
from	NULL
Ar-5	NULL
cells	NULL
that	NULL
had	NULL
been	NULL
stimulated	NULL
with	NULL
the	NULL
calcium	NULL
ionophore	NULL
ionomycin	NULL
for	NULL
15	NULL
min	NULL
were	NULL
also	NULL
tested	NULL
for	NULL
the	NULL
presence	NULL
of	NULL
«	NULL
3	NULL
binding	NULL
activity	NULL
.	NULL

As	NULL
demonstrated	NULL
in	NULL
Fig	NULL
.	NULL

8	NULL
A	NULL
,	NULL
the	NULL
inducible	NULL
upper	NULL
and	NULL
lower	NULL
«	NULL
3	NULL
binding	NULL
complexes	NULL
were	NULL
apparent	NULL
in	NULL
nuclear	NULL
extracts	NULL
from	NULL
cells	NULL
treated	NULL
with	NULL
1	NULL
uM	NULL
of	NULL
ionomycin	NULL
but	NULL
not	NULL
in	NULL
nuclear	NULL
extracts	NULL
from	NULL
uninduced	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

8	NULL
,	NULL
lanes	NULL
1	NULL
and	NULL
2	NULL
)	NULL
.	NULL

A	NULL
lower	NULL
concentration	NULL
of	NULL
ionomycin	NULL
(	NULL
100	NULL
nM	NULL
)	NULL
slightly	NULL
induced	NULL
the	NULL
lower	NULL
complex	NULL
(	NULL
Fig	NULL
.	NULL

8	NULL
,	NULL
lane	NULL
3	NULL
)	NULL
.	NULL

The	NULL
equivalence	NULL
of	NULL
protein	NULL
loading	NULL
and	NULL
the	NULL
specificity	NULL
of	NULL
x3	NULL
inducible	NULL
binding	NULL
was	NULL
confirmed	NULL
by	NULL
using	NULL
the	NULL
same	NULL
extracts	NULL
to	NULL
bind	NULL
to	NULL
the	NULL
-61	NULL
to	NULL
-27	NULL
n	NULL
probe	NULL
(	NULL
Fig	NULL
.	NULL

8	NULL
,	NULL
lanes	NULL
4-6	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
ionomycin-mediated	NULL
induction	NULL
of	NULL
the	NULL
upper	NULL
and	NULL
lower	NULL
x3	NULL
binding	NULL
complexes	NULL
was	NULL
blocked	NULL
by	NULL
CsA	NULL
(	NULL
Fig	NULL
.	NULL

8	NULL
B	NULL
,	NULL
compare	NULL
lanes	NULL
2	NULL
and	NULL
4	NULL
)	NULL
and	NULL
was	NULL
unaffected	NULL
by	NULL
protein	NULL
synthesis	NULL
inhibitors	NULL
(	NULL
Fig	NULL
.	NULL

8	NULL
,	NULL
lane	NULL
6	NULL
)	NULL
.	NULL

Again	NULL
the	NULL
-61	NULL
to	NULL
-27	NULL
n	NULL
probe	NULL
bound	NULL
to	NULL
a	NULL
constitutive	NULL
factor	NULL
whose	NULL
binding	NULL
was	NULL
unaffected	NULL
under	NULL
these	NULL
conditions	NULL
(	NULL
Fig	NULL
.	NULL

8	NULL
,	NULL
lanes	NULL
7-12	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
as	NULL
in	NULL
the	NULL
case	NULL
with	NULL
«	NULL
CD3	NULL
induction	NULL
,	NULL
ionomycin-inducible	NULL
binding	NULL
of	NULL
the	NULL
x3	NULL
binding	NULL
factor	NULL
(	NULL
s	NULL
)	NULL
paralleled	NULL
TNF-a	NULL
mRNA	NULL
induction	NULL
by	NULL
ionomycin	NULL
.	NULL

Characterization	NULL
of	NULL
the	NULL
«	NULL
3	NULL
Binding	NULL
Factor	NULL
(	NULL
s	NULL
)	NULL
The	NULL
«	NULL
3	NULL
Binding	NULL
Factor	NULL
Is	NULL
Distinct	NULL
from	NULL
NF-KB	NULL
but	NULL
May	NULL
Resemble	NULL
NFAT	NULL
.	NULL

-	NULL
To	NULL
establish	NULL
that	NULL
the	NULL
inducible	NULL
x3	NULL
binding	NULL
1373	NULL
Goldfeld	NULL
et	NULL
al	NULL
.	NULL

complexes	NULL
bound	NULL
specifically	NULL
to	NULL
the	NULL
«	NULL
3	NULL
sequence	NULL
,	NULL
the	NULL
ability	NULL
of	NULL
nuclear	NULL
extracts	NULL
from	NULL
stimulated	NULL
T	NULL
cells	NULL
to	NULL
bind	NULL
to	NULL
the	NULL
radiolabeled	NULL
«	NULL
3	NULL
oligonucleotide	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
an	NULL
excess	NULL
of	NULL
unlabeled	NULL
«	NULL
3	NULL
competitor	NULL
oligonucleotide	NULL
was	NULL
tested	NULL
.	NULL

Unlabeled	NULL
«	NULL
3	NULL
oligonucleotide	NULL
competed	NULL
for	NULL
binding	NULL
to	NULL
both	NULL
the	NULL
upper	NULL
and	NULL
lower	NULL
complexes	NULL
(	NULL
Fig	NULL
.	NULL

9	NULL
,	NULL
lanes	NULL
1-2	NULL
)	NULL
,	NULL
whereas	NULL
oligonucleotides	NULL
corresponding	NULL
to	NULL
the	NULL
two	NULL
other	NULL
NF-	NULL
«	NULL
B	NULL
consensus	NULL
sites	NULL
in	NULL
the	NULL
TNF-a	NULL
promoter	NULL
,	NULL
x1	NULL
and	NULL
«	NULL
2	NULL
,	NULL
which	NULL
are	NULL
not	NULL
involved	NULL
in	NULL
the	NULL
induction	NULL
and	NULL
CsA	NULL
sensitivity	NULL
of	NULL
the	NULL
gene	NULL
(	NULL
see	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
,	NULL
did	NULL
not	NULL
compete	NULL
for	NULL
binding	NULL
(	NULL
Fig	NULL
.	NULL

9	NULL
,	NULL
lanes	NULL
3	NULL
and	NULL
4	NULL
)	NULL
.	NULL

Previous	NULL
studies	NULL
(	NULL
16	NULL
)	NULL
employing	NULL
human	NULL
B	NULL
cell	NULL
nuclear	NULL
extracts	NULL
had	NULL
demonstrated	NULL
that	NULL
x1	NULL
,	NULL
x2	NULL
,	NULL
and	NULL
x3	NULL
specifically	NULL
bound	NULL
a	NULL
complex	NULL
that	NULL
could	NULL
be	NULL
competed	NULL
by	NULL
an	NULL
oligonucleotide	NULL
matching	NULL
the	NULL
murine	NULL
Ig	NULL
x	NULL
chain	NULL
enhancer	NULL
NF-KB	NULL
site	NULL
,	NULL
but	NULL
not	NULL
by	NULL
an	NULL
oligonucleotide	NULL
that	NULL
was	NULL
mutated	NULL
in	NULL
three	NULL
guanine	NULL
residues	NULL
absolutely	NULL
required	NULL
for	NULL
NF-KB	NULL
binding	NULL
.	NULL

Therefore	NULL
,	NULL
whereas	NULL
x1	NULL
,	NULL
x2	NULL
,	NULL
«	NULL
3	NULL
,	NULL
and	NULL
the	NULL
Ig	NULL
x	NULL
chain	NULL
enhancer	NULL
NF-KB	NULL
site	NULL
are	NULL
all	NULL
capable	NULL
of	NULL
binding	NULL
to	NULL
the	NULL
same	NULL
protein	NULL
in	NULL
B	NULL
cells	NULL
,	NULL
the	NULL
K3	NULL
binding	NULL
factor	NULL
appears	NULL
specific	NULL
for	NULL
the	NULL
«	NULL
3	NULL
site	NULL
alone	NULL
,	NULL
consistent	NULL
with	NULL
the	NULL
unique	NULL
role	NULL
of	NULL
this	NULL
site	NULL
in	NULL
the	NULL
induction	NULL
of	NULL
the	NULL
TNF-a	NULL
gene	NULL
in	NULL
activated	NULL
T	NULL
cells	NULL
.	NULL

Subsequent	NULL
studies	NULL
established	NULL
that	NULL
x3	NULL
does	NULL
not	NULL
form	NULL
any	NULL
DNA-protein	NULL
complex	NULL
with	NULL
purified	NULL
p50/p65	NULL
NF-KB	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
indicating	NULL
that	NULL
the	NULL
x3	NULL
binding	NULL
factor	NULL
is	NULL
distinct	NULL
from	NULL
the	NULL
p50	NULL
homodimer	NULL
or	NULL
the	NULL
p50/p65	NULL
NK-	NULL
«	NULL
B	NULL
heterodimer	NULL
.	NULL

The	NULL
«	NULL
3	NULL
site	NULL
can	NULL
bind	NULL
to	NULL
proteins	NULL
in	NULL
cellular	NULL
extracts	NULL
from	NULL
Ntera	NULL
cells	NULL
transfected	NULL
with	NULL
c-rel	NULL
and	NULL
p50	NULL
(	NULL
54	NULL
,	NULL
55	NULL
)	NULL
,	NULL
however	NULL
,	NULL
the	NULL
complex	NULL
formed	NULL
migrates	NULL
with	NULL
different	NULL
mobility	NULL
from	NULL
the	NULL
x3	NULL
binding	NULL
complex	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Moreover	NULL
,	NULL
antibodies	NULL
to	NULL
c-rel	NULL
,	NULL
p50	NULL
,	NULL
and	NULL
p65	NULL
(	NULL
56	NULL
)	NULL
do	NULL
not	NULL
react	NULL
with	NULL
the	NULL
«	NULL
3	NULL
binding	NULL
complex	NULL
detected	NULL
in	NULL
nuclear	NULL
extracts	NULL
from	NULL
Ar-5	NULL
cells	NULL
stimulated	NULL
with	NULL
«	NULL
CD3	NULL
or	NULL
ionomycin	NULL
or	NULL
from	NULL
Ar-5	NULL
cytosolic	NULL
extracts	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

We	NULL
conclude	NULL
that	NULL
the	NULL
x3	NULL
binding	NULL
complex	NULL
in	NULL
activated	NULL
T	NULL
cells	NULL
does	NULL
not	NULL
contain	NULL
c-rel	NULL
,	NULL
p50	NULL
,	NULL
or	NULL
p65	NULL
,	NULL
and	NULL
is	NULL
thus	NULL
distinct	NULL
from	NULL
NF-KB	NULL
.	NULL

Other	NULL
studies	NULL
employing	NULL
nuclear	NULL
extracts	NULL
from	NULL
stimulated	NULL
T	NULL
cells	NULL
showed	NULL
that	NULL
an	NULL
NFAT	NULL
-like	NULL
factor	NULL
bound	NULL
to	NULL
the	NULL
Ig	NULL
k	NULL
chain	NULL
enhancer	NULL
NF-KB	NULL
site	NULL
,	NULL
and	NULL
this	NULL
binding	NULL
involved	NULL
residues	NULL
at	NULL
the	NULL
3	NULL
'	NULL
end	NULL
of	NULL
the	NULL
«	NULL
B	NULL
site	NULL
(	NULL
49	NULL
)	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
the	NULL
«	NULL
3	NULL
binding	NULL
factor	NULL
might	NULL
be	NULL
related	NULL
to	NULL
this	NULL
NFAT	NULL
-like	NULL
factor	NULL
,	NULL
a	NULL
competition	NULL
analysis	NULL
was	NULL
done	NULL
with	NULL
Ig	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
NFAT	NULL
oligonucleotides	NULL
.	NULL

Oligonucleotides	NULL
matching	NULL
the	NULL
wild-type	NULL
Ig	NULL
k	NULL
chain	NULL
enhancer	NULL
NF-KB	NULL
site	NULL
(	NULL
WT	NULL
)	NULL
,	NULL
and	NULL
the	NULL
NF-KB	NULL
site	NULL
from	NULL
the	NULL
IFN-	NULL
(	NULL
gene	NULL
(	NULL
PRDII	NULL
)	NULL
competed	NULL
for	NULL
binding	NULL
of	NULL
the	NULL
«	NULL
3	NULL
binding	NULL
factor	NULL
.	NULL

However	NULL
,	NULL
an	NULL
Ig	NULL
NF-KB	NULL
oligonucleotide	NULL
that	NULL
was	NULL
mutated	NULL
in	NULL
three	NULL
guanine	NULL
residues	NULL
absolutely	NULL
required	NULL
for	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
(	NULL
27	NULL
)	NULL
also	NULL
competed	NULL
for	NULL
binding	NULL
to	NULL
the	NULL
«	NULL
3	NULL
oligonucleotide	NULL
(	NULL
M5	NULL
,	NULL
Fig	NULL
.	NULL

9	NULL
,	NULL
lane	NULL
7	NULL
)	NULL
,	NULL
whereas	NULL
an	NULL
oligonucleotide	NULL
mutated	NULL
in	NULL
the	NULL
3	NULL
'	NULL
residues	NULL
was	NULL
no	NULL
longer	NULL
able	NULL
to	NULL
compete	NULL
for	NULL
binding	NULL
(	NULL
M3	NULL
'	NULL
,	NULL
Fig	NULL
.	NULL

9	NULL
,	NULL
lane	NULL
8	NULL
)	NULL
.	NULL

This	NULL
pattern	NULL
of	NULL
competition	NULL
was	NULL
identical	NULL
to	NULL
that	NULL
seen	NULL
for	NULL
the	NULL
binding	NULL
of	NULL
the	NULL
NFAT	NULL
related	NULL
factor	NULL
to	NULL
the	NULL
Ig	NULL
NF-KB	NULL
site	NULL
(	NULL
49	NULL
)	NULL
,	NULL
and	NULL
suggested	NULL
that	NULL
the	NULL
«	NULL
3	NULL
binding	NULL
factor	NULL
was	NULL
related	NULL
to	NULL
NFAT	NULL
.	NULL

Consistent	NULL
with	NULL
this	NULL
,	NULL
an	NULL
oligonucleotide	NULL
matching	NULL
the	NULL
distal	NULL
NFAT	NULL
site	NULL
from	NULL
the	NULL
murine	NULL
IL-2	NULL
gene	NULL
promoter	NULL
competed	NULL
for	NULL
binding	NULL
to	NULL
the	NULL
3	NULL
binding	NULL
factor	NULL
(	NULL
Fig	NULL
.	NULL

9	NULL
,	NULL
lane	NULL
9	NULL
)	NULL
.	NULL

Methylation	NULL
Interference	NULL
Analysis	NULL
of	NULL
the	NULL
Upper	NULL
and	NULL
Lower	NULL
x3	NULL
Binding	NULL
Complexes	NULL
Suggests	NULL
that	NULL
the	NULL
Same	NULL
Sequences	NULL
Required	NULL
for	NULL
In	NULL
Vivo	NULL
Activity	NULL
Participate	NULL
in	NULL
the	NULL
Formation	NULL
of	NULL
Both	NULL
Complexes	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
the	NULL
upper	NULL
and	NULL
lower	NULL
«	NULL
3	NULL
binding	NULL
complexes	NULL
contracted	NULL
different	NULL
bases	NULL
of	NULL
the	NULL
«	NULL
3	NULL
oligonucleotide	NULL
,	NULL
a	NULL
methylation	NULL
interference	NULL
analysis	NULL
using	NULL
nuclear	NULL
extracts	NULL
from	NULL
ionomycin-stimulated	NULL
Ar-5	NULL
cells	NULL
was	NULL
performed	NULL
.	NULL

Both	NULL
the	NULL
5	NULL
``	NULL
and	NULL
3	NULL
'	NULL
sequences	NULL
of	NULL
the	NULL
site	NULL
contacted	NULL
DNA-binding	NULL
Coding	NULL
Strand	NULL
Non	NULL
-Coding	NULL
Strand	NULL
s	NULL
&	NULL
g	NULL
$	NULL
s	NULL
og	NULL
is	NULL
i	NULL
g	NULL
Eo	NULL
3	NULL
E	NULL
.J	NULL
C	NULL
LL	NULL
D	NULL
UC	NULL
.J	NULL
C	NULL
*¢	NULL
C	NULL
«	NULL
ut	NULL
-	NULL
as	NULL
wie	NULL
-	NULL
kho	NULL
3a	NULL
E	NULL
¥	NULL
¢	NULL
T	NULL
[	NULL
4	NULL
«	NULL
n	NULL
.	NULL

p	NULL
f	NULL
#	NULL
-	NULL
#	NULL
-	NULL
#	NULL
|	NULL
&	NULL
A	NULL
6-	NULL
&	NULL
-	NULL
#	NULL
€	NULL
G	NULL
“	NULL
«	NULL
<	NULL
to	NULL
«	NULL
-	NULL
lly	NULL
El	NULL
T	NULL
A	NULL
Ii	NULL
fl	NULL
C	NULL
dh	NULL
«	NULL
»	NULL
«	NULL
ih	NULL
ases	NULL
—g\	NULL
(	NULL
T	NULL
:	NULL
@	NULL
-	NULL
t	NULL
-	NULL
«	NULL
n	NULL
-C	NULL
6	NULL
Pa	NULL
&	NULL
-	NULL
&	NULL
*	NULL
t	NULL
-C	NULL
A	NULL
T	NULL
56	NULL
«	NULL
+	NULL
«	NULL
«	NULL
»	NULL
=	NULL
65	NULL
,	NULL
10	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
10	NULL
~106	NULL
o	NULL
o	NULL
e	NULL
-87	NULL
Upper	NULL
-	NULL
5	NULL
GAGCTCATGGGTTTCTCCAC	NULL
3	NULL
Complex	NULL
_	NULL
3	NULL
'	NULL
CTCGAGTACCCAAAGAGGTG	NULL
5	NULL
!	NULL

Lower	NULL
-	NULL
5°	NULL
GAGCTCATGGGTTTCTCCAC	NULL
5	NULL
Complex	NULL
_	NULL
3	NULL
``	NULL
CTCGAGTACCCAAAGAGGTG	NULL
5°	NULL
Figure	NULL
10	NULL
.	NULL

Methylation	NULL
interference	NULL
analysis	NULL
shows	NULL
that	NULL
the	NULL
5	NULL
'	NULL
and	NULL
3	NULL
'	NULL
nucleotides	NULL
are	NULL
involved	NULL
in	NULL
binding	NULL
of	NULL
both	NULL
the	NULL
upper	NULL
and	NULL
lower	NULL
x3	NULL
binding	NULL
complexes	NULL
.	NULL

(	NULL
Top	NULL
)	NULL
A	NULL
comparison	NULL
of	NULL
cleavage	NULL
patterns	NULL
of	NULL
methylated	NULL
x3	NULL
oligonucleotide	NULL
bound	NULL
to	NULL
the	NULL
upper	NULL
or	NULL
lower	NULL
complex	NULL
.	NULL

The	NULL
«	NULL
3	NULL
oligonucleotide	NULL
was	NULL
labeled	NULL
on	NULL
the	NULL
coding	NULL
strand	NULL
(	NULL
lanes	NULL
1-5	NULL
)	NULL
or	NULL
the	NULL
noncoding	NULL
strand	NULL
(	NULL
lanes	NULL
6-10	NULL
)	NULL
and	NULL
methylated	NULL
.	NULL

Nuclear	NULL
extracts	NULL
from	NULL
Ar-5	NULL
cells	NULL
that	NULL
had	NULL
been	NULL
induced	NULL
with	NULL
1	NULL
M	NULL
ionomycin	NULL
for	NULL
30	NULL
min	NULL
were	NULL
incubated	NULL
with	NULL
the	NULL
methylated	NULL
probe	NULL
.	NULL

Free	NULL
and	NULL
bound	NULL
probes	NULL
were	NULL
then	NULL
isolated	NULL
,	NULL
cleaved	NULL
with	NULL
piperidine	NULL
,	NULL
and	NULL
analyzed	NULL
on	NULL
a	NULL
12	NULL
%	NULL
denaturing	NULL
gel	NULL
.	NULL

Fragments	NULL
that	NULL
are	NULL
underrepresented	NULL
in	NULL
the	NULL
bound	NULL
probe	NULL
as	NULL
compared	NULL
to	NULL
the	NULL
free	NULL
probe	NULL
result	NULL
from	NULL
cleavage	NULL
at	NULL
guanine	NULL
residues	NULL
whose	NULL
methylation	NULL
interferes	NULL
with	NULL
binding	NULL
.	NULL

(	NULL
Free	NULL
)	NULL
Unbound	NULL
oligonucleotide	NULL
;	NULL
(	NULL
upper	NULL
and	NULL
lower	NULL
)	NULL
oligonucleotide	NULL
bound	NULL
to	NULL
complexes	NULL
corresponding	NULL
to	NULL
the	NULL
upper	NULL
and	NULL
lower	NULL
complexes	NULL
in	NULL
the	NULL
EMSAs	NULL
displayed	NULL
in	NULL
Fig	NULL
.	NULL

9	NULL
,	NULL
A	NULL
and	NULL
B	NULL
.	NULL

(	NULL
Bottom	NULL
)	NULL
Summary	NULL
of	NULL
the	NULL
methylation	NULL
interference	NULL
analysis	NULL
for	NULL
the	NULL
upper	NULL
and	NULL
lower	NULL
complexes	NULL
.	NULL

The	NULL
«	NULL
3	NULL
site	NULL
is	NULL
shown	NULL
with	NULL
the	NULL
coding	NULL
strand	NULL
on	NULL
top	NULL
in	NULL
the	NULL
5	NULL
``	NULL
to	NULL
3	NULL
'	NULL
orientation	NULL
for	NULL
both	NULL
the	NULL
upper	NULL
and	NULL
lower	NULL
complexes	NULL
.	NULL

(	NULL
Closed	NULL
circles	NULL
)	NULL
Nucleotides	NULL
whose	NULL
methylation	NULL
interferes	NULL
with	NULL
binding	NULL
;	NULL
(	NULL
open	NULL
circles	NULL
)	NULL
positions	NULL
at	NULL
which	NULL
methylation	NULL
resulted	NULL
in	NULL
partial	NULL
interference	NULL
.	NULL

proteins	NULL
(	NULL
Fig	NULL
.	NULL

10	NULL
)	NULL
.	NULL

Specifically	NULL
,	NULL
methylation	NULL
of	NULL
the	NULL
three	NULL
guanine	NULL
residues	NULL
in	NULL
the	NULL
5	NULL
end	NULL
of	NULL
the	NULL
x3	NULL
element	NULL
(	NULL
relative	NULL
to	NULL
the	NULL
coding	NULL
strand	NULL
)	NULL
substantially	NULL
interfered	NULL
with	NULL
binding	NULL
of	NULL
the	NULL
upper	NULL
complex	NULL
(	NULL
Fig	NULL
.	NULL

10	NULL
,	NULL
compare	NULL
lane	NULL
2	NULL
with	NULL
lanes	NULL
1	NULL
and	NULL
3	NULL
)	NULL
,	NULL
whereas	NULL
methylation	NULL
of	NULL
two	NULL
of	NULL
the	NULL
three	NULL
guanines	NULL
in	NULL
the	NULL
3	NULL
'	NULL
end	NULL
of	NULL
the	NULL
site	NULL
eliminated	NULL
binding	NULL
of	NULL
the	NULL
upper	NULL
complex	NULL
(	NULL
Fig	NULL
.	NULL

10	NULL
,	NULL
compare	NULL
lane	NULL
7	NULL
to	NULL
lanes	NULL
6	NULL
and	NULL
8	NULL
)	NULL
.	NULL

For	NULL
the	NULL
lower	NULL
complex	NULL
,	NULL
methylation	NULL
of	NULL
the	NULL
same	NULL
5	NULL
'	NULL
and	NULL
3	NULL
'	NULL
nucleotides	NULL
resulted	NULL
in	NULL
partial	NULL
interference	NULL
with	NULL
binding	NULL
(	NULL
Fig	NULL
.	NULL

10	NULL
,	NULL
compare	NULL
lane	NULL
4	NULL
with	NULL
lanes	NULL
3	NULL
and	NULL
5	NULL
and	NULL
lane	NULL
9	NULL
with	NULL
lanes	NULL
8	NULL
and	NULL
10	NULL
)	NULL
.	NULL

Similar	NULL
results	NULL
were	NULL
obtained	NULL
using	NULL
nuclear	NULL
extracts	NULL
that	NULL
had	NULL
been	NULL
stimulated	NULL
with	NULL
«	NULL
CD3	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Methylation	NULL
also	NULL
interferes	NULL
with	NULL
binding	NULL
to	NULL
sequences	NULL
which	NULL
flank	NULL
the	NULL
5°	NULL
nucleotides	NULL
(	NULL
see	NULL
noncoding	NULL
strand	NULL
,	NULL
ATGAG	NULL
)	NULL
,	NULL
indicating	NULL
that	NULL
these	NULL
sequences	NULL
may	NULL
also	NULL
be	NULL
involved	NULL
in	NULL
the	NULL
binding	NULL
of	NULL
the	NULL
upper	NULL
and	NULL
lower	NULL
complexes	NULL
.	NULL

In	NULL
conclusion	NULL
,	NULL
the	NULL
same	NULL
5	NULL
(	NULL
TGGG	NULL
)	NULL
and	NULL
3	NULL
'	NULL
(	NULL
CTCC	NULL
)	NULL
nucleotides	NULL
that	NULL
are	NULL
crucial	NULL
for	NULL
the	NULL
TCR-	NULL
and	NULL
ionophore-mediated	NULL
induction	NULL
of	NULL
the	NULL
TNF-a	NULL
promoter	NULL
are	NULL
also	NULL
crucial	NULL
for	NULL
the	NULL
binding	NULL
of	NULL
the	NULL
upper	NULL
and	NULL
lower	NULL
«	NULL
3	NULL
binding	NULL
complexes	NULL
to	NULL
the	NULL
x3	NULL
oligonucleotide	NULL
.	NULL

Moreover	NULL
,	NULL
this	NULL
analysis	NULL
indicates	NULL
that	NULL
both	NULL
the	NULL
upper	NULL
and	NULL
lower	NULL
x3	NULL
binding	NULL
complexes	NULL
bind	NULL
with	NULL
similar	NULL
recognition	NULL
properties	NULL
to	NULL
the	NULL
«	NULL
3	NULL
oligonucleotide	NULL
.	NULL

These	NULL
complexes	NULL
may	NULL
therefore	NULL
contain	NULL
the	NULL
same	NULL
inducible	NULL
nuclear	NULL
factor	NULL
,	NULL
and	NULL
the	NULL
difference	NULL
in	NULL
mobility	NULL
between	NULL
the	NULL
two	NULL
complexes	NULL
may	NULL
be	NULL
due	NULL
to	NULL
differential	NULL
modification	NULL
and/or	NULL
association	NULL
with	NULL
a	NULL
different	NULL
nuclear	NULL
factor	NULL
.	NULL

The	NULL
«	NULL
3	NULL
Binding	NULL
Factor	NULL
Preexists	NULL
in	NULL
Unstimulated	NULL
T	NULL
Cells	NULL
The	NULL
rapid	NULL
induction	NULL
of	NULL
the	NULL
«	NULL
3	NULL
binding	NULL
factor	NULL
and	NULL
its	NULL
independence	NULL
from	NULL
de	NULL
novo	NULL
protein	NULL
synthesis	NULL
suggested	NULL
that	NULL
it	NULL
is	NULL
present	NULL
in	NULL
unstimulated	NULL
Ar-5	NULL
cells	NULL
.	NULL

Since	NULL
specific	NULL
x3	NULL
binding	NULL
activity	NULL
was	NULL
not	NULL
detected	NULL
in	NULL
nuclear	NULL
extracts	NULL
from	NULL
unstimulated	NULL
Ar-5	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
,	NULL
A	NULL
and	NULL
B	NULL
,	NULL
lanes	NULL
1	NULL
and	NULL
2	NULL
)	NULL
,	NULL
cytosolic	NULL
extracts	NULL
from	NULL
unstimulated	NULL
cells	NULL
were	NULL
tested	NULL
for	NULL
«	NULL
3	NULL
binding	NULL
activity	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

11	NULL
,	NULL
the	NULL
«	NULL
3	NULL
oligonucleotide	NULL
specifically	NULL
bound	NULL
to	NULL
a	NULL
protein	NULL
(	NULL
s	NULL
)	NULL
in	NULL
cytosolic	NULL
extracts	NULL
from	NULL
unstimulated	NULL
Ar-5	NULL
cells	NULL
.	NULL

The	NULL
radiolabeled	NULL
«	NULL
3	NULL
oligonucleotide	NULL
formed	NULL
two	NULL
specific	NULL
complexes	NULL
that	NULL
migrated	NULL
similarly	NULL
to	NULL
those	NULL
seen	NULL
when	NULL
nuclear	NULL
extracts	NULL
from	NULL
stimulated	NULL
T	NULL
cells	NULL
were	NULL
used	NULL
(	NULL
compare	NULL
to	NULL
Figs	NULL
.	NULL

7	NULL
and	NULL
9	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
x3	NULL
binding	NULL
factor	NULL
preexists	NULL
in	NULL
unstimulated	NULL
Ar-5	NULL
cells	NULL
,	NULL
either	NULL
sequestered	NULL
in	NULL
the	NULL
cytosol	NULL
or	NULL
in	NULL
an	NULL
inactive	NULL
form	NULL
that	NULL
can	NULL
be	NULL
extracted	NULL
from	NULL
the	NULL
nuclei	NULL
of	NULL
unstimulated	NULL
cells	NULL
under	NULL
our	NULL
extraction	NULL
conditions	NULL
.	NULL

Furthermore	NULL
,	NULL
the	NULL
level	NULL
of	NULL
«	NULL
3	NULL
binding	NULL
factor	NULL
proteins	NULL
in	NULL
the	NULL
cytosolic	NULL
extracts	NULL
decreased	NULL
by	NULL
>	NULL
65	NULL
%	NULL
after	NULL
stimulation	NULL
with	NULL
ionomycin	NULL
,	NULL
and	NULL
,	NULL
pretreatment	NULL
of	NULL
the	NULL
cells	NULL
with	NULL
CsA	NULL
blocked	NULL
this	NULL
decrease	NULL
(	NULL
Fig	NULL
.	NULL

11	NULL
B	NULL
,	NULL
lanes	NULL
1-3	NULL
)	NULL
.	NULL

However	NULL
,	NULL
when	NULL
we	NULL
employed	NULL
the	NULL
-61	NULL
to	NULL
-27	NULL
n	NULL
probe	NULL
and	NULL
tested	NULL
its	NULL
binding	NULL
to	NULL
these	NULL
extracts	NULL
,	NULL
we	NULL
also	NULL
detected	NULL
a	NULL
decrease	NULL
in	NULL
binding	NULL
after	NULL
induction	NULL
by	NULL
ionomycin	NULL
(	NULL
Fig	NULL
.	NULL

11	NULL
,	NULL
lanes	NULL
4-6	NULL
)	NULL
,	NULL
whereas	NULL
a	NULL
probe	NULL
matching	NULL
the	NULL
AP1	NULL
site	NULL
from	NULL
the	NULL
murine	NULL
co	NULL
gene	NULL
bound	NULL
a	NULL
protein	NULL
that	NULL
did	NULL
not	NULL
decrease	NULL
after	NULL
induction	NULL
(	NULL
Fig	NULL
.	NULL

11	NULL
,	NULL
lanes	NULL
7-9	NULL
)	NULL
.	NULL

The	NULL
binding	NULL
complexes	NULL
formed	NULL
by	NULL
the	NULL
-61	NULL
to	NULL
-27	NULL
n	NULL
and	NULL
AP1	NULL
probes	NULL
may	NULL
represent	NULL
proteins	NULL
that	NULL
are	NULL
leached	NULL
from	NULL
the	NULL
nucleus	NULL
during	NULL
the	NULL
preparation	NULL
of	NULL
cytosolic	NULL
extracts	NULL
.	NULL

This	NULL
is	NULL
commonly	NULL
observed	NULL
for	NULL
a	NULL
variety	NULL
of	NULL
nuclear	NULL
proteins	NULL
including	NULL
rb	NULL
(	NULL
57	NULL
)	NULL
and	NULL
ets	NULL
proteins	NULL
(	NULL
58	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
although	NULL
1374	NULL
Novel	NULL
CsA-sensitive	NULL
Element	NULL
in	NULL
Human	NULL
TNF-	NULL
Gene	NULL
Promoter	NULL
A	NULL
B	NULL
Probe	NULL
--	NULL
-Competitor	NULL
-	NULL
3	NULL
1	NULL
«	NULL
2	NULL
H	NULL
sgl	NULL
==	NULL
(	NULL
ports	NULL
=-	NULL
Lower	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
A1	NULL
Probe	NULL
«	NULL
m-	NULL
K3	NULL
--	NULL
m-Binto	NULL
2ina	NULL
_	NULL
m	NULL
--	NULL
AP1	NULL
--	NULL
UN	NULL
+	NULL
+/CsA	NULL
UN	NULL
++/CsA	NULL
UN	NULL
+	NULL
+/CsA	NULL
het	NULL
ind	NULL
“	NULL
54	NULL
“	NULL
“	NULL
u	NULL
|u	NULL
P	NULL
3	NULL
4	NULL
5	NULL
6	NULL
1	NULL
8	NULL
39	NULL
Figure	NULL
11	NULL
.	NULL

(	NULL
A	NULL
)	NULL
The	NULL
«	NULL
3	NULL
binding	NULL
factor	NULL
is	NULL
present	NULL
in	NULL
cytosolic	NULL
extracts	NULL
from	NULL
unstimulated	NULL
T	NULL
cells	NULL
.	NULL

Unstimulated	NULL
Ar-5	NULL
cells	NULL
were	NULL
lysed	NULL
in	NULL
hypotonic	NULL
buffer	NULL
containing	NULL
NP-40	NULL
,	NULL
and	NULL
the	NULL
soluble	NULL
proteins	NULL
were	NULL
concentrated	NULL
by	NULL
ammonium	NULL
sulfate	NULL
precipitation	NULL
.	NULL

After	NULL
resuspension	NULL
and	NULL
dialysis	NULL
,	NULL
the	NULL
proteins	NULL
were	NULL
assayed	NULL
in	NULL
an	NULL
EMSA	NULL
for	NULL
binding	NULL
to	NULL
the	NULL
x3	NULL
oligonucleotide	NULL
.	NULL

Two	NULL
specific	NULL
complexes	NULL
,	NULL
designated	NULL
upper	NULL
and	NULL
lower	NULL
(	NULL
arrows	NULL
)	NULL
,	NULL
bind	NULL
to	NULL
the	NULL
x3	NULL
oligonucleotide	NULL
.	NULL

The	NULL
binding	NULL
of	NULL
these	NULL
complexes	NULL
was	NULL
competed	NULL
by	NULL
an	NULL
excess	NULL
of	NULL
unlabeled	NULL
3	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
,	NULL
but	NULL
not	NULL
by	NULL
x1	NULL
or	NULL
«	NULL
2	NULL
(	NULL
lanes	NULL
3	NULL
and	NULL
4	NULL
)	NULL
.	NULL

(	NULL
B	NULL
)	NULL
The	NULL
«	NULL
3	NULL
binding	NULL
factor	NULL
decreases	NULL
in	NULL
cytosolic	NULL
extracts	NULL
from	NULL
cells	NULL
stimulated	NULL
by	NULL
ionomycin	NULL
.	NULL

Cells	NULL
were	NULL
unstimulated	NULL
(	NULL
UN	NULL
)	NULL
or	NULL
stimulated	NULL
with	NULL
1	NULL
uM	NULL
ionomycin	NULL
for	NULL
30	NULL
min	NULL
(	NULL
+	NULL
)	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
CsA	NULL
,	NULL
and	NULL
cytosolic	NULL
extracts	NULL
were	NULL
prepared	NULL
as	NULL
described	NULL
in	NULL
(	NULL
A	NULL
)	NULL
.	NULL

The	NULL
proteins	NULL
were	NULL
assayed	NULL
in	NULL
an	NULL
EMSA	NULL
for	NULL
binding	NULL
to	NULL
the	NULL
x3	NULL
oligonucleotide	NULL
(	NULL
lanes	NULL
1-3	NULL
)	NULL
,	NULL
the	NULL
-61	NULL
to	NULL
-27	NULL
n	NULL
oligonucleotide	NULL
(	NULL
lanes	NULL
4-6	NULL
)	NULL
and	NULL
the	NULL
AP1	NULL
oligonucleotide	NULL
(	NULL
lanes	NULL
7-9	NULL
)	NULL
.	NULL

we	NULL
have	NULL
demonstrated	NULL
that	NULL
the	NULL
x3	NULL
binding	NULL
factor	NULL
is	NULL
detected	NULL
in	NULL
the	NULL
cytosolic	NULL
fraction	NULL
of	NULL
unstimulated	NULL
T	NULL
cells	NULL
and	NULL
appears	NULL
rapidly	NULL
in	NULL
nuclear	NULL
extracts	NULL
upon	NULL
stimulation	NULL
,	NULL
we	NULL
can	NULL
not	NULL
conclude	NULL
definitively	NULL
that	NULL
there	NULL
is	NULL
a	NULL
translocation	NULL
of	NULL
the	NULL
£3	NULL
binding	NULL
factor	NULL
from	NULL
the	NULL
cytosol	NULL
to	NULL
the	NULL
nucleus	NULL
in	NULL
stimulated	NULL
T	NULL
cells	NULL
.	NULL

Immunofluorescence	NULL
experiments	NULL
using	NULL
antibodies	NULL
to	NULL
purified	NULL
K3	NULL
binding	NULL
protein	NULL
will	NULL
be	NULL
required	NULL
to	NULL
resolve	NULL
this	NULL
question	NULL
.	NULL

Discussion	NULL
Induction	NULL
of	NULL
the	NULL
Endogenous	NULL
TNF-	NULL
Gene	NULL
in	NULL
Murine	NULL
T	NULL
Cells	NULL
.	NULL

We	NULL
have	NULL
demonstrated	NULL
that	NULL
the	NULL
TNF-a	NULL
gene	NULL
is	NULL
one	NULL
of	NULL
the	NULL
earliest	NULL
genes	NULL
induced	NULL
in	NULL
T	NULL
cells	NULL
activated	NULL
by	NULL
TCR	NULL
ligands	NULL
.	NULL

TNF-	NULL
mRNA	NULL
levels	NULL
increase	NULL
strikingly	NULL
within	NULL
15-30	NULL
min	NULL
of	NULL
exposure	NULL
of	NULL
a	NULL
murine	NULL
T	NULL
cell	NULL
clone	NULL
to	NULL
activating	NULL
antibodies	NULL
against	NULL
the	NULL
TCR-CD3	NULL
complex	NULL
.	NULL

This	NULL
increase	NULL
reflects	NULL
an	NULL
increase	NULL
in	NULL
TNF-	NULL
gene	NULL
transcription	NULL
as	NULL
judged	NULL
by	NULL
the	NULL
commensurate	NULL
increase	NULL
in	NULL
CAT	NULL
activity	NULL
in	NULL
transient	NULL
transfection	NULL
assays	NULL
using	NULL
human	NULL
TNF-a	NULL
promoter	NULL
CAT	NULL
fusion	NULL
plasmids	NULL
.	NULL

The	NULL
transcriptional	NULL
activation	NULL
of	NULL
the	NULL
TNF-a	NULL
gene	NULL
is	NULL
not	NULL
dependent	NULL
on	NULL
de	NULL
novo	NULL
protein	NULL
synthesis	NULL
,	NULL
since	NULL
pretreatment	NULL
of	NULL
the	NULL
cells	NULL
with	NULL
protein	NULL
synthesis	NULL
inhibitors	NULL
has	NULL
no	NULL
effect	NULL
on	NULL
the	NULL
kinetics	NULL
or	NULL
magnitude	NULL
of	NULL
TNF-a	NULL
mRNA	NULL
expression	NULL
.	NULL

Thus	NULL
,	NULL
in	NULL
contrast	NULL
to	NULL
genes	NULL
encoding	NULL
most	NULL
other	NULL
lym-phokines	NULL
and	NULL
lymphokine	NULL
receptors	NULL
,	NULL
including	NULL
IL-2	NULL
,	NULL
whose	NULL
1375	NULL
Goldfeld	NULL
et	NULL
al	NULL
.	NULL

transcription	NULL
is	NULL
dependent	NULL
upon	NULL
de	NULL
novo	NULL
protein	NULL
synthesis	NULL
(	NULL
for	NULL
reviews	NULL
see	NULL
references	NULL
59	NULL
and	NULL
60	NULL
)	NULL
,	NULL
the	NULL
TNF-a	NULL
gene	NULL
behaves	NULL
as	NULL
an	NULL
immediate	NULL
early	NULL
gene	NULL
in	NULL
activated	NULL
T	NULL
cells	NULL
.	NULL

Induction	NULL
of	NULL
the	NULL
TNF-a	NULL
gene	NULL
in	NULL
Ar-5	NULL
T	NULL
cells	NULL
is	NULL
mediated	NULL
by	NULL
a	NULL
calcium-dependent	NULL
pathway	NULL
since	NULL
it	NULL
occurs	NULL
in	NULL
T	NULL
cells	NULL
stimulated	NULL
with	NULL
calcium	NULL
ionophore	NULL
alone	NULL
.	NULL

Moreover	NULL
,	NULL
induction	NULL
does	NULL
not	NULL
require	NULL
the	NULL
&	NULL
and	NULL
(	NULL
3	NULL
isozymes	NULL
of	NULL
protein	NULL
kinase	NULL
C	NULL
,	NULL
since	NULL
it	NULL
occurs	NULL
efficiently	NULL
in	NULL
cells	NULL
that	NULL
have	NULL
been	NULL
depleted	NULL
of	NULL
these	NULL
isozymes	NULL
by	NULL
prolonged	NULL
treatment	NULL
with	NULL
the	NULL
phorbol	NULL
ester	NULL
PDBu	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

These	NULL
data	NULL
again	NULL
differentiate	NULL
the	NULL
induction	NULL
requirements	NULL
of	NULL
the	NULL
TNF-a	NULL
gene	NULL
from	NULL
those	NULL
of	NULL
other	NULL
activation-related	NULL
genes	NULL
such	NULL
as	NULL
IL-2	NULL
,	NULL
whose	NULL
transcription	NULL
requires	NULL
both	NULL
the	NULL
protein	NULL
kinase	NULL
C	NULL
and	NULL
calcium-mediated	NULL
signals	NULL
(	NULL
36	NULL
,	NULL
61	NULL
)	NULL
and	NULL
is	NULL
abolished	NULL
by	NULL
protein	NULL
kinase	NULL
C	NULL
depletion	NULL
(	NULL
46	NULL
,	NULL
and	NULL
Goldfeld	NULL
,	NULL
A.	NULL
E.	NULL
,	NULL
P.	NULL
G.	NULL
McCaffrey	NULL
,	NULL
and	NULL
A.	NULL
Rao	NULL
,	NULL
unpublished	NULL
observations	NULL
)	NULL
.	NULL

However	NULL
,	NULL
the	NULL
induction	NULL
of	NULL
TNF-a	NULL
gene	NULL
transcription	NULL
resembles	NULL
the	NULL
induction	NULL
of	NULL
other	NULL
lymphokine	NULL
genes	NULL
in	NULL
that	NULL
it	NULL
is	NULL
completely	NULL
blocked	NULL
by	NULL
the	NULL
immunosuppressive	NULL
agents	NULL
CsA	NULL
and	NULL
FK506	NULL
.	NULL

The	NULL
«	NULL
3	NULL
Element	NULL
Is	NULL
an	NULL
eCD3	NULL
and	NULL
Ionophore-inducible	NULL
Promoter	NULL
Element	NULL
in	NULL
Activated	NULL
Murine	NULL
T-cells	NULL
.	NULL

'The	NULL
region	NULL
between	NULL
-118	NULL
and	NULL
-87	NULL
n	NULL
of	NULL
the	NULL
human	NULL
TNF-a	NULL
gene	NULL
promoter	NULL
contains	NULL
a	NULL
previously	NULL
identified	NULL
NF-KB	NULL
consensus	NULL
sequence	NULL
,	NULL
K3	NULL
.	NULL

Site-directed	NULL
mutagenesis	NULL
of	NULL
«	NULL
3	NULL
within	NULL
the	NULL
context	NULL
of	NULL
the	NULL
-199	NULL
TNF-a	NULL
promoter	NULL
decreased	NULL
but	NULL
did	NULL
not	NULL
obliterate	NULL
«	NULL
CD3	NULL
in	NULL
duction	NULL
,	NULL
suggesting	NULL
that	NULL
although	NULL
K3	NULL
is	NULL
a	NULL
key	NULL
element	NULL
,	NULL
other	NULL
sequences	NULL
participate	NULL
in	NULL
TCR-mediated	NULL
induction	NULL
of	NULL
the	NULL
TNF-a	NULL
promoter	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
ionomycin	NULL
induction	NULL
appeared	NULL
to	NULL
be	NULL
primarily	NULL
mediated	NULL
through	NULL
the	NULL
«	NULL
3	NULL
element	NULL
as	NULL
mutation	NULL
of	NULL
the	NULL
5	NULL
or	NULL
3	NULL
'	NULL
nucleotides	NULL
almost	NULL
entirely	NULL
obliterated	NULL
the	NULL
promoter	NULL
's	NULL
inducibility	NULL
.	NULL

The	NULL
specificity	NULL
of	NULL
this	NULL
effect	NULL
is	NULL
confirmed	NULL
by	NULL
the	NULL
observation	NULL
that	NULL
the	NULL
mutation	NULL
of	NULL
other	NULL
sequences	NULL
within	NULL
the	NULL
promoter	NULL
did	NULL
not	NULL
decrease	NULL
the	NULL
promoter	NULL
's	NULL
inducibility	NULL
or	NULL
CsA	NULL
sensitivity	NULL
.	NULL

A	NULL
Preexisting	NULL
«	NULL
3	NULL
Binding	NULL
Factor	NULL
Is	NULL
a	NULL
Target	NULL
for	NULL
CsA	NULL
.	NULL

The	NULL
protein	NULL
(	NULL
s	NULL
)	NULL
binding	NULL
to	NULL
the	NULL
«	NULL
3	NULL
element	NULL
,	NULL
the	NULL
x3	NULL
binding	NULL
factor	NULL
,	NULL
preexists	NULL
in	NULL
unstimulated	NULL
T	NULL
cells	NULL
.	NULL

Although	NULL
its	NULL
location	NULL
can	NULL
not	NULL
be	NULL
definitively	NULL
established	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
antibody	NULL
reagents	NULL
,	NULL
it	NULL
is	NULL
absent	NULL
from	NULL
nuclear	NULL
extracts	NULL
of	NULL
unstimulated	NULL
T	NULL
cells	NULL
,	NULL
but	NULL
is	NULL
present	NULL
in	NULL
cytosolic	NULL
extracts	NULL
from	NULL
unstimulated	NULL
T	NULL
cells	NULL
.	NULL

This	NULL
indicates	NULL
that	NULL
it	NULL
either	NULL
normally	NULL
resides	NULL
in	NULL
the	NULL
cytoplasm	NULL
of	NULL
unstimulated	NULL
cells	NULL
or	NULL
that	NULL
it	NULL
is	NULL
extracted	NULL
from	NULL
nuclei	NULL
of	NULL
unstimulated	NULL
cells	NULL
under	NULL
our	NULL
extraction	NULL
conditions	NULL
.	NULL

In	NULL
either	NULL
case	NULL
,	NULL
binding	NULL
of	NULL
the	NULL
x3	NULL
binding	NULL
factor	NULL
to	NULL
the	NULL
«	NULL
3	NULL
element	NULL
in	NULL
nuclear	NULL
extracts	NULL
requires	NULL
a	NULL
modification	NULL
event	NULL
that	NULL
occurs	NULL
upon	NULL
T	NULL
cell	NULL
activation	NULL
.	NULL

It	NULL
is	NULL
rapidly	NULL
detected	NULL
(	NULL
within	NULL
15	NULL
min	NULL
)	NULL
in	NULL
nuclear	NULL
extracts	NULL
from	NULL
T	NULL
cells	NULL
stimulated	NULL
by	NULL
«	NULL
CD3	NULL
or	NULL
ionomycin	NULL
.	NULL

Furthermore	NULL
,	NULL
induction	NULL
of	NULL
the	NULL
«	NULL
3	NULL
binding	NULL
factor	NULL
is	NULL
completely	NULL
concordant	NULL
with	NULL
induction	NULL
of	NULL
TNF-a	NULL
gene	NULL
expression	NULL
itself	NULL
:	NULL
neither	NULL
process	NULL
requires	NULL
de	NULL
novo	NULL
protein	NULL
synthesis	NULL
and	NULL
both	NULL
can	NULL
be	NULL
totally	NULL
blocked	NULL
by	NULL
pretreatment	NULL
with	NULL
CsA	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
these	NULL
data	NULL
suggest	NULL
that	NULL
TCR	NULL
stimulation	NULL
and	NULL
the	NULL
ensuing	NULL
increase	NULL
in	NULL
intracellular	NULL
calcium	NULL
activate	NULL
the	NULL
«	NULL
3	NULL
binding	NULL
factor	NULL
by	NULL
causing	NULL
its	NULL
posttranslational	NULL
modification	NULL
and/or	NULL
translocation	NULL
to	NULL
the	NULL
nucleus	NULL
,	NULL
and	NULL
that	NULL
the	NULL
nuclear	NULL
«	NULL
3	NULL
binding	NULL
complex	NULL
participates	NULL
in	NULL
TNF-a	NULL
gene	NULL
induction	NULL
.	NULL

The	NULL
rapid	NULL
disappearance	NULL
of	NULL
the	NULL
x3	NULL
binding	NULL
factor	NULL
from	NULL
nuclear	NULL
extracts	NULL
after	NULL
induction	NULL
may	NULL
reflect	NULL
its	NULL
recycling	NULL
back	NULL
to	NULL
the	NULL
cytoplasm	NULL
,	NULL
inactivation	NULL
,	NULL
or	NULL
degradation	NULL
.	NULL

The	NULL
«	NULL
3	NULL
element	NULL
thus	NULL
represents	NULL
a	NULL
novel	NULL
cyclosporin-sensitive	NULL
regulatory	NULL
element	NULL
and	NULL
the	NULL
first	NULL
example	NULL
characterized	NULL
in	NULL
a	NULL
gene	NULL
other	NULL
than	NULL
IL-2	NULL
.	NULL

Relationship	NULL
of	NULL
the	NULL
«	NULL
3-Binding	NULL
Factor	NULL
to	NULL
other	NULL
Transcription	NULL
Factors	NULL
.	NULL

Despite	NULL
the	NULL
resemblance	NULL
of	NULL
the	NULL
«	NULL
3	NULL
element	NULL
to	NULL
an	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
site	NULL
(	NULL
16	NULL
)	NULL
,	NULL
the	NULL
p50/p65	NULL
NF-kB	NULL
heterodimer	NULL
and/or	NULL
c-rel	NULL
are	NULL
not	NULL
part	NULL
of	NULL
the	NULL
«	NULL
3	NULL
binding	NULL
complex	NULL
.	NULL

First	NULL
,	NULL
the	NULL
«	NULL
3	NULL
element	NULL
does	NULL
not	NULL
bind	NULL
to	NULL
purified	NULL
p50/p65	NULL
NF-	NULL
«	NULL
B	NULL
in	NULL
an	NULL
EMSA	NULL
.	NULL

Second	NULL
,	NULL
the	NULL
appearance	NULL
of	NULL
the	NULL
p50/p65	NULL
NF-	NULL
«	NULL
B	NULL
heterodimer	NULL
in	NULL
nuclear	NULL
extracts	NULL
of	NULL
activated	NULL
Ar-5	NULL
T	NULL
cells	NULL
is	NULL
not	NULL
inhibited	NULL
by	NULL
CsA	NULL
at	NULL
30	NULL
min	NULL
after	NULL
activation	NULL
,	NULL
and	NULL
is	NULL
only	NULL
partially	NULL
inhibited	NULL
at	NULL
2	NULL
h	NULL
(	NULL
49	NULL
,	NULL
and	NULL
McCaffrey	NULL
,	NULL
P.	NULL
G.	NULL
,	NULL
and	NULL
A.	NULL
Rao	NULL
,	NULL
unpublished	NULL
results	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
the	NULL
nuclear	NULL
induction	NULL
of	NULL
the	NULL
«	NULL
3	NULL
binding	NULL
complex	NULL
is	NULL
completely	NULL
blocked	NULL
by	NULL
CsA	NULL
in	NULL
all	NULL
time	NULL
points	NULL
tested	NULL
.	NULL

Third	NULL
,	NULL
an	NULL
oligonucleotide	NULL
that	NULL
is	NULL
mutated	NULL
in	NULL
the	NULL
5	NULL
guanines	NULL
crucial	NULL
for	NULL
binding	NULL
of	NULL
the	NULL
p50/p65	NULL
NF-	NULL
«	NULL
B	NULL
heterodimer	NULL
competes	NULL
for	NULL
binding	NULL
to	NULL
the	NULL
«	NULL
3	NULL
binding	NULL
factor	NULL
.	NULL

Finally	NULL
,	NULL
antibodies	NULL
to	NULL
p50	NULL
,	NULL
p65	NULL
,	NULL
or	NULL
c-rel	NULL
have	NULL
no	NULL
effect	NULL
on	NULL
the	NULL
mobility	NULL
of	NULL
the	NULL
«	NULL
3	NULL
binding	NULL
complex	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
«	NULL
3	NULL
binding	NULL
factor	NULL
is	NULL
distinct	NULL
from	NULL
p50/p65	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
does	NULL
not	NULL
contain	NULL
c-rel	NULL
.	NULL

The	NULL
«	NULL
3	NULL
binding	NULL
factor	NULL
is	NULL
clearly	NULL
distinct	NULL
from	NULL
the	NULL
factors	NULL
oct-1	NULL
and	NULL
OAP-40	NULL
(	NULL
44	NULL
)	NULL
,	NULL
which	NULL
bind	NULL
to	NULL
the	NULL
NFIL2A	NULL
site	NULL
of	NULL
the	NULL
IL-2	NULL
promoter	NULL
.	NULL

Although	NULL
the	NULL
induction	NULL
of	NULL
multimers	NULL
of	NULL
the	NULL
NFIL2	NULL
site	NULL
is	NULL
blocked	NULL
by	NULL
CsA	NULL
and	NULL
FK506	NULL
(	NULL
37	NULL
)	NULL
,	NULL
their	NULL
maximal	NULL
induction	NULL
requires	NULL
stimulation	NULL
with	NULL
both	NULL
phorbol	NULL
ester	NULL
and	NULL
ionophore	NULL
,	NULL
whereas	NULL
the	NULL
«	NULL
3	NULL
multimer	NULL
constructs	NULL
are	NULL
inducible	NULL
by	NULL
ionomycin	NULL
alone	NULL
.	NULL

The	NULL
oct-1	NULL
protein	NULL
is	NULL
constitu-tively	NULL
expressed	NULL
in	NULL
nuclear	NULL
extracts	NULL
of	NULL
unstimulated	NULL
T	NULL
cells	NULL
and	NULL
its	NULL
binding	NULL
is	NULL
not	NULL
affected	NULL
by	NULL
CsA	NULL
or	NULL
FK506	NULL
(	NULL
37	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
the	NULL
octamer-associated	NULL
protein	NULL
OAP-40	NULL
,	NULL
although	NULL
inducible	NULL
in	NULL
a	NULL
gel	NULL
shift	NULL
assay	NULL
,	NULL
requires	NULL
protein	NULL
synthesis	NULL
for	NULL
its	NULL
induction	NULL
(	NULL
44	NULL
)	NULL
.	NULL

The	NULL
relationship	NULL
of	NULL
the	NULL
«	NULL
3	NULL
binding	NULL
factor	NULL
to	NULL
the	NULL
factor	NULL
binding	NULL
to	NULL
the	NULL
NFAT	NULL
site	NULL
of	NULL
the	NULL
IL-2	NULL
promoter	NULL
remains	NULL
to	NULL
be	NULL
elucidated	NULL
.	NULL

This	NULL
factor	NULL
,	NULL
also	NULL
termed	NULL
NFAT	NULL
,	NULL
consists	NULL
of	NULL
a	NULL
preexisting	NULL
subunit	NULL
(	NULL
NFATp	NULL
)	NULL
present	NULL
in	NULL
cytosolic	NULL
extracts	NULL
of	NULL
unstimulated	NULL
T	NULL
cells	NULL
(	NULL
41-43	NULL
,	NULL
62	NULL
)	NULL
,	NULL
which	NULL
associates	NULL
with	NULL
fos	NULL
and	NULL
jun	NULL
proteins	NULL
in	NULL
the	NULL
nuclei	NULL
of	NULL
activated	NULL
T	NULL
cells	NULL
(	NULL
42	NULL
)	NULL
.	NULL

The	NULL
preexisting	NULL
NFATp	NULL
subunit	NULL
resembles	NULL
the	NULL
£3	NULL
binding	NULL
factor	NULL
in	NULL
that	NULL
its	NULL
appearance	NULL
in	NULL
nuclear	NULL
extracts	NULL
of	NULL
activated	NULL
T	NULL
cells	NULL
can	NULL
be	NULL
induced	NULL
with	NULL
calcium	NULL
ionophore	NULL
,	NULL
does	NULL
not	NULL
require	NULL
de	NULL
novo	NULL
protein	NULL
synthesis	NULL
,	NULL
and	NULL
is	NULL
completely	NULL
blocked	NULL
by	NULL
CsA	NULL
(	NULL
41-43	NULL
,	NULL
62-64	NULL
)	NULL
.	NULL

Previous	NULL
studies	NULL
have	NULL
shown	NULL
that	NULL
NFATp	NULL
is	NULL
a	NULL
substrate	NULL
for	NULL
calcineurin	NULL
,	NULL
the	NULL
serine/threonine	NULL
phosphatase	NULL
whose	NULL
activity	NULL
is	NULL
inhibited	NULL
by	NULL
CsA-cyclophilin	NULL
and	NULL
FK506-FKBP	NULL
complexes	NULL
(	NULL
43	NULL
)	NULL
.	NULL

The	NULL
data	NULL
presented	NULL
here	NULL
indicate	NULL
that	NULL
the	NULL
x3	NULL
binding	NULL
factor	NULL
may	NULL
also	NULL
be	NULL
a	NULL
calcineurin	NULL
substrate	NULL
.	NULL

The	NULL
NFAT	NULL
site	NULL
shares	NULL
no	NULL
clear	NULL
sequence	NULL
similarity	NULL
with	NULL
the	NULL
«	NULL
3	NULL
element	NULL
,	NULL
other	NULL
than	NULL
being	NULL
pyrimidine	NULL
rich	NULL
.	NULL

However	NULL
,	NULL
factors	NULL
related	NULL
to	NULL
NF-ATp	NULL
are	NULL
capable	NULL
of	NULL
binding	NULL
to	NULL
several	NULL
NF-	NULL
«	NULL
B	NULL
sequence	NULL
motifs	NULL
(	NULL
49	NULL
)	NULL
,	NULL
and	NULL
we	NULL
have	NULL
shown	NULL
that	NULL
the	NULL
murine	NULL
IL-2	NULL
NFAT	NULL
oligonucleotide	NULL
is	NULL
able	NULL
to	NULL
compete	NULL
with	NULL
«	NULL
3	NULL
for	NULL
binding	NULL
.	NULL

It	NULL
is	NULL
therefore	NULL
possible	NULL
that	NULL
the	NULL
«	NULL
3	NULL
binding	NULL
factor	NULL
may	NULL
be	NULL
a	NULL
member	NULL
of	NULL
a	NULL
closely	NULL
related	NULL
family	NULL
of	NULL
transcription	NULL
factors	NULL
resembling	NULL
NF-ATp	NULL
,	NULL
that	NULL
undergo	NULL
a	NULL
shared	NULL
calcium-dependent	NULL
,	NULL
CsA-sensitive	NULL
posttranslational	NULL
modification	NULL
step	NULL
.	NULL

Alternatively	NULL
,	NULL
NFATp	NULL
itself	NULL
could	NULL
be	NULL
a	NULL
part	NULL
of	NULL
the	NULL
x3	NULL
binding	NULL
complex	NULL
.	NULL

In	NULL
conclusion	NULL
,	NULL
the	NULL
TNF-a	NULL
gene	NULL
represents	NULL
a	NULL
new	NULL
model	NULL
system	NULL
for	NULL
the	NULL
study	NULL
of	NULL
those	NULL
signal	NULL
transduction	NULL
events	NULL
after	NULL
T	NULL
cell	NULL
activation	NULL
that	NULL
results	NULL
in	NULL
CsA-sensitive	NULL
inducible	NULL
gene	NULL
transcription	NULL
.	NULL

The	NULL
protein	NULL
product	NULL
of	NULL
the	NULL
TNF-	NULL
gene	NULL
cooperates	NULL
in	NULL
the	NULL
differentiation	NULL
and	NULL
proliferation	NULL
of	NULL
B	NULL
and	NULL
T	NULL
cells	NULL
(	NULL
4	NULL
,	NULL
5	NULL
,	NULL
65	NULL
)	NULL
,	NULL
the	NULL
generation	NULL
of	NULL
dendritic	NULL
Langerhans	NULL
cells	NULL
(	NULL
66	NULL
)	NULL
,	NULL
and	NULL
is	NULL
capable	NULL
of	NULL
inducing	NULL
latent	NULL
HIV-1	NULL
into	NULL
a	NULL
productive	NULL
infection	NULL
(	NULL
7	NULL
,	NULL
67	NULL
)	NULL
.	NULL

Recent	NULL
studies	NULL
have	NULL
demonstrated	NULL
that	NULL
TNF-a	NULL
plays	NULL
a	NULL
critical	NULL
role	NULL
in	NULL
superantigen-triggered	NULL
lethal	NULL
shock	NULL
mediated	NULL
by	NULL
T	NULL
cells	NULL
(	NULL
68	NULL
)	NULL
,	NULL
and	NULL
elevated	NULL
TNF-	NULL
@	NULL
levels	NULL
are	NULL
associated	NULL
with	NULL
renal	NULL
and	NULL
cardiac	NULL
allograft	NULL
rejection	NULL
(	NULL
69	NULL
,	NULL
70	NULL
)	NULL
and	NULL
several	NULL
infectious	NULL
diseases	NULL
(	NULL
71	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
in	NULL
addition	NULL
to	NULL
providing	NULL
insight	NULL
into	NULL
the	NULL
molecular	NULL
events	NULL
that	NULL
follow	NULL
lymphocyte	NULL
activation	NULL
,	NULL
and	NULL
mechanisms	NULL
of	NULL
inducible	NULL
gene	NULL
tran-scription	NULL
,	NULL
these	NULL
studies	NULL
could	NULL
have	NULL
a	NULL
practical	NULL
impact	NULL
upon	NULL
the	NULL
modulation	NULL
by	NULL
immunosuppressants	NULL
of	NULL
TNF-	NULL
levels	NULL
in	NULL
transplant	NULL
medicine	NULL
,	NULL
lymphoproliferative	NULL
disorders	NULL
,	NULL
and	NULL
other	NULL
disease	NULL
states	NULL
.	NULL

1376	NULL
Novel	NULL
CsA-sensitive	NULL
Element	NULL
in	NULL
Human	NULL
TNF-	NULL
Gene	NULL
Promoter	NULL
We	NULL
would	NULL
like	NULL
to	NULL
thank	NULL
Drs	NULL
.	NULL

Samuel	NULL
Speck	NULL
,	NULL
Erik	NULL
Flemington	NULL
,	NULL
Carolyn	NULL
Doyle	NULL
,	NULL
Jaekyoon	NULL
Shin	NULL
,	NULL
and	NULL
Brian	NULL
Schaeffer	NULL
for	NULL
helpful	NULL
discussions	NULL
;	NULL
and	NULL
Cynthia	NULL
Theodos	NULL
for	NULL
performance	NULL
of	NULL
the	NULL
L	NULL
cell	NULL
killing	NULL
assays	NULL
.	NULL

We	NULL
are	NULL
indebted	NULL
to	NULL
Nancy	NULL
Rice	NULL
,	NULL
Ulrich	NULL
Siebenlist	NULL
,	NULL
and	NULL
Sankar	NULL
Ghosh	NULL
for	NULL
their	NULL
generous	NULL
provision	NULL
of	NULL
reagents	NULL
.	NULL

This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
grants	NULL
to	NULL
A.	NULL
E.	NULL
Goldfeld	NULL
(	NULL
AI-00683	NULL
and	NULL
CA-58735	NULL
)	NULL
,	NULL
A.	NULL
Rao	NULL
(	NULL
CA-42471	NULL
and	NULL
GM-46227	NULL
)	NULL
,	NULL
and	NULL
J.	NULL
L.	NULL
Strominger	NULL
.	NULL

P.	NULL
G.	NULL
McCaffrey	NULL
is	NULL
a	NULL
Special	NULL
Fellow	NULL
of	NULL
the	NULL
Leukemia	NULL
Society	NULL
of	NULL
America	NULL
.	NULL

Address	NULL
correspondence	NULL
to	NULL
Dr.	NULL
Anne	NULL
E.	NULL
Goldfeld	NULL
,	NULL
Division	NULL
of	NULL
Tumor	NULL
Virology	NULL
,	NULL
Departments	NULL
of	NULL
Medicine	NULL
and	NULL
Pathology	NULL
,	NULL
Dana-Farber	NULL
Cancer	NULL
Institute	NULL
,	NULL
Harvard	NULL
Medical	NULL
School	NULL
,	NULL
44	NULL
Binney	NULL
Street	NULL
,	NULL
Boston	NULL
,	NULL
MA	NULL
02114	NULL
.	NULL

Received	NULL
for	NULL
publication	NULL
15	NULL
March	NULL
1993	NULL
and	NULL
in	NULL
revised	NULL
form	NULL
11	NULL
June	NULL
1993	NULL
.	NULL

References	NULL
1	NULL
.	NULL

10	NULL
.	NULL

11	NULL
.	NULL

Lowenthal	NULL
,	NULL
JW	NULL
.	NULL

,	NULL
D.W.	NULL
Ballard	NULL
,	NULL
H.	NULL
Bogerd	NULL
,	NULL
E.	NULL
Bohnlein	NULL
,	NULL
and	NULL
WC	NULL
.	NULL

Greene	NULL
.	NULL

1989	NULL
.	NULL

Tumor	NULL
necrosis	NULL
factor-a	NULL
activation	NULL
of	NULL
the	NULL
IL-2	NULL
receptor-a	NULL
gene	NULL
involves	NULL
the	NULL
induction	NULL
of	NULL
«	NULL
B-specific	NULL
DNA	NULL
binding	NULL
proteins	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

142:3121.	NULL
.	NULL

Poupart	NULL
,	NULL
P.	NULL
,	NULL
P.	NULL
Vandenabeele	NULL
,	NULL
S.	NULL
Cayphas	NULL
,	NULL
J	NULL
.	NULL

Van	NULL
Snick	NULL
,	NULL
G.	NULL
Haegeman	NULL
,	NULL
V.	NULL
Kruys	NULL
,	NULL
W.	NULL
Fiers	NULL
,	NULL
and	NULL
J	NULL
.	NULL

Content	NULL
.	NULL

1987	NULL
.	NULL

B	NULL
cell	NULL
growth	NULL
modulating	NULL
and	NULL
differentiating	NULL
activity	NULL
of	NULL
recombinant	NULL
human	NULL
26-kd	NULL
protein	NULL
(	NULL
BSF-2	NULL
,	NULL
HuIFN-32	NULL
,	NULL
HPGF	NULL
)	NULL
.	NULL

EMBO	NULL
(	NULL
Eur	NULL
.	NULL

Mol	NULL
.	NULL

Biol	NULL
.	NULL

Organ	NULL
.	NULL
)	NULL

J	NULL
.	NULL

6:1219.	NULL
.	NULL

Poli	NULL
,	NULL
G.	NULL
,	NULL
P.	NULL
Bressler	NULL
,	NULL
A.	NULL
Kinter	NULL
,	NULL
E.	NULL
Duh	NULL
,	NULL
W.C.	NULL
Timmer	NULL
,	NULL
A.	NULL
Rabson	NULL
,	NULL
J.S	NULL
.	NULL

Justement	NULL
,	NULL
S.	NULL
Stanley	NULL
,	NULL
and	NULL
A.S.	NULL
Fauci	NULL
.	NULL

1990	NULL
.	NULL

Interleukin	NULL
6	NULL
induces	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
expression	NULL
in	NULL
infected	NULL
monocytic	NULL
cells	NULL
alone	NULL
and	NULL
in	NULL
synergy	NULL
with	NULL
tumor	NULL
necrosis	NULL
factor	NULL
a	NULL
by	NULL
transcriptional	NULL
and	NULL
post-transcriptional	NULL
mechanisms	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

172:151.	NULL
.	NULL

Rieckmann	NULL
,	NULL
P.	NULL
,	NULL
G.	NULL
Poli	NULL
,	NULL
J.H	NULL
.	NULL

Kehrl	NULL
,	NULL
and	NULL
A.S.	NULL
Fauci	NULL
.	NULL

1991	NULL
.	NULL

Ac	NULL
tivated	NULL
B	NULL
lymphocytes	NULL
from	NULL
human	NULL
immunodeficiency	NULL
virus-infected	NULL
individuals	NULL
induce	NULL
virus	NULL
expression	NULL
in	NULL
infected	NULL
T	NULL
cells	NULL
and	NULL
a	NULL
promonocyte	NULL
cell	NULL
line	NULL
,	NULL
U1	NULL
.	NULL

J.	NULL
Exp	NULL
Med	NULL
.	NULL

173:1.	NULL
.	NULL

Lowenthal	NULL
,	NULL
JW	NULL
.	NULL

,	NULL
DW	NULL
.	NULL

Ballard	NULL
,	NULL
E.	NULL
Bohnlein	NULL
,	NULL
and	NULL
W.C.	NULL
Greene	NULL
.	NULL

1989	NULL
.	NULL

Tumor	NULL
necrosis	NULL
factor	NULL
x	NULL
induces	NULL
proteins	NULL
that	NULL
bind	NULL
specifically	NULL
to	NULL
«	NULL
B-like	NULL
enhancer	NULL
elements	NULL
and	NULL
regulate	NULL
interleukin	NULL
2	NULL
receptor	NULL
-chain	NULL
gene	NULL
expression	NULL
in	NULL
primary	NULL
human	NULL
T	NULL
lymphocytes	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
.	NULL

86:2331.	NULL
.	NULL

Brenner	NULL
,	NULL
D.A	NULL
.	NULL

,	NULL
M.	NULL
O'Hara	NULL
,	NULL
P.	NULL
Angel	NULL
,	NULL
M.	NULL
Chojkier	NULL
,	NULL
and	NULL
M.	NULL
Karin	NULL
.	NULL

1989	NULL
.	NULL

Prolonged	NULL
activation	NULL
of	NULL
jun	NULL
collagenase	NULL
genes	NULL
by	NULL
tumor	NULL
necrosis	NULL
factor-	NULL
.	NULL

Nature	NULL
(	NULL
Lond	NULL
.	NULL
)	NULL

.	NULL

337:661.	NULL
.	NULL

Osborn	NULL
,	NULL
L.	NULL
,	NULL
S.	NULL
Kunkel	NULL
,	NULL
and	NULL
G.	NULL
Nabel	NULL
.	NULL

1989	NULL
.	NULL

Tumor	NULL
necrosis	NULL
factor	NULL
x	NULL
and	NULL
interleukin	NULL
1	NULL
stimulate	NULL
the	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
enhancer	NULL
by	NULL
activation	NULL
of	NULL
the	NULL
nuclear	NULL
factor	NULL
KB	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
.	NULL

86:2336.	NULL
.	NULL

Hazan	NULL
,	NULL
U.	NULL
,	NULL
D.	NULL
Thomas	NULL
,	NULL
J.	NULL
Alcami	NULL
,	NULL
F.	NULL
Bachelerie	NULL
,	NULL
N.	NULL
Israel	NULL
,	NULL
H.	NULL
Yssel	NULL
,	NULL
J.-L.	NULL
Virelizier	NULL
,	NULL
and	NULL
F.	NULL
Arenzana-Seisdedos	NULL
.	NULL

1990	NULL
.	NULL

Stimulation	NULL
of	NULL
a	NULL
human	NULL
T-cell	NULL
clone	NULL
with	NULL
anti-CD3	NULL
or	NULL
tumor	NULL
necrosis	NULL
factor	NULL
induces	NULL
NF-	NULL
«	NULL
B	NULL
translocation	NULL
but	NULL
not	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
1	NULL
enhancer-dependent	NULL
transcription	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
.	NULL

87:7861.	NULL
.	NULL

Carswell	NULL
,	NULL
EA	NULL
.	NULL

,	NULL
L.J	NULL
.	NULL

Old	NULL
,	NULL
R.L	NULL
.	NULL

Kassel	NULL
,	NULL
S.	NULL
Green	NULL
,	NULL
N.	NULL
Fiore	NULL
,	NULL
and	NULL
B.	NULL
Williamson	NULL
.	NULL

1975	NULL
.	NULL

An	NULL
endotoxin-induced	NULL
serum	NULL
factor	NULL
that	NULL
causes	NULL
necrosis	NULL
of	NULL
tumors	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
.	NULL

72:3666	NULL
.	NULL

Goeddel	NULL
,	NULL
DV	NULL
.	NULL

,	NULL
B.B	NULL
.	NULL

Aggarwal	NULL
,	NULL
PW	NULL
.	NULL

Gray	NULL
,	NULL
D.W.	NULL
Leung	NULL
,	NULL
G.E	NULL
.	NULL

Nedwin	NULL
,	NULL
M.A	NULL
.	NULL

Palladino	NULL
,	NULL
J.S	NULL
.	NULL

Patton	NULL
,	NULL
D.	NULL
Pennica	NULL
,	NULL
H.M.	NULL
Shepard	NULL
,	NULL
B.J	NULL
.	NULL

Sugarman	NULL
,	NULL
and	NULL
G.	NULL
Wong	NULL
.	NULL

1986	NULL
.	NULL

Tumor	NULL
necrosis	NULL
factors	NULL
:	NULL
gene	NULL
structure	NULL
and	NULL
biological	NULL
activities	NULL
.	NULL

Cold	NULL
Spring	NULL
Harbor	NULL
Symp	NULL
Quant	NULL
.	NULL

Biol	NULL
.	NULL

60:597	NULL
.	NULL

Beutler	NULL
,	NULL
B.	NULL
,	NULL
and	NULL
A.	NULL
Cerami	NULL
.	NULL

1988	NULL
.	NULL

The	NULL
common	NULL
mediator	NULL
of	NULL
1377	NULL
Goldfeld	NULL
et	NULL
al	NULL
.	NULL

12	NULL
.	NULL

13	NULL
.	NULL

14	NULL
.	NULL

15	NULL
.	NULL

16	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

24.	NULL
shock	NULL
,	NULL
cachexia	NULL
,	NULL
and	NULL
tumor	NULL
necrosis	NULL
.	NULL

Adv	NULL
.	NULL

Immunol	NULL
.	NULL

42:213	NULL
.	NULL

Sung	NULL
,	NULL
S.-S.J	NULL
.	NULL

,	NULL
J.M	NULL
.	NULL

Bjorndahl	NULL
,	NULL
C.Y	NULL
.	NULL

Wang	NULL
,	NULL
HT	NULL
.	NULL

Kao	NULL
,	NULL
and	NULL
S.M	NULL
.	NULL

Fu	NULL
.	NULL

19882	NULL
.	NULL

Production	NULL
of	NULL
tumor	NULL
necrosis	NULL
factor/cachectin	NULL
by	NULL
human	NULL
T	NULL
cell	NULL
lines	NULL
and	NULL
peripheral	NULL
blood	NULL
T	NULL
lymphocytes	NULL
stimulated	NULL
by	NULL
phorbol	NULL
myristate	NULL
and	NULL
anti-CD3	NULL
antibody	NULL
.	NULL

J.	NULL
Exp	NULL
Med	NULL
.	NULL

167:937	NULL
.	NULL

Sung	NULL
,	NULL
S.-S.J	NULL
.	NULL

,	NULL
L.K.L	NULL
.	NULL

Jung	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
Walters	NULL
,	NULL
W.	NULL
Chen	NULL
,	NULL
CY	NULL
.	NULL

Wang	NULL
,	NULL
and	NULL
S.M	NULL
.	NULL

Fu	NULL
.	NULL

1988	NULL
.	NULL

Production	NULL
of	NULL
tumor	NULL
necrosis	NULL
factor/	NULL
cachectin	NULL
by	NULL
human	NULL
B	NULL
cell	NULL
lines	NULL
and	NULL
tonsillar	NULL
B	NULL
cells	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

168:1539	NULL
.	NULL

Goldfeld	NULL
,	NULL
A.E	NULL
.	NULL

,	NULL
and	NULL
T.	NULL
Maniatis	NULL
.	NULL

1989	NULL
.	NULL

Coordinate	NULL
viral	NULL
induction	NULL
of	NULL
tumor	NULL
necrosis	NULL
factor	NULL
«	NULL
&	NULL
and	NULL
interferon	NULL
3	NULL
in	NULL
human	NULL
B	NULL
cells	NULL
and	NULL
monocytes	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
.	NULL

86:1490	NULL
.	NULL

Kinkhabwala	NULL
,	NULL
M.	NULL
,	NULL
P.	NULL
Sehajpal	NULL
,	NULL
E.	NULL
Skolnik	NULL
,	NULL
D.	NULL
Smith	NULL
,	NULL
V.K	NULL
.	NULL

Sharma	NULL
,	NULL
H.	NULL
Vlassara	NULL
,	NULL
A.	NULL
Cerami	NULL
,	NULL
and	NULL
M.	NULL
Suthanthiran	NULL
.	NULL

1990	NULL
.	NULL

A	NULL
novel	NULL
addition	NULL
to	NULL
the	NULL
T	NULL
cell	NULL
repertory	NULL
.	NULL

Cell	NULL
surface	NULL
expression	NULL
of	NULL
tumor	NULL
necrosis	NULL
factor/cachectin	NULL
by	NULL
activated	NULL
normal	NULL
human	NULL
T	NULL
cells	NULL
.	NULL

J.	NULL
Exp	NULL
Med	NULL
.	NULL

171:941	NULL
.	NULL

Goldfeld	NULL
,	NULL
A.E	NULL
.	NULL

,	NULL
C.	NULL
Doyle	NULL
,	NULL
and	NULL
T.	NULL
Maniatis	NULL
.	NULL

1990	NULL
.	NULL

Human	NULL
tumor	NULL
necrosis	NULL
factor	NULL
a	NULL
gene	NULL
regulation	NULL
by	NULL
virus	NULL
and	NULL
lipopolysaccha-ride	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
.	NULL

87:9769	NULL
.	NULL

Goldfeld	NULL
,	NULL
A.E	NULL
.	NULL

,	NULL
K.	NULL
Birch-Limberger	NULL
,	NULL
RT	NULL
.	NULL

Schooley	NULL
,	NULL
and	NULL
B.D	NULL
.	NULL

Walker	NULL
,	NULL
19912	NULL
.	NULL

HIV-1	NULL
infection	NULL
does	NULL
not	NULL
induce	NULL
tumor	NULL
necrosis	NULL
factor-ox	NULL
or	NULL
interferon-	NULL
gene	NULL
transcription	NULL
.	NULL

J	NULL
.	NULL

Acquired	NULL
Immune	NULL
Defic	NULL
.	NULL

Synd	NULL
.	NULL

4:41	NULL
.	NULL

Goldfeld	NULL
,	NULL
A.E	NULL
.	NULL

,	NULL
J.L	NULL
.	NULL

Strominger	NULL
,	NULL
and	NULL
C.	NULL
Doyle	NULL
.	NULL

1991	NULL
.	NULL

Human	NULL
tumor	NULL
necrosis	NULL
factor	NULL
ax	NULL
gene	NULL
regulation	NULL
in	NULL
phorbol	NULL
ester	NULL
stimulated	NULL
T	NULL
and	NULL
B	NULL
cell	NULL
lines	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

174:73	NULL
.	NULL

Goldfeld	NULL
,	NULL
A.E	NULL
.	NULL

,	NULL
EK	NULL
.	NULL

Flemington	NULL
,	NULL
V.A	NULL
.	NULL

Boussiotis	NULL
,	NULL
C.M	NULL
.	NULL

The-odose	NULL
,	NULL
R.G	NULL
.	NULL

Titus	NULL
,	NULL
J.L	NULL
.	NULL

Strominger	NULL
,	NULL
and	NULL
S.H	NULL
.	NULL

Speck	NULL
.	NULL

1992	NULL
.	NULL

Transcription	NULL
of	NULL
the	NULL
TNF-a	NULL
gene	NULL
is	NULL
rapidly	NULL
induced	NULL
by	NULL
anti-immunoglobulin	NULL
and	NULL
blocked	NULL
by	NULL
cyclosporin	NULL
A	NULL
and	NULL
FK506	NULL
in	NULL
human	NULL
B-cells	NULL
.	NULL

Proc	NULL
Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
.	NULL

89:12198	NULL
.	NULL

Abbas	NULL
,	NULL
A.K	NULL
.	NULL

,	NULL
A.H.	NULL
Lichtman	NULL
,	NULL
and	NULL
J.S	NULL
.	NULL

Pober	NULL
.	NULL

1991	NULL
.	NULL

Cellular	NULL
and	NULL
Molecular	NULL
Immunology	NULL
.	NULL

W.B	NULL
.	NULL

Saunders	NULL
Co.	NULL
,	NULL
Philadelphia	NULL
.	NULL

417	NULL
pp	NULL
.	NULL

Rao	NULL
,	NULL
A	NULL
.	NULL

1991	NULL
.	NULL

Signalling	NULL
mechanisms	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

Immunology	NULL
.	NULL

10:495	NULL
.	NULL

Economou	NULL
,	NULL
J.S	NULL
.	NULL

,	NULL
K.	NULL
Rhoades	NULL
,	NULL
R.	NULL
Essner	NULL
,	NULL
W.H	NULL
.	NULL

McBride	NULL
,	NULL
J.C.	NULL
Gasson	NULL
,	NULL
and	NULL
D.L	NULL
.	NULL

Morton	NULL
.	NULL

1989	NULL
.	NULL

Genetic	NULL
analysis	NULL
of	NULL
the	NULL
human	NULL
tumor	NULL
necrosis	NULL
factor	NULL
«	NULL
/cachectin	NULL
promoter	NULL
region	NULL
in	NULL
a	NULL
mac-rophage	NULL
cell	NULL
line	NULL
.	NULL

J.	NULL
Exp	NULL
Med	NULL
.	NULL

170:321	NULL
.	NULL

Hensel	NULL
,	NULL
G.	NULL
,	NULL
A.	NULL
Meichle	NULL
,	NULL
K.	NULL
Pfizenmaier	NULL
,	NULL
and	NULL
M.	NULL
Kronke	NULL
.	NULL

1989	NULL
.	NULL

PMA-responsive	NULL
5	NULL
'	NULL
flanking	NULL
sequences	NULL
of	NULL
the	NULL
human	NULL
TNF	NULL
gene	NULL
.	NULL

Lymphokine	NULL
Res	NULL
.	NULL

8:347	NULL
.	NULL

Leitman	NULL
,	NULL
D.C.	NULL
,	NULL
ER	NULL
.	NULL

Mackow	NULL
,	NULL
T.	NULL
Williams	NULL
,	NULL
J.D	NULL
.	NULL

Baxter	NULL
,	NULL
and	NULL
25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

40	NULL
.	NULL

BL	NULL
.	NULL

West	NULL
.	NULL

1992	NULL
.	NULL

The	NULL
core	NULL
promoter	NULL
region	NULL
of	NULL
the	NULL
tumor	NULL
necrosis	NULL
factor	NULL
x	NULL
gene	NULL
confers	NULL
phorbol	NULL
ester	NULL
responsiveness	NULL
to	NULL
upstream	NULL
transcriptional	NULL
activators	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

12:1352	NULL
.	NULL

Rhoades	NULL
,	NULL
K.L	NULL
.	NULL

,	NULL
S.H	NULL
.	NULL

Golub	NULL
,	NULL
and	NULL
J.S	NULL
.	NULL

Economou	NULL
.	NULL

1992	NULL
.	NULL

The	NULL
regulation	NULL
of	NULL
the	NULL
human	NULL
tumor	NULL
necrosis	NULL
factor	NULL
&	NULL
promoter	NULL
region	NULL
in	NULL
macrophage	NULL
,	NULL
T	NULL
cell	NULL
,	NULL
and	NULL
B	NULL
cell	NULL
lines	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

267:22102	NULL
.	NULL

Leitman	NULL
,	NULL
D.C.	NULL
,	NULL
R.C.J	NULL
.	NULL

Ribeiro	NULL
,	NULL
E.R	NULL
.	NULL

Mackow	NULL
,	NULL
J.D	NULL
.	NULL

Baxter	NULL
,	NULL
and	NULL
BL	NULL
.	NULL

West	NULL
.	NULL

1991	NULL
.	NULL

Identification	NULL
of	NULL
a	NULL
tumor	NULL
necrosis	NULL
factor-responsive	NULL
element	NULL
in	NULL
the	NULL
tumor	NULL
necrosis	NULL
factor	NULL
a	NULL
gene	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

266:9343	NULL
.	NULL

Lenardo	NULL
,	NULL
M.J.	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1989	NULL
.	NULL

NF-	NULL
«	NULL
B	NULL
:	NULL
a	NULL
pleiotropic	NULL
mediator	NULL
of	NULL
inducible	NULL
and	NULL
tissue-specific	NULL
gene	NULL
control	NULL
.	NULL

Cell	NULL
.	NULL

58:227	NULL
.	NULL

Shakhov	NULL
,	NULL
A.N	NULL
.	NULL

,	NULL
M.A	NULL
.	NULL

Collart	NULL
,	NULL
P.	NULL
Vassalli	NULL
,	NULL
S.A.	NULL
Nedospasov	NULL
,	NULL
and	NULL
C.V.	NULL
Jongeneel	NULL
.	NULL

1990	NULL
.	NULL

«	NULL
B-type	NULL
enhancers	NULL
are	NULL
involved	NULL
in	NULL
lipopolysaccharide-mediated	NULL
transcriptional	NULL
activation	NULL
of	NULL
the	NULL
tumor	NULL
necrosis	NULL
factor	NULL
&	NULL
gene	NULL
in	NULL
primary	NULL
macrophages	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

171:35	NULL
.	NULL

Collart	NULL
,	NULL
M.A	NULL
.	NULL

,	NULL
P.	NULL
Baeurele	NULL
,	NULL
and	NULL
P.	NULL
Vassalli	NULL
.	NULL

1990	NULL
.	NULL

Regulation	NULL
of	NULL
tumor	NULL
necrosis	NULL
factor	NULL
&	NULL
transcription	NULL
in	NULL
macrophages	NULL
:	NULL
involvement	NULL
of	NULL
four	NULL
«	NULL
B-like	NULL
motifs	NULL
and	NULL
of	NULL
constitutive	NULL
and	NULL
inducible	NULL
forms	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

10:1498	NULL
.	NULL

Schreiber	NULL
,	NULL
S.L	NULL
.	NULL

1991	NULL
.	NULL

Chemistry	NULL
and	NULL
biology	NULL
of	NULL
the	NULL
immuno-philins	NULL
and	NULL
their	NULL
immunosuppressive	NULL
ligands	NULL
.	NULL

Science	NULL
(	NULL
Wash.	NULL
DC	NULL
)	NULL
.	NULL

251:283	NULL
.	NULL

Tocci	NULL
,	NULL
M.J.	NULL
,	NULL
D.A	NULL
.	NULL

Matkovich	NULL
,	NULL
K.A	NULL
.	NULL

Collier	NULL
,	NULL
P.	NULL
Kwok	NULL
,	NULL
F.	NULL
Dumont	NULL
,	NULL
S.	NULL
Lin	NULL
,	NULL
S.	NULL
Degudicibus	NULL
,	NULL
J.J.	NULL
Siekierka	NULL
,	NULL
and	NULL
N.I	NULL
.	NULL

Hutch-inson	NULL
.	NULL

1989	NULL
.	NULL

The	NULL
immunosuppressant	NULL
FK506	NULL
selectively	NULL
inhibits	NULL
expression	NULL
of	NULL
early	NULL
T	NULL
cell	NULL
activation	NULL
genes	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

143:718	NULL
.	NULL

Santis	NULL
,	NULL
A.G.	NULL
,	NULL
M.R	NULL
.	NULL

Campanero	NULL
,	NULL
J.L	NULL
.	NULL

Alonso	NULL
,	NULL
A.	NULL
Tugores	NULL
,	NULL
M.A	NULL
.	NULL

Alonso	NULL
,	NULL
E.	NULL
Yague	NULL
,	NULL
J.P.	NULL
Pivel	NULL
,	NULL
and	NULL
F.	NULL
Sanchez-Madrid	NULL
.	NULL

1992	NULL
.	NULL

Tumor	NULL
necrosis	NULL
factor-a	NULL
production	NULL
induced	NULL
in	NULL
T	NULL
lymphocytes	NULL
through	NULL
the	NULL
AIM/CD69	NULL
activation	NULL
pathway	NULL
.	NULL

Fur	NULL
J.	NULL
Immunol	NULL
.	NULL

22:1253	NULL
.	NULL

Liu	NULL
,	NULL
J.	NULL
,	NULL
J.D	NULL
.	NULL

Farmer	NULL
,	NULL
W.S	NULL
.	NULL

Lane	NULL
,	NULL
J.	NULL
Friedman	NULL
,	NULL
I.	NULL
Weissman	NULL
,	NULL
and	NULL
S.L	NULL
.	NULL

Schreiber	NULL
.	NULL

1991	NULL
.	NULL

Calcineurin	NULL
is	NULL
a	NULL
common	NULL
target	NULL
of	NULL
cyclophilin-cyclosporin	NULL
A	NULL
and	NULL
FKBP-FK506	NULL
complexes	NULL
.	NULL

Cell	NULL
.	NULL

66:807	NULL
.	NULL

Sigal	NULL
,	NULL
N.H.	NULL
,	NULL
and	NULL
FJ	NULL
.	NULL

Dumont	NULL
.	NULL

1992	NULL
.	NULL

Cyclosporin	NULL
A	NULL
,	NULL
FK-506	NULL
and	NULL
eapamycin	NULL
:	NULL
pharmacological	NULL
probes	NULL
of	NULL
lymphocyte	NULL
signal	NULL
transduction	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

10:519	NULL
.	NULL

Schreiber	NULL
,	NULL
S.L	NULL
.	NULL

,	NULL
and	NULL
G.R	NULL
.	NULL

Crabtree	NULL
.	NULL

1992	NULL
.	NULL

The	NULL
mechanism	NULL
of	NULL
action	NULL
of	NULL
cyclosporin	NULL
A	NULL
and	NULL
FK506	NULL
.	NULL

Immunol	NULL
.	NULL

Today	NULL
.	NULL

13:136	NULL
.	NULL

Mattila	NULL
,	NULL
PS	NULL
.	NULL

,	NULL
K.S	NULL
.	NULL

Ullman	NULL
,	NULL
S.	NULL
Fiering	NULL
,	NULL
E.A	NULL
.	NULL

Emmel	NULL
,	NULL
M.	NULL
McCutcheon	NULL
,	NULL
G.R	NULL
.	NULL

Crabtree	NULL
,	NULL
and	NULL
L.A.	NULL
Herzenberg	NULL
.	NULL

1990	NULL
.	NULL

The	NULL
actions	NULL
of	NULL
cyclosporin	NULL
A	NULL
and	NULL
FK506	NULL
suggest	NULL
a	NULL
novel	NULL
step	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
T	NULL
lymphocytes	NULL
.	NULL

EMBO	NULL
(	NULL
Eur	NULL
.	NULL

Mol	NULL
.	NULL

Biol	NULL
.	NULL

Organ	NULL
.	NULL
)	NULL

J	NULL
.	NULL

94425	NULL
.	NULL

Banerji	NULL
,	NULL
S.S.	NULL
,	NULL
J.N	NULL
.	NULL

Parsons	NULL
,	NULL
and	NULL
M.J.	NULL
Tocei	NULL
.	NULL

1991	NULL
.	NULL

The	NULL
immunosuppressant	NULL
FK-506	NULL
specifically	NULL
inhibits	NULL
mitogen-induced	NULL
activation	NULL
of	NULL
the	NULL
interleukin-2	NULL
promoter	NULL
and	NULL
the	NULL
isolated	NULL
enhancer	NULL
elements	NULL
NFIL-2A	NULL
and	NULL
NF-AT1	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

11:4074	NULL
.	NULL

O'Keefe	NULL
,	NULL
S.J	NULL
.	NULL

,	NULL
J.	NULL
Tamura	NULL
,	NULL
R.L	NULL
.	NULL

Kincaid	NULL
,	NULL
M.J.	NULL
Tocci	NULL
,	NULL
and	NULL
E.A	NULL
.	NULL

O'Neill	NULL
.	NULL

1992	NULL
.	NULL

FK-506-	NULL
and	NULL
CsA-sensitive	NULL
activation	NULL
of	NULL
the	NULL
interleukin-2	NULL
promoter	NULL
by	NULL
calcineurin	NULL
.	NULL

Nature	NULL
(	NULL
Lond	NULL
.	NULL
)	NULL

.	NULL

357:692	NULL
.	NULL

Clipstone	NULL
,	NULL
N.A	NULL
.	NULL

,	NULL
and	NULL
G.A	NULL
.	NULL

Crabtree	NULL
.	NULL

1992	NULL
.	NULL

Identification	NULL
of	NULL
calcineurin	NULL
as	NULL
a	NULL
key	NULL
signalling	NULL
enzyme	NULL
in	NULL
T-lymphocyte	NULL
activation	NULL
.	NULL

Nature	NULL
(	NULL
Lond	NULL
.	NULL
)	NULL

.	NULL

357:695	NULL
.	NULL

Shaw	NULL
,	NULL
J.-P.	NULL
,	NULL
P.J	NULL
.	NULL

Utz	NULL
,	NULL
D.B	NULL
.	NULL

Durand	NULL
,	NULL
J.J.	NULL
Toole	NULL
,	NULL
E.A	NULL
.	NULL

Emmel	NULL
,	NULL
and	NULL
G.R	NULL
.	NULL

Crabtree	NULL
.	NULL

1988	NULL
.	NULL

Identification	NULL
of	NULL
a	NULL
putative	NULL
regulator	NULL
of	NULL
early	NULL
T	NULL
cell	NULL
activation	NULL
genes	NULL
.	NULL

Science	NULL
(	NULL
Wash.	NULL
DC	NULL
)	NULL
.	NULL

241:202	NULL
.	NULL

1378	NULL
41	NULL
.	NULL

42	NULL
.	NULL

43	NULL
.	NULL

44	NULL
.	NULL

45	NULL
.	NULL

46	NULL
.	NULL

47	NULL
.	NULL

48	NULL
.	NULL

49	NULL
.	NULL

50	NULL
.	NULL

51	NULL
.	NULL

52	NULL
.	NULL

53	NULL
.	NULL

54	NULL
.	NULL

55	NULL
.	NULL

56	NULL
.	NULL

57	NULL
.	NULL

58	NULL
.	NULL

59	NULL
.	NULL

60	NULL
Flanagan	NULL
,	NULL
W.M	NULL
.	NULL

,	NULL
B.	NULL
Corthesy	NULL
,	NULL
R.J.	NULL
Bram	NULL
,	NULL
and	NULL
G.R	NULL
.	NULL

Crabtree	NULL
.	NULL

1991	NULL
.	NULL

Nuclear	NULL
association	NULL
of	NULL
a	NULL
T-cell	NULL
transcription	NULL
factor	NULL
blocked	NULL
by	NULL
FK-506	NULL
and	NULL
cyclosporin	NULL
A	NULL
.	NULL

Nature	NULL
(	NULL
Lond	NULL
.	NULL
)	NULL

.	NULL

352:803	NULL
.	NULL

Jain	NULL
,	NULL
J.	NULL
,	NULL
P.G	NULL
.	NULL

McCaffrey	NULL
,	NULL
V.E	NULL
.	NULL

Valge-Archer	NULL
,	NULL
and	NULL
A.	NULL
Rao	NULL
.	NULL

1992	NULL
.	NULL

Nuclear	NULL
factor	NULL
of	NULL
activated	NULL
T	NULL
cells	NULL
contains	NULL
Fos	NULL
and	NULL
Jun	NULL
.	NULL

Nature	NULL
(	NULL
Lond	NULL
.	NULL
)	NULL

.	NULL

356:801	NULL
.	NULL

McCaffrey	NULL
,	NULL
PG	NULL
.	NULL

,	NULL
B.A	NULL
.	NULL

Perrino	NULL
,	NULL
T.R	NULL
.	NULL

Soderling	NULL
,	NULL
and	NULL
A.	NULL
Rao	NULL
.	NULL

1993	NULL
.	NULL

NF-ATp	NULL
,	NULL
a	NULL
T	NULL
lymphocyte	NULL
DNA-binding	NULL
protein	NULL
that	NULL
is	NULL
a	NULL
target	NULL
for	NULL
calcineurin	NULL
and	NULL
immunosuppressive	NULL
drugs	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

268:3747	NULL
.	NULL

Ullman	NULL
,	NULL
K.S	NULL
.	NULL

,	NULL
J.P.	NULL
Northrop	NULL
,	NULL
A.	NULL
Admon	NULL
,	NULL
and	NULL
G.A	NULL
.	NULL

Crabtree	NULL
.	NULL

1993	NULL
.	NULL

Jun	NULL
family	NULL
members	NULL
are	NULL
controlled	NULL
by	NULL
a	NULL
calcium-regulated	NULL
cyclosporin	NULL
A-sensitive	NULL
signaling	NULL
pathway	NULL
in	NULL
activated	NULL
T	NULL
lymphocytes	NULL
.	NULL

Genes	NULL
&	NULL
Dev	NULL
.	NULL

7:188	NULL
.	NULL

Jain	NULL
,	NULL
J.	NULL
,	NULL
PG	NULL
.	NULL

McCaffrey	NULL
,	NULL
Z	NULL
.	NULL

Miner	NULL
,	NULL
T.K	NULL
.	NULL

Kerppola	NULL
,	NULL
J.N	NULL
.	NULL

Lam-bert	NULL
,	NULL
G.L	NULL
.	NULL

Verdine	NULL
,	NULL
T.	NULL
Curran	NULL
,	NULL
and	NULL
A.	NULL
Rao	NULL
.	NULL

1993	NULL
.	NULL

The	NULL
T	NULL
cell	NULL
transcription	NULL
factor	NULL
NFATp	NULL
is	NULL
a	NULL
substrate	NULL
for	NULL
calcineurin	NULL
and	NULL
interacts	NULL
with	NULL
the	NULL
DNA-binding	NULL
domains	NULL
of	NULL
fos	NULL
and	NULL
jun	NULL
.	NULL

Nature	NULL
(	NULL
Lond	NULL
)	NULL
.	NULL

In	NULL
press	NULL
.	NULL

Valge	NULL
,	NULL
V.E	NULL
.	NULL

,	NULL
G.J.P	NULL
.	NULL

Wong	NULL
,	NULL
BM	NULL
.	NULL

Datlof	NULL
,	NULL
A.J	NULL
.	NULL

Sinskey	NULL
,	NULL
and	NULL
A.	NULL
Rao	NULL
.	NULL

1988	NULL
.	NULL

Protein	NULL
kinase	NULL
C	NULL
is	NULL
required	NULL
for	NULL
responses	NULL
to	NULL
T	NULL
cell	NULL
receptor	NULL
ligands	NULL
but	NULL
not	NULL
to	NULL
interleukin-2	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

Cell	NULL
55:101	NULL
.	NULL

Jain	NULL
,	NULL
J.	NULL
,	NULL
V.E	NULL
.	NULL

Valge-Archer	NULL
,	NULL
and	NULL
A.	NULL
Rao	NULL
.	NULL

1992	NULL
.	NULL

Analysis	NULL
of	NULL
the	NULL
AP-1	NULL
sites	NULL
in	NULL
the	NULL
IL-2	NULL
promoter	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

148:1240	NULL
.	NULL

Rao	NULL
,	NULL
A.	NULL
,	NULL
S.J	NULL
.	NULL

Faas	NULL
,	NULL
and	NULL
H.	NULL
Cantor	NULL
.	NULL

1984	NULL
.	NULL

Activation	NULL
specificity	NULL
of	NULL
arsonate-reactive	NULL
T	NULL
cell	NULL
clones	NULL
.	NULL

Structural	NULL
requirements	NULL
for	NULL
hapten	NULL
recognition	NULL
and	NULL
comparison	NULL
with	NULL
monoclonal	NULL
anti-bodies	NULL
.	NULL

J.	NULL
Exp	NULL
Med	NULL
.	NULL

159:479	NULL
.	NULL

McCaffrey	NULL
,	NULL
PG	NULL
.	NULL

,	NULL
J.	NULL
Jain	NULL
,	NULL
C.	NULL
Jamieson	NULL
,	NULL
R.	NULL
Sen	NULL
,	NULL
and	NULL
A.	NULL
Rao	NULL
.	NULL

1992	NULL
.	NULL

A	NULL
T	NULL
cell	NULL
nuclear	NULL
factor	NULL
ensembling	NULL
NF-AT	NULL
binds	NULL
to	NULL
an	NULL
NF-KB	NULL
site	NULL
and	NULL
to	NULL
the	NULL
conserved	NULL
lymphokine	NULL
promoter	NULL
sequence	NULL
``	NULL
cytokine-1	NULL
.	NULL
``	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

267:1864	NULL
.	NULL

Flemington	NULL
,	NULL
EK	NULL
.	NULL

,	NULL
A.E	NULL
.	NULL

Goldfeld	NULL
,	NULL
and	NULL
S.H	NULL
.	NULL

Speck	NULL
.	NULL

1991	NULL
.	NULL

Efficient	NULL
transcription	NULL
of	NULL
the	NULL
Epstein-Barr	NULL
virus	NULL
immediate-early	NULL
BZF1	NULL
and	NULL
BRLF1	NULL
genes	NULL
requires	NULL
protein	NULL
synthesis	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

65:7073	NULL
.	NULL

Zinn	NULL
,	NULL
K.	NULL
,	NULL
D.	NULL
KiMaio	NULL
,	NULL
and	NULL
T.	NULL
Maniatis	NULL
.	NULL

1983	NULL
.	NULL

Identification	NULL
of	NULL
two	NULL
distinct	NULL
regulatory	NULL
regions	NULL
adjacent	NULL
to	NULL
the	NULL
human	NULL
B-interferon	NULL
gene	NULL
.	NULL

Cell	NULL
.	NULL

34:865	NULL
.	NULL

Enoch	NULL
,	NULL
T.	NULL
,	NULL
K.	NULL
Zinn	NULL
,	NULL
and	NULL
T.	NULL
Maniatis	NULL
.	NULL

1986	NULL
.	NULL

Activation	NULL
of	NULL
the	NULL
human	NULL
3-interferon	NULL
gene	NULL
requires	NULL
an	NULL
interferon	NULL
inducible	NULL
factor	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

6:801	NULL
.	NULL

Prost	NULL
,	NULL
E.	NULL
,	NULL
and	NULL
D.	NULL
Moore	NULL
.	NULL

1986	NULL
.	NULL

CAT	NULL
vectors	NULL
for	NULL
analysis	NULL
of	NULL
eukaryotic	NULL
promoters	NULL
and	NULL
enhancers	NULL
.	NULL

Gene	NULL
.	NULL

45:107	NULL
.	NULL

Bours	NULL
,	NULL
V.	NULL
,	NULL
P.R	NULL
.	NULL

Burd	NULL
,	NULL
K.	NULL
Brown	NULL
,	NULL
J.	NULL
Villalobos	NULL
,	NULL
S.	NULL
Park	NULL
,	NULL
R.-P.	NULL
Ryseck	NULL
,	NULL
R.	NULL
Bravo	NULL
,	NULL
K.	NULL
Kelly	NULL
,	NULL
and	NULL
U.	NULL
Siebenlist	NULL
.	NULL

1992	NULL
.	NULL

A	NULL
novel	NULL
mitogen-inducible	NULL
gene	NULL
product	NULL
related	NULL
to	NULL
p50-p105-NF-	NULL
«	NULL
B	NULL
participates	NULL
in	NULL
transactivation	NULL
through	NULL
a	NULL
KB	NULL
site	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

12:685	NULL
.	NULL

Brown	NULL
,	NULL
K.	NULL
,	NULL
S.	NULL
Park	NULL
,	NULL
T.	NULL
Kanno	NULL
,	NULL
G.	NULL
Franzoso	NULL
,	NULL
and	NULL
U.	NULL
Siebenlist	NULL
.	NULL

1993	NULL
.	NULL

Mutual	NULL
regulation	NULL
of	NULL
the	NULL
transcriptional	NULL
activator	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
its	NULL
inhibitor	NULL
,	NULL
IxB-ax	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
.	NULL

90:2532	NULL
.	NULL

Rice	NULL
,	NULL
N.R	NULL
.	NULL

,	NULL
M.L	NULL
.	NULL

MacKichan	NULL
,	NULL
and	NULL
A.	NULL
Israel	NULL
.	NULL

1992	NULL
.	NULL

The	NULL
precursor	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
p50	NULL
has	NULL
IxB-like	NULL
functions	NULL
.	NULL

Cell	NULL
.	NULL

71:243	NULL
.	NULL

Pognonec	NULL
,	NULL
P.	NULL
,	NULL
K.E	NULL
.	NULL

Boulukos	NULL
,	NULL
and	NULL
J.	NULL
Ghyscael	NULL
.	NULL

1989	NULL
.	NULL

The	NULL
c-ets-1	NULL
protein	NULL
is	NULL
chromatin	NULL
associated	NULL
and	NULL
binds	NULL
to	NULL
DNA	NULL
in	NULL
vitro	NULL
.	NULL

Oncogene	NULL
.	NULL

4:691	NULL
.	NULL

Mittnacht	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
R.A.	NULL
Weinberg	NULL
.	NULL

1991	NULL
.	NULL

G1/S	NULL
phosphoryla-tion	NULL
of	NULL
the	NULL
retinoblastoma	NULL
protein	NULL
is	NULL
associated	NULL
with	NULL
an	NULL
altered	NULL
affinity	NULL
for	NULL
the	NULL
nuclear	NULL
compartment	NULL
.	NULL

Cell	NULL
.	NULL

65:381	NULL
.	NULL

Crabtree	NULL
,	NULL
G.R	NULL
.	NULL

1989	NULL
.	NULL

Contingent	NULL
genetic	NULL
regulatory	NULL
events	NULL
in	NULL
T	NULL
lymphocyte	NULL
activation	NULL
.	NULL

Science	NULL
(	NULL
Wash.	NULL
DC	NULL
)	NULL
.	NULL

243:355.	NULL
.	NULL

Ullman	NULL
,	NULL
K.S	NULL
.	NULL

,	NULL
J.P.	NULL
Northrop	NULL
,	NULL
C.L	NULL
.	NULL

Verweij	NULL
,	NULL
and	NULL
G.R	NULL
.	NULL

Crab	NULL
Novel	NULL
CsA-sensitive	NULL
Element	NULL
in	NULL
Human	NULL
TNF-	NULL
Gene	NULL
Promoter	NULL
61	NULL
.	NULL

62	NULL
.	NULL

63	NULL
.	NULL

64	NULL
.	NULL

65.	NULL
tree	NULL
.	NULL

1990	NULL
.	NULL

Transmission	NULL
of	NULL
signals	NULL
from	NULL
the	NULL
T	NULL
lymphocyte	NULL
antigen	NULL
receptor	NULL
to	NULL
the	NULL
genes	NULL
responsible	NULL
for	NULL
cell	NULL
proliferation	NULL
and	NULL
immune	NULL
function	NULL
:	NULL
the	NULL
missing	NULL
link	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

8:421	NULL
.	NULL

Hivroz-Burgaud	NULL
,	NULL
C.	NULL
,	NULL
N.A	NULL
.	NULL

Clipstone	NULL
,	NULL
and	NULL
D.A	NULL
.	NULL

Cantrell	NULL
.	NULL

1991	NULL
.	NULL

Signalling	NULL
requirements	NULL
for	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
transactivating	NULL
factor	NULL
NF-AT	NULL
in	NULL
human	NULL
T	NULL
lymphocytes	NULL
.	NULL

Euz	NULL
J.	NULL
Immunol	NULL
.	NULL

21	NULL
:	NULL
2811	NULL
.	NULL

Jain	NULL
,	NULL
J.	NULL
,	NULL
Z	NULL
.	NULL

Miner	NULL
,	NULL
and	NULL
A.	NULL
Rao	NULL
.	NULL

1993	NULL
.	NULL

Analysis	NULL
of	NULL
the	NULL
preexisting	NULL
and	NULL
nuclear	NULL
forms	NULL
of	NULL
NF-AT	NULL
(	NULL
nuclear	NULL
factor	NULL
of	NULL
activated	NULL
T	NULL
cells	NULL
)	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

In	NULL
press	NULL
.	NULL

Serfling	NULL
,	NULL
E.	NULL
,	NULL
R.	NULL
Barthelmas	NULL
,	NULL
I.	NULL
Pfeuffer	NULL
,	NULL
B.	NULL
Schenk	NULL
,	NULL
S.	NULL
Zarius	NULL
,	NULL
R.	NULL
Swoboda	NULL
,	NULL
F.	NULL
Mercurio	NULL
,	NULL
and	NULL
M.	NULL
Karin	NULL
.	NULL

1989	NULL
.	NULL

Ubiquitous	NULL
and	NULL
lymphocyte-specific	NULL
factors	NULL
are	NULL
involved	NULL
in	NULL
the	NULL
induction	NULL
of	NULL
the	NULL
mouse	NULL
interleukin	NULL
2	NULL
gene	NULL
in	NULL
T	NULL
lymphocytes	NULL
.	NULL

EMBO	NULL
(	NULL
Eur	NULL
.	NULL

Mol	NULL
.	NULL

Biol	NULL
.	NULL

Organ	NULL
.	NULL
)	NULL

J	NULL
.	NULL

8:465	NULL
.	NULL

Randak	NULL
,	NULL
C.	NULL
,	NULL
T.	NULL
Brabletz	NULL
,	NULL
M.	NULL
Hergenrother	NULL
,	NULL
I.	NULL
Sobotta	NULL
,	NULL
and	NULL
E.	NULL
Serfling	NULL
.	NULL

1990	NULL
.	NULL

Cyclosporin	NULL
A	NULL
suppresses	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
interleukin	NULL
2	NULL
gene	NULL
by	NULL
inhibiting	NULL
the	NULL
binding	NULL
or	NULL
lymphocyte-specific	NULL
factors	NULL
to	NULL
the	NULL
II	NULL
>	NULL
2	NULL
enhancer	NULL
.	NULL

EMBO	NULL
(	NULL
Eur	NULL
.	NULL

Mol	NULL
.	NULL

Biol	NULL
.	NULL

Organ	NULL
.	NULL
)	NULL

J	NULL
.	NULL

9:2529	NULL
.	NULL

Kehrl	NULL
,	NULL
J.H	NULL
.	NULL

,	NULL
A.	NULL
Miller	NULL
,	NULL
and	NULL
A.S.	NULL
Fauci	NULL
.	NULL

1987	NULL
.	NULL

Effect	NULL
of	NULL
tumor	NULL
necrosis	NULL
factor	NULL
&	NULL
on	NULL
mitogen-activated	NULL
human	NULL
B	NULL
cells	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

1379	NULL
Goldfeld	NULL
et	NULL
al	NULL
.	NULL

66	NULL
.	NULL

67	NULL
.	NULL

68	NULL
.	NULL

69	NULL
.	NULL

70	NULL
.	NULL

71	NULL
.	NULL

Med	NULL
.	NULL

166:786	NULL
.	NULL

Caux	NULL
,	NULL
C.	NULL
,	NULL
C.	NULL
Dezutter-Dambuyant	NULL
,	NULL
D.	NULL
Schmitt	NULL
,	NULL
and	NULL
J.	NULL
Ban-chereau	NULL
.	NULL

1992	NULL
.	NULL

GM-CSF	NULL
and	NULL
TNF-a	NULL
cooperate	NULL
in	NULL
the	NULL
generation	NULL
of	NULL
dendritic	NULL
Langerhans	NULL
cells	NULL
.	NULL

Nature	NULL
(	NULL
Lond	NULL
.	NULL
)	NULL

.	NULL

360:258	NULL
.	NULL

Folks	NULL
,	NULL
TM	NULL
.	NULL

,	NULL
K.A	NULL
.	NULL

Clouse	NULL
,	NULL
J.	NULL
Justement	NULL
,	NULL
A.	NULL
Rabson	NULL
,	NULL
E.	NULL
Duh	NULL
,	NULL
J.H	NULL
.	NULL

Kehrl	NULL
,	NULL
and	NULL
A.S.	NULL
Fauci	NULL
.	NULL

1989	NULL
.	NULL

Tumor	NULL
necrosis	NULL
factor	NULL
a	NULL
induces	NULL
expression	NULL
of	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
in	NULL
a	NULL
chronically	NULL
infected	NULL
T-cell	NULL
clone	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
.	NULL

86:2365	NULL
.	NULL

Miethke	NULL
,	NULL
T.	NULL
,	NULL
C.	NULL
Wahl	NULL
,	NULL
K.	NULL
Heeg	NULL
,	NULL
B.	NULL
Echtenacher	NULL
,	NULL
P.H	NULL
.	NULL

Krammer	NULL
,	NULL
and	NULL
H.	NULL
Wagner	NULL
.	NULL

1992	NULL
.	NULL

T	NULL
cell-mediated	NULL
lethal	NULL
shock	NULL
triggered	NULL
in	NULL
mice	NULL
by	NULL
the	NULL
superantigen	NULL
staphylococcal	NULL
enterotoxin	NULL
B	NULL
:	NULL
critical	NULL
role	NULL
of	NULL
tumor	NULL
necrosis	NULL
factor	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

175:91	NULL
.	NULL

Tsuchida	NULL
,	NULL
A.	NULL
,	NULL
H.	NULL
Salem	NULL
,	NULL
N.	NULL
Thomson	NULL
,	NULL
and	NULL
W.W.	NULL
Hancock	NULL
.	NULL

1992	NULL
.	NULL

Tumor	NULL
necrosis	NULL
factor	NULL
production	NULL
during	NULL
human	NULL
renal	NULL
allograft	NULL
rejection	NULL
is	NULL
associated	NULL
with	NULL
depression	NULL
of	NULL
plasma	NULL
protein	NULL
C	NULL
and	NULL
free	NULL
protein	NULL
S	NULL
levels	NULL
and	NULL
decreased	NULL
intragraft	NULL
throm-bomodulin	NULL
expression	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

175:81	NULL
.	NULL

Bolling	NULL
,	NULL
S.F	NULL
.	NULL

,	NULL
S.L	NULL
.	NULL

Kunkel	NULL
,	NULL
and	NULL
H.	NULL
Lin	NULL
.	NULL

1992	NULL
.	NULL

Prolongation	NULL
of	NULL
cardiac	NULL
allograft	NULL
survival	NULL
in	NULL
rats	NULL
by	NULL
anti-TNF	NULL
and	NULL
cyclospo-rine	NULL
combination	NULL
therapy	NULL
.	NULL

Transplantation	NULL
(	NULL
Baltimore	NULL
)	NULL
.	NULL

53:283	NULL
.	NULL

Titus	NULL
,	NULL
R.G	NULL
.	NULL

,	NULL
B.	NULL
Sherry	NULL
,	NULL
and	NULL
A.	NULL
Cerami	NULL
.	NULL

1991	NULL
.	NULL

The	NULL
involvement	NULL
of	NULL
TNF	NULL
,	NULL
IL-1	NULL
and	NULL
IL-6	NULL
in	NULL
the	NULL
immune	NULL
response	NULL
to	NULL
protozoan	NULL
parasites	NULL
.	NULL

Immunol	NULL
.	NULL

Today	NULL
.	NULL

12:13	NULL
.	NULL

